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Abstract 
ABSTRACT 
A third of the world's population (2,000 million people) is infected with 
tuberculosis (TB)[1] and in 2000, there were an estimated 8.3 million new 
cases of TB. [2] After a few decades of neglect, it has re-emerged as a global 
emergency in 1993[1] when it combined with HIV. The two main control 
measures emphasised by World Health Organisation (WHO) are improved case 
detection and cure rates. High case detection level, especially of smear 
positive cases, is of great importance to decrease personal suffering, risk of 
death and limit transmission in the community. However, TB is also a social 
disease and many social aspects greatly influence TB control programme. One 
such aspect is the patients' understanding of their symptoms and their 
assessment of health care resources which further affect their health seeking 
behaviour. [3] 
Malaysia is a country with intermediate burden of TB. [4] However, Sabah, one 
of the two states in East Malaysia has a notification rate of two and a half 
times that of the country's and contributes one third of the total cases. [5] 
Two studies have been conducted in West Malaysia on delay among TB 
patients but no such study has been done in East Malaysia. This research was 
conducted in 2 phases over a period of one year in 10 out of 23 districts in 
Sabah, East Malaysia. Phase I utilised a qualitative approach of face to face 
interviews to get a better understanding of the perception and health seeking 
behaviour of TB patients and those involved in their care. A total of 32 
individuals (PTB patients, relatives and members of their communities) were 
interviewed. The findings also informed the questionnaire used in the cross 
sectional study in phase 2, conducted among 296 newly registered smear 
positive TB patients. The questionnaire was used to collect information on the 
different factors that affect the time period from onset of symptoms to start 
of TB treatment. 
In this study, the percentage of patients who sought treatment after 30 days 
was 51.8% (95% Cl: 45.9 - 57.8) and the median patient time period was 60 
days. After adjustment of confounders using multivariate analysis, those 
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whose usual first treatment choice was a non-government health facility were 
twice as likely to have patient delay than those whose usual first choice was a 
government facility (Adjusted OR: 2.28, CI: 1.03 - 5.06). This is in contrast to 
a study conducted in Penang, West Malaysia where it was found that being 
mate, those with lower than secondary education and misusing drugs were 
more likely to have patient delay. The median for doctor time period was 20 
days and almost 43% of the respondents were put on treatment within 14 days 
of being seen by a medical doctor. In the multivariate analysis for doctor 
delay, those who had never used government facility, had chest pain and loss 
of weight were twice more likely to be associated with doctor delay. A repeat 
visit to the first provider was associated with an approximately 4 times 
greater risk of doctor delay than those who did not (AOR: 3.88, Cl: 1.79 - 
8.39). In the Penang study, West Malaysia, those whose first consultation were 
at government clinics had shorter doctor delay compared to those who 
consulted private practitioners. 
Recommendations for improvement of current public health practice for the 
control of TB include ensuring greater awareness and adherence to existing 
guidelines on the management of TB patients by both government and private 
doctors. This will lead to high index of suspicion for TB among patients with 
cough thus ensuring timely sputum examinations. There is also the need for 
continuous health education on TB aim at raising awareness and at correcting 
misconceptions regarding cause, transmission and infectivity which will lessen 
stigma towards TB patients. The research findings on the patient and doctor 
delay can be -used as baseline data to monitor improvement in health 
promotion activities and health service provision. This research found that 
around 43% of the respondents have no doctor delay of 14 days. A Quality 
Assurance Programme (QAP) can be developed to shorten doctor delay and 
such efforts would limit the period of infectiousness of the patient and thus 
the transmission to contacts. 
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Integrating statement about DrPH 
DrPH programme would most likely appeal to someone with management and 
public health background. Its three components presented a wide range of 
opportunities to (earn both formally and informally through classroom 
discussions, interaction with colleagues in the school and during the 
Professional Attachment and through conducting research. However, these 
exciting opportunities demanded patience, management skills and ability to 
learn and adapt. 
The components of the DrPH programme are (1) Compulsory teaching units 
and three other units, (2) Professional Attachment and (3) Research. The 
compulsory teaching units consisted of (a) Evidence based Public Health 
Practice (2 units) and (b) Leadership, Management and Development. These 
units enabled me to consolidate previous understanding on public health and 
management and presented new ways of thinking on policy matters. The units 
on evidence based public health practice were particularly important in 
developing the skills on ways to influence policy makers through the 
understanding of processes in policy making and utilising evidence such as 
research findings. This understanding proved invaluable especially during my 
professional attachment and facilitated the analysis of policy making 
processes and the roles of different stakeholders. During the sessions on 
Leadership, Management and Development, there were many occasions to 
reflect upon my own management skills and leadership styles. In addition, 
there was the added advantage of interaction and discussion with other 
colleagues and lecturers who shared similar interests in management and 
public health. 
Most DrPH students started with the compulsory units but due to late 
registration, I started with these three units: 
a. Study Design: Writing a Study Proposal 
b. Statistical Methods in Epidemiology (SME) and 
c. Epidemiology It Control of Communicable Diseases (ECCD). 
Integrating statement about DrPH 
They were handpicked to help me later on with my research on TB. The first 
study unit allowed me to address issues surrounding research design white the 
ECCD unit helped with epidemiological issues and thinking processes. SME 
proved invaluable especially during data analysis. 
My professional attachment took me for the first time to Cambodia where I 
was attached to CENAT, the National Centre for Control of Tuberculosis and 
Leprosy for 3 months. The strategies adopted in the TB Control Programme in 
Cambodia was similar to that in Malaysia with one obvious difference; many 
stakeholders were involved with the control programme including local and 
international non-governmental organisations. I decided to learn and write 
about the relationship and interaction between the different stakeholders. 
This stakeholder analysis provided a map, of interest, power and influence of 
the various stakeholders. My professional attachment report also discussed 
policy making within the MOH and CENAT in relation to two important events; 
the health sector reform and the adoption of DOTS strategy. It also 
highlighted organisation design, culture and leadership issues and by 
dissecting these issues, a meaningful SWOT (Strength, Weakness, Opportunity 
and Threat) analysis was performed. The recommendations made did not 
address singular issue but the broader aspects of all the issues. 
I proceeded with my field work soon after the professional attachment and 
spent 8 months conducting my research in Sabah, East Malaysia. I have worked 
in Sabah for the whole of my career life, from being a doctor in several 
hospitals to being a public health officer in several area health units. I have, 
in the past learned so much by being hands-on with my job and yet, learned 
so much more by doing my research on TB. It provided a different perspective 
of looking at life in general, gave insight to patients' lives which were rarely 
shared with outsiders and became a neutral spectator in the health provider- 
patient-community relationship. The process of doing research was an arduous 
task requiring patience, perseverance and dedication. My experience in 
conducting this research which involved both qualitative and quantitative 
approaches demanded the continuous process of making informed decision, 
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trying out new approaches and refining the understanding on theories and the 
thinking processes. Using both approaches gave a better picture of the health 
and health care seeking behaviour of TB patients. At its completion, there 
was an indescribable sense of achievement. However, despite spending three 
and a half years in such an extensive learning process, the words of Will 
Durant reflect my current sentiment, "Sixty years ago I knew everything; now 
l know nothing; education is a progressive discovery of our own ignorance. " 
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I Chapter 1: Background and rationale 
This chapter introduces the reason for the study on time period from the 
onset of symptoms to the start of treatment for TB patients and the need to 
identify possible explanatory factors for delay from onset of symptoms to 
presentation at health care provider (patient delay) and from consultation 
with a doctor to the commencement of treatment (doctor delay). It also 
describes the background for the research in terms of the epidemiology of TB, 
the DOTS strategy, the health care system and the TB Control Programme. 
1.1 Public health problem 
TB is a disease of ancient times; DNA analysis of tissue samples from 
mummified bodies and skeletal remains revealed that TB has inflicted 
humankind for more than 5000 years. [6] However, it continues to puzzle 
researchers and policy makers even today. This is because, although the 
organism responsible for TB has been known for 124 years and treatment for 
TB is available, TB remains a public health problem. TB is one of the most 
important yet neglected international health priorities. [7] The reduced 
numbers of TB cases in developed nations may partly contribute to this 
neglect. In most developed countries, a 'natural' decline in TB mortality over 
several decades occurred which could not be specifically attributed to any 
specific measures. However, due to scanty and unreliable data on TB 
mortality among developing countries, annual infection rates a for these 
countries have been used instead which show no 'natural' decline. However, 
if specific control measures such as early detection and compliance with 
treatment were taken, a decrease will be observed. [8] Today, TB is 
responsible for between 2.2 and 3 million deaths annually including at least 
100,000 children throughout the world. [1] Eight million people a year are 
infected and a third of the world's population have already been infected. [1, 
9] 
a Annual Infection Rate; this is calculated from prevalence surveys. Source: 
http: //www. who. int/healthinfo/statistics/indtbincidence/en/index. html 
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The potential threat of TB was realised in the wake of the HIV epidemic. HIV 
is the strongest risk factor for TB in infected subjects. [10] Due to this and the 
absence of a solution to face the two combined diseases, in April 1993, WHO 
declared TB a global emergency. [11] 
TB is a contagious disease. A person can be infected at any age and may 
remain so for a long time. About 5-10% of those infected will get TB disease 
and become infectious at some time in their lives. Over 90% of smear positive 
cases develop cough not long after the onset of disease. [2] However, cough is 
not specific to TB; it is also a prominent symptom in other respiratory tract 
infections and may be a constant irritation among smokers. The non-specific 
and non-threatening early symptoms of TB may have resulted in infectious 
persons not seeking treatment early. 
Studies by Shaw et at, Grzybowski et at and Van Geuns et at have confirmed 
that patients with sputum smear positive pulmonary TB are more infectious 
that sputum negative PTB patients. [12] Therefore, it is more important to 
limit the duration of infectiousness of smear positive patients. Rouillon et at 
found that the proportion of contacts infected at the usual time of diagnosis 
of a sputum smear positive patient is around 30 to 40%. [12] This proportion 
would naturally be higher if the patient was left undiagnosed. The major 
factors that determine the risk of becoming exposed to tubercle bacilli 
include not just the `pool' of infectious cases in the community but also the 
duration of their infectiousness and the number and nature of interactions 
between a TB case and a susceptible contact per unit of time of 
infectiousness. [12] 
A shorter time period from onset of symptoms to presentation at health care 
provider and eventually to commencement of treatment is the aim in 
managing the control of TB. This will decrease suffering and the risk of death 
among the patients and those affected by his/her disease and in addition 
17 
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decrease the risk of spread to contacts and the community. These effects are 
elaborated on here. 
1.1.1 Suffering and risk of death 
The sufferings of TB patients have been reported throughout the history of TB. 
Perhaps, the worse kind of suffering, aside from physical and economic, is 
rejection as a result of the stigma associated with TB which have been 
documented in many studies. [3,13-18] This will be discussed in more detail in 
Chapter 2. 
Case fatality rates among TB sufferers are high in the absence of appropriate 
chemotherapy. Studies in developed countries by Drotet, Lindhart, Gattung 
Hansen showed this rate to be consistently in the 50 to 60% range. The same 
5-year study in India demonstrated that 49% of confirmed cases (smear and 
culture positive or smear negative but culture positive) died within 5 
years[19], the majority of them actually died in the first 18 months, 33% 
recover spontaneously and the remaining 18% still have positive sputum[20, 
21]. Case fatality rate for smear positive TB is even higher; Rutledge Et Crouch 
and Lindhart noted this to be 66%[19] after a period of 4 years. [21] Two thirds 
of undiagnosed and untreated patients with smear positive TB die within 2 
years of development of the disease. [22] 
1.1.2 Financial burden on the patient and family 
TB affects patients and their families economically in both direct and indirect 
ways. The direct cost mainly include the cost of treatment white TB indirectly 
affects the patients financially such as through loss of work. Several studies 
have assessed the financial burden of TB on its patients such as described 
here. 
A study done in India where the mean monthly income of the study population 
was (Rupees)' Rs. 875 ± SD 1148 showed that the mean direct cost for getting 
treated for TB was Rs. 2052, indirect cost was Rs. 3934 and the total cost was 
b One USD is approximately 40.7 Indian rupees 
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Rs. 5986 (USD171), which is 40% of the annual family income. The mean 
number of work days lost was 83. Sixty seven percents of rural and 75% of 
urban patients borrowed money on account of the disease and mean debts 
was estimated to be Rs. 2079. Among school children with affected parents, 
11% discontinued their studies and an additional 8% took up employment to 
support their family. [23] In another small study in neighbouring Bangladesh, 
the mean financial loss to a village patient was estimated to be very high at 
USD245. [24] In Thailand, patients whose income was below the poverty line 
were particularly affected with out-of-pocket expenses exceeding 15% of the 
annual household income and a 5% reduction in income. Expenditures were 
met through bank loans (11.8%) and through sales of property (15.9%). [25] 
Among patients seeking treatment in Zambia, a mean total cost equivalent to 
127% of their mean monthly income was incurred. [26] Clearly, TB is not only a 
disease among the poor but capable of creating a vicious cycle that further 
incapacitates the poor. It also affects the whole family, the quality of child 
care, education of children and contributed to child tabour. [27] 
TB has the greatest effect on the economically productive adults, who are 
also the parents, on whom rest the survival and development of children. [7] 
The considerable number of work days lost from an economically productive 
segment of the society will affect the productivity of the nation. 
1.1.3 Risk of spread to contacts and the community 
The best way to reduce transmission of tuberculosis infection and thus the 
number of TB cases is to cure smear-positive TB patients as they are 
reservoirs of infection. Various epidemiological studies have been used to 
quantify this transmission effect. An untreated case remains infectious for a 
long time as shown by a 5-year study in India in which 20% of bacteriological 
confirmed cases remained sputum positive after 5 years. [20] Styblo estimated 
that prior to the chemotherapy era, an infectious source can infect on 
average 20 persons during a2 year-period of being infectious. Not all infected 
persons develop clinical TB. If the lifetime risk of becoming infectious 
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following infection is 5%, then two prevalent cases correspond to one incident 
case per year, each producing 10 successful transmissions per year. [12] 
Several studies have reported the risk of close contacts such as family 
members, co-workers and fellow students becoming infected from 
undiagnosed TB patients. A case study report on 2 cases of TB in an office in 
Melbourne, Australia found that following an exposure to undiagnosed TB case 
for 4 months, at least 24% of the 195 co-workers were infected. [28] In a 
community college outbreak in Leicester, UK, an undiagnosed TB student 
resulted in 21 other cases in the college and 3 more among retatives. [29] In a 
study done in Los Angeles County, one in five TB patients sought treatment 
within 60 days and each had exposed an average of 8 close contacts` at home 
and work place tb TB. [30] These figures suggest that close contacts either at 
home or place of work/study is more at risk of being infected compared to 
other community contacts. 
By decreasing the risk of TB infection, there will be a reduction in the number 
of TB cases and a reduction in the danger from current sources of infection. 
This, in turn will reduce the number of future cases of TB. [31] 
1.2 The importance of studying time period 
DOTS strategy has been shown to be the most cost-effective strategy for the 
control of TB in many countries. [2] One of its elements is to detect as many 
cases as possible through the use of microscopic sputum examination. In order 
to be able to detect infected individuals, we rely heavily, due to resource 
constraints, on passive case detection. Passive case detection, in turn, 
depends on the health seeking behaviour of the patients which is determined 
by many factors such as the social, environmental and health culture of the 
community. Health culture can be defined as the understanding and 
'The definition used for contact was person living in the respondent's usual sleeping place or 
who worked in the same room for more than 1 hour each day. 
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information people have from family, friends, and neighbours as to the nature 
of a health problem, its cause, and its implications. [3] 
A person who has been inflicted with an illness needs to recognise that the 
symptoms he/she is having are indicative of a disease. He then develops the 
`process' of illness response often described as health seeking behaviour. 
Health seeking behaviour is a term which is rooted in psychology and used in 
social cognition models. One such model is the Health Belief model which is 
elaborated on further in Chapter 3. According to Tipping and Segall, the 
utilisation of any formal system described as `health care seeking behaviour', 
is influenced by socio-economic, sex, age, social status of female, type of 
illness, access to services and perceived quality of the service. [32] For TB, 
these factors often interact in a complex weave. People's confusion as to the 
implications of the TB symptoms, costs of transportation, the social stigma, 
the high cost of medication and patients' perception of clinic facilities as 
inhospitable all contribute to the complexity. [3] 
Between men and women, there are often different patterns in health care 
utilisation. In some societies, women prefer visits to traditional healers[15, 
33] prior to diagnosis or to self -medicate (34]. In some areas, women have 
problem accessing health services. [35] A study in Vietnam did not find any 
difference in access or utilisation but found that the women were not 
diagnosed as quickly as men; the mean doctor delay was 5.4 weeks for women 
compared to 3.8 weeks for men. [36] 
Assessing time period from onset to consultation is, in fact, a way of 
understanding health and health care seeking behaviour. This time period 
could also be regarded as an indicator of transmission of TB in the 
community[37] though the extent of transmission in the community for those 
with prolonged time period is assumed rather than measured. The extent of 
transmission among close contacts has been described in section 1.1.3. 
The time between onset of symptoms and consultation differs due to many 
factors that affect the health care seeking behaviours. Making an informed 
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cut-off point allows us to focus on those with unacceptably prolonged time 
period and assess whether the responsible factors are remediable. 
For TB, having chosen a particular health care provider does not mean the 
end of the problem. He/she is required to provide at least 3 sputum samples 
which have to be provided to the laboratory on two consecutive days and then 
to have a chest x-ray done. All the examinations may not be available at the 
clinic he/she first attended. Again, assessing the time period between 
consultation and diagnosis and eventually treatment will be a way to examine 
the pattern of health care utilisation and the efficiency of the health services. 
Similarly, by using a cut-off point for this time period allows us to focus on 
remediable factors in health services availability and uptake. 
This aim of this study, conducted in Sabah in East Malaysia, was to understand 
the health and health care seeking behaviour among TB patients and to assess 
the various time periods from onset of symptoms to start of treatment and 
factors associated with delay in both attending and receiving treatment. The 
background for this study is described in the next section. 
1.3 Country setting 
Malaysia ties in the heart of Southeast Asia and comprises of the Malay 
Peninsula in the west and Sabah and Sarawak in the east. (Map 1) The country 
has a total (and area of about 330 242 sq. km and a population of 26.6 millions 
in 2006. [38] Sabah and Sarawak are separated from the Peninsula by about 
530 km of the South China Sea. Malaysia has 13 states and two federal 
territories. There are 3 major ethnic groups in West Malaysia; Malays, Chinese 
and Indians. In contrast, there are more than 50 ethnic groups in East 
Malaysia. [39] 
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Map 1: Map of Malaysia 
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Malaysia is a developing nation with about a third of the population under the 
age of 15 years. As of 2001, approximately 58.1 percent of the population live 
in urban areas although there are variations among the states. Sabah 
currently has a population of about 2.6 millions and a population density of 35 
people for every km2. About 48% of the population reside in urban areas and 
about a quarter of the total population are in-migrants mostly from Indonesia 
and Philippines. [41] 
1.4 The epidemiology of TB in Malaysia 
TB is endemic in Malaysia and ranked by WHO as a country with intermediate 
burden of TB. It is a notifiable disease under the Prevention Et Control of 
Infectious Diseases Act of 1988 (Act 342). Since the control programme was 
put in place in 1951, TB notification rates have been on the decline until 
about 1995 after which they started to rise again and started to decline again 
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in 2002 before rising again in recent years. (Figure 1.1) WHO has attributed 
the pattern to be due to several factors such as mobility of certain 
populations especially migrant workers, HIV-TB co-infection and rural poverty 
in some states such as Sabah. [42] However, data and further analysis are 
required to identify the specific factors and their contribution to the trend in 
notification rates. The case detection rated has not yet reached the target of 
70% set by WHO; in 2004, case detection rate for smear positive cases was 
69%. [43] 
Figure 1.1: Case notification rates for all types of TB (per 100 000 
population), Malaysia 1980-2004 
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Source of data: [44] 
Slightly more than half of all TB cases are smear positive. The notification 
rates of smear positive TB differs by age and sex. More males are affected 
than females. The notification rate is almost similar from birth until early 
Case detection rate = annual new smear positive notification (country) 
estimated annual new smear positive incidence (country) 
The incidence of tuberculosis is an important measure to monitor the progression of the disease at country 
level. Estimates of incidence are derived from notifications to WI 10; from disease prevalence surveys; or 
from surveys of the prevalence of infection in children, used to calculate the annual risk of' '1'13 infection 
(ARTI). Source: http: //www. who. int/healthinfo/statistics/indtbincidencc/en/index. html 
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adulthood after which a remarkable and widening difference is seen between 
the two genders. It is possible that the presence of migrant workers who tend 
to be mate and from areas with high prevalence of TB infection may be a 
possible reason for this difference. The rates for both males and females are 
highest among those over the age of 65 years as shown in Table 1.1. [44] 
Table 1.1: New smear positive TB case notification rates (per 100 000 
population) by age and sex, Malaysia, 2004 
Age group 0- 14 15 - 24 25 --34- 34 - 35 - 44 45 - 54 55-- 4 -65+ 
(years) 
Male 5 51 108 131 149 200 296 
Female 6 42 53 52 56 86 88 
Source of data: [44] 
As shown in Figure 1.2, the notification rate for Sabah is about two and a half 
times that of the country's figure and this account for more than one third of 
all TB cases in the country. 
Figure 1.2: Case notification rates for all types of TB (per 100 000 
population) by state, Malaysia 1997 - 2000 
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In Sabah, the notification rate for the state was on the decline in the 1960s 
but has fluctuated between 100 and 200 per 100 000 population since the 
1970s. (Figure 1.3) 
Figure 1.3: Case notification rates for all types of TB (per 100 000 
population), Sabah 1960-2002 
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Source of data: [5] 
As with the whole of Malaysia, in Sabah, the highest rate is seen among the 
older age group of 60 and above. The overall mate to female ratio is 1.4 to 1. 
Since 1990, about 24% of the cases are foreigners from Indonesia and 
Philippines. [5] 
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Figure 1.4: Case notification rate for all types of TB (per 100 000 
population) by age group, Sabah, 2001 
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With regards to ethnic group, the combined group of the major indigenous 
groups (Kadazan, Dusun and Murut) had a notification rate of more than 250 
cases per 100 000 populations for the past 10 years. The Chinese has a rate of 
less than 100 cases per 100 000 populations. Notification rates among 
foreigners (Indonesians and Filipino) ranges from 100 to 150 cases per 100 000 
populations. [5] 
1.4.1 HIV - TB Co-infection in Malaysia 
The first HIV case in Malaysia was reported in December 1986. By 2000, the 
cumulative number of HIV cases was 38,340, of which 12.3% were AIDS cases 
and both numbers are rising. Data on HIV/AIDS have been collected through 
various surveillance activities such as routine surveillance and HIV sentinel 
surveillance. Currently, HIV testing which started in 1989, is targeted at 8 
groups: antenatal mothers attending government facilities, blood donors, 
inmates of drug rehabilitation centres and prison, confirmed TB cases, STD 
0-4 5-9 10-14 15-19 20-24 25 29 30-34 35.39 40-44 45.49 50-54 55-59 60+ 
14.5 19.18 29.35 103.3 154.87 162.52 197.13 224.48 270.79 278.72 365.59 498.79 693.83 
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cases, patients with suspected clinical symptoms and contacts of HIV infected 
individuals. [42] 
The prevalence of HIV is more in mates than females. The most common mode 
of transmission is through intravenous drug abuse-[45] HIV prevalence among 
antenatal mothers and blood donors is less than 0.1%. In 2000, around 285 000 
antenatal women were tested and only 0.03% were found to be HIV-positive. 
Among 330 000 blood donors tested in 1999, only 0.01% was positive. [45] In 
general, the prevalence of HIV in the adult population is less than 1%. WHO 
has estimated this prevalence to be 0.35% and has classified Malaysia as a 
country experiencing a concentrated epidemic, since HIV prevalence has been 
less than 1% among the general population, but consistently higher than 5% 
among injecting drug users over the past 10 years. [42] 
HIV screening has been performed on all TB patients since 1990 and 
intensified in 1998. [46] In 1990, only six cases of TB with HIV co-infection 
were reported out of the total 10,873 cases notified (0.05%) [47] and since 
then has been on the rise reaching 900 cases out of 14,389 registered TB cases 
(6.2%) in 2002. [42] The prevalence of HIV among adult TB patients (15-49 
years old) was 2.5% in 2004. [43] TB-HIV co-infection is less of a problem in 
Sabah. In 2001, the accumulated numbers of HIV patients were 120 and in the 
same year, only three TB patients were found to have HIV infection. [48] 
1.4.2 Multi-drug Resistance TB (MDR-TB) 
MDR-TB is fortunately low in Malaysia. In 2004, only 0.1% of the new TB cases 
were MDR-TB while there were none among previously treated TB cases. [43] 
The MDR-TB situation in Sabah is also low; in 2001, the accumulated number 
of MDR cases was 13. [49] The most common cause for the emergence of 
resistant strains in Malaysia is incomplete or inadequate treatment. [50] 
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1.5 The TB Control Programme in Malaysia 
1.5.1 DOTS Strategy 
The most cost-effective strategy for TB control of TB in many countries has 
been proven to be DOTS strategy. [2] Borgdorff et at have reviewed various 
studies on the various interventions in TB control and concluded that with 
WHO directly observed treatment, short-course (DOTS) around US$5-40 per 
disability-adjusted life year (DALY) was gained in a middle income country in 
the absence of HIV. [51 ] 
Malaysia adopted the DOTS strategy in the 1999. [42] In Sabah, over the past 
few years, better facilities for diagnosis in terms of equipment and personnel 
have been put in place in many health centres. This was in tine with the 
practice of decentralizing diagnosis from hospital to health centres. Strict 
adherence to treatment regime as outlined in the national guideline is 
observed by both government and private practitioners. Directly observed 
therapy-short course has also been employed where ingestion of the tablets is 
observed by treatment supervisors; health personnel, family members or 
health volunteers. The final element in DOTS strategy is monitoring and 
reporting of treatment outcome. In 2003, a new information system, the TB 
Information System (TBIS) has replaced the previous system with the revision 
of existing databases and reporting formats. This system has allowed for data 
to be stored in a more systematic and efficient way in the form of Registry 
and Report books. These books are maintained at the District Health Office by 
Health Inspectors and at the treatment centres by Medical Assistants. As a 
result of all these steps, in 2002, the coverage for DOTS in Sabah was 93.8% 
with variability among the districts from 81.9% to 100%. [46) 
1.5.2 The general structure of health care system 
There is extensive network of health facilities in the country. Primary health 
care is available through existing health care facilities such as health centres 
and community clinics white secondary and tertiary care is provided in both 
public and private hospitals. A community clinic is the basic unit of the health 
29 
Chapter 1: Background and rationale 
care system covering a population of approximately 2000. It is often manned 
by community nurses and focuses on the Maternal and Child Health 
programme. However, basic curative services can also be provided. Sputum 
examination is not routinely done in these clinics. However, in the rural areas 
where the incidence of TB is high, the nurses are trained to collect the 
sputum specimen and prepare the slides for examination at the nearest health 
clinic. Once treatment for TB is started at the health centres, it can be 
continued at the community clinics. 
Larger units, health centres covering a population of 7 to 10 thousands, 
provide curative services by the Primary Care Unit in the health centres and 
also implement all health programmes including the TB control programme. 
They are manned by Medical Assistants, nurses, laboratory technicians and 
Assistant Public Health officers. In Sabah, some health centres especially in 
urban areas and those with heavy work toad have doctors. 
The health cost is heavily subsidized by the government. There are no charges 
for local citizens for out-patient care which includes laboratory investigations 
and treatment at the health clinics. There is a small fee for out-patient 
services at government hospitals, approximately USD0.26 for Malaysians. Non- 
Malaysians have to pay approximately USD3.9 which is equivalent to a 'simple' 
consultation with a private doctor. The hospitalisation cost for notifiable 
diseases such as TB is free for both Malaysians and non-Malaysians. 
Human resources are still a problem in the country but are more pronounced 
in Sabah. In 2006, there are only 998 doctors in both public and private clinics 
thereby resulting in a doctor: population ratio of 1: 2938. Throughout Sabah, 
there are 19 public hospitals, 11 private hospitals, 82 health clinics, 187 
community clinics, 18 Maternal and Child Health clinics and 8 mobile 
clinics. [52] 
v 
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1.5.3 TB Control Programme in Sabah 
The scope of the TB Control Programme in Sabah is shown in Figure 1.5. Case 
detection and treatment are but two of the 10 elements in the control efforts. 
Due to limited human resources as highlighted in 1.5.2, the wisdom in 
integrating a vertical programme like TB into the main public health activities 
as was done in the 1990s becomes apparent. A considerable amount of 
cooperation and networking occur with other units such as the Maternal and 
Child Health Unit for immunisation and Primary Care Unit for case detection 
and treatment. These are two different Units working side by side in the 
health centres. 
Figure 1.5: Scope of TB Control Programme in Sabah 
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Source: [53] 
There is a TB Control Unit in every district. The overall responsibility for the 
implementation of TB control efforts rest' with the Area Medical Officer and 
his/her team in every district which consist of the personnel shown in Figure 
1.6 who are based at the District Health Office. The organisation chart for TB 
Control programme in a district is shown in Figure 1.6. 
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Figure 1.6: Organisation chart for TB Control Programme in a district in 
Sabah 
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Source: [53] 
The Health Inspector in-charge of this unit is responsible for maintaining the 
TB Registry for, the district as well as for case investigation and contact 
tracing. The Senior Medical Assistant supervises all the Medical Assistants at 
the health facilities in term of curative services. A laboratory technician is 
responsible for ensuring that sputum microscopy is performed in a timely way 
and accurately. Slides are sent monthly to the Central Laboratory in Kota 
Kinabalu, state capital of Sabah, for quality control. Feedback is sent to the 
district within 2 months and any discrepancies in terms of bacterial load of 
the sputum are corrected in the monthly report and patient record. Ensuring 
uninterrupted supply of anti-TB drugs is the responsibility of a Pharmacist. 
Anti-TB drugs are available at all health facilities throughout Sabah. The 
Health Matron oversees the immunisation programme where all newborns 
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regardless of place of birth or personnel conducting the birth, are given BCG 
immunisation at birth. 
Supervisions and training of all staff are carried out by the team from the 
District Health Office. Health education to the patients is provided at all 
health facility by all levels of staff. Technical support is provided by the 
Health Education Unit also based at the District Health Office. This TB 
organisation structure at the district level mirrors the one that exists at the 
state level. 
1.6 Rationale for the thesis 
When Robert Koch announced the discovery of Mycobacterium tuberculosis to 
the Physiological Society of Berlin on the 24`h March 1882, the excitement was 
not on his discovery but at the accompanying certainty that the real fight 
against the disease could begin. [7] Several decades after the discovery of 
chemotherapy with no sign of TB being eliminated, DOTS strategy became the 
'buzz' word and welcomed globally. Almost a decade after it was introduced; 
only a gradual decline of TB is seen in many parts of the world such as in 
South East Asia and Western Pacific regions while in other parts such as Africa, 
a continuous rise is still evident. [54] 
In Malaysia, there is little change in notification rate among smear positive 
patients; 48 per 100 000 population in 2000 down to 46 per 100 000 in 
2004. [55] Sabah, in East Malaysia, contributes one third of the total cases in 
the country. Its notification rate for all cases has been hovering between 100 
to 200 per 100 000 population for almost a decade now. [5] TB control efforts 
in past years have been concentrated on setting up the infrastructure such as 
making available diagnostic facilities in almost all health facilities and 
training staff to handle the added responsibility. In Sabah, TB is still in its 
`pure' form, treatable using the current chemotherapy regime. MDR-TB is stilt 
very low and HIV-TB co-infection is, relatively tow. In many parts of the world 
such as Sub-Saharan Africa and in countries of former Soviet Union, the 
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struggle towards elimination has been made harder as a result of HIV and MDR. 
Thailand has a high prevalence of HIV/AIDS and due to higher awareness of 
HIV/AIDS compared to TB and the similarity of TB and AIDS symptoms, longer 
delay for TB was seen because patients were afraid to be diagnosed with 
AIDS. [56] For Sabah, a `window of opportunity' currently exists to lessen the 
burden of TB in the community with relatively little HIV driving TB rates. To 
date, there has not been any research on TB in Sabah with the objective of 
determining the time period from onset of symptoms to effective treatment. 
It is the hope that the findings of this study will contribute to the shortening 
of this infectiousness period and thus the transmission in the community. 
The importance of ensuring that infectious TB individuals are detected and 
put on treatment has been emphasised in section 1.2. The duration of 
infectiousness is an important factor in the control of TB. TB is a social 
disease and many factors affect the time from seeking treatment to being 
treated. The objectives of this research are to assess the duration of time 
from onset of symptoms to treatment and factors which influence the various 
time periods. 
Patients are often blamed when they 'delay' in presenting for treatment or 
when they do not comply with treatment. In terms of time frame, there is no 
general consensus as to what constitutes `delay'. Although I will be using the 
word `delay' as used and reported in other studies, in this research, the time 
between identified milestones will be referred to as time period. The word 
`delay' would mean that a cut-off point has been decided which dichotomised 
the time period into 'no delay' and otherwise. 
Two studies conducted in West Malaysia in the 1990s, have analysed delay in 
TB diagnosis. Both studies were conducted at urban hospitals among the 3 
main ethnic groups in West Malaysia [57,58] and found the median patient 
time period to be 2 weeks. In both studies, the median doctor delay was 
longer: 5 weeks[58] and 7 weeks[57]. The median total time period differed 
slightly between the studies: 12.5 weeks[57] and 12 weeks[58]. The authors of 
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these papers suggest that doctor delay was associated with seeking private 
practitioners who often did not suspect TB. 
No study on time periods from onset to consultation and to commencement of 
treatment has been conducted in East Malaysia. In the West Malaysia study in 
Penang[58], an urbanised island setting, 34% of the patients came 1 month 
after onset of symptoms and 27% came after 2 months. It is very likely that 
these figures will be higher in Sabah. This research involved both out-patient 
and public health clinics and different ethnic groups than those in the West 
Malaysia studies. 
This study aimed at assessing the various time periods; from onset to 
consultation (patient time period) and from consultation with a doctor to 
commencement of treatment (doctor time period). It also identified 
explanatory factors for patient and doctor delay using pre-determined cut-off 
points which are 30 days for patient delay and 14 days for doctor delay. In 
addition, explanatory factors for extreme patient delay (> 90 days) and doctor 
delay (> 60 days) were also determined. This was to determine the factors 
which may explain why patients remained in the community and thus posed as 
possible source of infection. 
Due to the lack of research on TB in Sabah, the decision was to conduct the 
research in two phases; the first phase used qualitative approaches while the 
second, quantitative methods. The first phase was to explore the perception 
and health seeking behaviour with regards to TB. This was done using face to 
face interviews with TB patients, relatives and key informants such as village 
headmen, traditional healers and health staff. By using this approach, a 
better understanding of other social aspects of TB can be gained such as 
issues related to stigma and effects of TB on its patients. The findings from 
this qualitative study also informed on the questionnaire to be used in the 
second phase in terms of definitions, range of answers and structure of the 
questionnaire. 
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The second phase was a cross sectional study which involved newly diagnosed 
PTB patients who fulfilled pre-set inclusion criteria in 10 selected districts in 
Sabah. A pre-tested questionnaire was administered to these respondents to 
identify patient and doctor time periods and explanatory factors associated 
with patient and doctor delay. 
1.7 Outline of the structure of the thesis 
This research details the time period between several milestones in the 
course of TB: the onset of symptoms, to first consultation, to diagnosis and 
finally to treatment in Sabah, East Malaysia. It also explores the factors that 
affect this time period. The rationale behind the research and an outline of 
the methods used is described in Chapter 1. It also describes the setting for 
the study; the epidemiology of TB, TB Control Programme and the health care 
structure in Malaysia. Chapter 2 focuses on literature reviews in which studies 
on time from onset of TB symptoms to start of treatment and perceptions of 
TB are summarised. In addition, the issues with stigma as a result of TB are 
also reviewed. Relevant issues surrounding time period such as the definitions 
of time period and `acceptable' delay are also discussed in Chapter 2 and 
possible explanatory factors for the various forms of delay are presented in 
the same chapter. The explanation of the conceptual framework on health 
and health care seeking behaviour for TB can be found in Chapter 3. The first 
part of the study which utilised qualitative methodologies such as in-depth 
interviews to gather information from TB patients, relatives and members of 
the community on issues such as health seeking behaviour, understanding of 
TB and stigma are documented in Chapter 4. The quantitative study is 
presented in five chapters: Chapter 5 is on the methods, Chapter 6 describes 
the characteristics of the respondents and symptoms experienced, Chapter 7 
describes the results on explanatory factors for patient delay, Chapter 8 
presents results on doctor delay and the discussion is presented in Chapter 9. 
Recommendations and conclusion are detailed in Chapter 10. 
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2 CHAPTER 2: Literature Review 
This chapter describes the literature review on time period and delay from onset 
of symptoms to start of treatment, perceptions of TB and stigma. Specific issues 
are drawn from the review namely the non-standardised definitions, factors 
responsible for delays and the 'over-use' of the term 'delay'. The importance of 
reviewing studies on the perception of TB is in its relation to health and health 
care seeking behaviour; for example a belief that TB is caused by 'evil' spirits 
could explain why a visit to a spiritualist was made. Stigma has often been linked 
with delay in getting treatment among TB patients. A basic understanding of why 
that is so, is relevant. The objectives of the literature review is to review 
articles with respect to (a) definitions of delay, (b) definitions of acceptable 
delay, (c) factors associated with delay, (d) perceptions of TB and (e) stigma. 
2.1 Methods for literature review 
A search was carried out to assemble the published literature (with no language 
restriction) on time period and/or delay using databases Medtine, CINAHL 
(Cumulative Index to Nursing It Allied Health Literature) and Cochrane. The 
keywords used were "TB, epidemiology, ethnology, prevention and control, 
transmission" AND "delay" or "time period". Grey literature and unpublished 
studies were also included as well as literature known to experts in the field, 
daisy chaining from articles, books and reviews and hand searching through 
particular journals such as the International Journal of Tuberculosis It Lung 
Disease and Social Science and Medicine Journal. All studies which either 
specifically addressed the issue of delay or as part of a larger research question 
were eligible. Similarly, this method was also applied for studies on *perception 
of TB and on stigma using the appropriate keywords; i. e. "TB" AND "perception" 
or "stigma". 
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2.2 Results on delay 
The literature search identified 262 articles on delay through Medline out of 
which 69 were eligible based on examining the titles and abstracts. The full 
manuscripts of these citations were examined and only 38 studies in 29 countries 
were identified to be relevant and summarised in Appendix 1. All but two were 
cross sectional studies, the other two were cohort studies [59,60]. Nineteen 
studies used patient questionnaire while others utilised data from registry or 
medical records and focus group discussions. Thirty one of them used median to 
describe the time period, three used the mean while another four used different 
cut-off points such as 4 weeks in the Zambia study[18] and 20 days in Mumbai 
study[61]. Only five studies reported on results of multivariate analysis of either 
Cox proportional hazard model or logistic regression. [30,62-65] 
2.2.1 Issues with definitions of delay 
Different definitions for delay have been used by various authors. Despite the 
different terminology used for patient delay, this time period generally refers to 
the time lapse between the onsets of symptoms to first consultation with any 
type of health care provider. With regards to this, there were differences 
between the studies in two areas: the presenting symptoms for which treatment 
was sought and the type of health provider. (Table 2.1) For example, some 
studies were specific in using pulmonary or chest symptoms [66] while others 
used the onset of symptoms such as cough, fever, lethargy, loss of weight which 
are suggestive of TB [67]. In terms of health care provider, some used the 
consultation to medical personnel" as the end point [30,60,62,66-68] while for 
the others, the end point was consultation with any health care providersf [61, 
69]. 
Medical personnel are trained doctors. 
r Health care providers include both practitioners of modem and traditional medicine. 
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For the other time periods such as doctor, health service, the differences were in 
relation to the final event; either diagnosis or treatment. Some used the first 
point as the time of consultation and the commencement of treatment as the 
end[60,62,64,65,70] while for others, the time to a definitive diagnosis[66]. 
(Table 2.1) One study referred the term `diagnostic delay' to the period between 
onset of symptoms to initiation of treatment. [26] This in turn would affect the 
definition of total delay where the end point could, be either the time of 
diagnosis or commencement of treatment. One study used `hospitalisation' as 
the end-point. [63] 
In addition, some studies further break the period from medical consultation to 
start of treatment in 2 phases; from consultation to diagnosis (physician delay) 
and from diagnosis to treatment (treatment delay). [67] 
Table 2.1: Definitions for delay 
Main Author Country Definitions 
PATIENT DELAY 
Demissie, M. [66] Ethiopia Time interval from appearance 
of major pulmonary symptom to 
first visit at a medical facility. 
Masjedi, M. R. [67] Iran Time between onsets of 
Diez, M. [62] Spain symptoms to first medical 
Rajeswari, R. [71] South India consultation. 
Lawn[72] Ghana 
Hooi, L. N. [58] West Malaysia 
Paynter, S. [60] London, UK 
Yamasaki-Nakagawa, M. [33] Nepal 
Ward, J. [70] Australia 
Wandwalo, E. R. [73] Tanzania 
Aoki, M. [74] Japan 
Yimer, S. [75] Ethiopia 
Golub, J. E. [59] Maryland, USA 
Chiang, C-Y. [76] Southern 
Taiwan 
Gagliotti, C. [77] Italy 
Odusanya 0 [68] Nigeria 
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Main Author Country Definitions 
Lienhardt, C. [69] The Gambia Time between onsets of 
Steen, T. W. [65] Botswana symptoms to any health care 
provider. 
Guneytioglu, D. [78] Turkey Patients' application interval: 
time interval between onset of 
symptoms and first doctor's visit 
Tamhane, A. [61] Mumbai, India Seeking care after 20 days of 
onset. 
Chakraborty, A. K. [79] India Interval between chest 
symptoms and action taken by 
patients for relief. (any 
provider) 
OTHER FORMS OF DELAY 
Needham, D. M. [26] Zambia Diagnostic delay: time from 
symptom onset to initiation of 
therapy. 
Odusanya 0. [68] Nigeria Doctor delay: time between visit 
to first facility and the chest 
clinic. 
Demissie, M. [66] Ethiopia Health service delay: first 
consultation to diagnosis. 
Masjedi, M. R. [67] Iran Physician delay: time taken by 
Diez, M. [62] Spain physician to diagnose TB 
Rajeswari, R. [71] South India Treatment delay: time after 
diagnosis before treatment. 
Tamhane, A. [61] Mumbai, India Treatment delay: treatment 
initiated after 14 days of first 
consultation. 
Chakraborty, A. K. [79] India Health system delay: interval 
action taken by patient and final 
diagnosis as TB. 
Total mean delay: interval 
between chest symptoms and 
final bacteriological diagnosis 
Lawn, S. D. [72] Ghana Doctor delay: from first 
Yamasaki-Nakagawa, M. [33) Nepal consultation until diagnosis. 
Aoki, M. [74] Total delay: from onset of 
Japan symptoms to diagnosis. 
Hooi, L. N. [58] West Malaysia Doctor delay: from consultation 
Paynter, S. [60] London, UK to commencement of treatment. 
Lienhardt, C. [69] The Gambia Health provider delay: from first 
visit to health care provider to 
first visit to LTI (Leprosy/Tb 
Inspectors). 
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Main Author, Country Definitions 
.,. ,., 
Diagnosing facility delay: from 
first visit to LTI to start of 
treatment. 
Total delay: from onset of 
symptoms to start of treatment. 
Ward, J. [70] Australia Health care system delay: 
Yimer, S. [75] Ethiopia difference in days from the date 
Golub, J. E. [59] Maryland, USA of first relevant presentation to 
Chiang, C-Y. [76] Southern a medical practitioner and the 
Taiwan date of starting treatment (or 
Gagliotti, C. [77] Italy diagnosis if no treatment was 
Wandwalo, E. R. [73] Tanzania given) 
Steen, T. W. [65] Botswana Diagnostic delay: difference 
Date, J. [80] Yemen between the date of first 
consultation and date of 
diagnosis. 
Treatment delay: difference 
between the date of diagnosis 
and the initial treatment date. 
When comparison is made with other studies, one should be aware of the 
different definitions for these time periods and different units of measurements. 
Standardised definitions would ideally help data comparison. 
2.2.2 Acceptable delay 
Different approaches have been used to define "delay" and/or acceptable delay. 
In some studies, the median was used to dichotomise patients into shorter or 
longer delay. [62] Therefore, one should be careful in making comparison across 
studies as the time lapse or median may be different in each studies. Patient 
delay in West Malaysia is defined as greater than 30 days from onset to 
consultation[58] but in Spain, patient delay was defined as greater than 22 
days. [75] Following the same argument, a factor which resulted in delay in one 
setting may not have the same association in another. As mentioned, some 
studies used the mean to define delay. 
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More importantly,, there is no general agreement as to what an 'acceptable' 
delay for patient or doctor time periods should be. Some authors, for example in 
West Malaysia consider an acceptable delay between first consultation and start 
of treatment as one month or tess[58] or in Zambia, between onset of symptoms 
and first consultation as 4 weeks [18] or 30 days in Ethiopia and Nigeria [66,68] 
or between onset of symptoms and initiation of treatment as 1 month[81] or 2 
months in Japan [74]. One study suggested that the definition of a reasonable 
delay in a given situation will depend on the prevalence of TB and the nature of 
the health care system. [70] For example, in that study conducted in Lusaka, 
Zambia, delay of more than 4 weeks for patients with cough was taken to be 
significant as the national guidelines were that patients with cough of more than 
3 weeks duration should be investigated further. [18] In Tanzania, a consensus 
among general practitioners and a specialist chose '30 days' as maximum 
acceptable patient delay and '10 days' for health system delay. These decisions 
were based on medical knowledge and the socio-economic conditions of their 
patients. [73] In the California study, 60 days from onset to medical consultation 
was defined as 'clinically significant delay' based on previous study which 
showed that exposed domestic contacts of active TB patients frequently showed 
signs of infection after 2 months of exposure. [30] 
In a similar way, one might need to take partly into consideration the location of 
diagnostic facilities. In some health care settings, consultation, diagnostic 
facilities and treatment centres could be in different locations, as in the 
Gambia[69]. In Lagos, patients had to be referred to the Chest Clinic for 
diagnosis and treatment and doctor delay meant that this period between 
referral and diagnosis exceeded 15 days. [68] 
2.2.3 Factors affecting delay 
Different factors affect the different time periods for TB case finding. Generally, 
it is thought that patient delay is mostly due to patient factors and once a 
patient is seen by a health care provider any delay is due to the health care 
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provider. While this may be true, patients may not be able to abide with the 
procedural demands made by the health care provider and therefore may also 
contribute to delay. Patients are required to provide a minimum of three samples 
submitted consecutively over 2-3 days, for sputum examination which may 
require them to attend another facility. Patients, due to whatever reasons, may 
not be able to do so within the required time and therefore contribute to the 
health care provider delay. 
Factors associated with health services such as lack of diagnostic facilities, 
practices and staff attitudes were not assessed in most of the studies reviewed. 
Therefore, some elements of health care provider which may be responsible for 
delay were not highlighted. Studies found different factors affecting delay and 
some of these factors need to be interpreted within the context of the research 
setting, for example, the case of someone who does not speak English such as an 
immigrant in New York and has health care delay[64] has no relevance in a 
setting where in-migration of people with different mother tongues is not an 
important issue. 
a. Patient delay 
Table 2.2 summarises factors associated with patient delay and more details can 
be found in Appendix 1. Studies have found that both men and women may 
delay, presumably due to their health care seeking behaviour. Older age group 
tend to delay more. For example, in New York, those age 55 to 64 years old were 
10 times more likely to delay than those aged 15 to 24. The profiles of those who 
delay seem to lean towards those who are less privileged: those with low 
economic standing [30,82], lower education level [71], [73], and rural residents 
[73] and those who live far from health facility with long travelling time [18,71, 
73,75,83]. In a study in Yemen, the author suggested the reason illiterate 
patients had delay was because they do not question the diagnosis given to them 
by the doctors. If they were told they had 'common illness', they were reluctant 
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to seek further evaluation whereas literate patients were more sceptical and 
only accept their diagnosis in the presence of definite evidence such as 
laboratory results. [80] 
In terms of health utilisation: generally those who seek non-government health 
facilities and those whose perceptions of the health services were poor tend to 
have patient delay. Those with social problems also tend to delay seeking 
treatment. These associations are to be expected in most circumstances. In 
developed and low prevalence settings, local born and those with no index TB 
case seem to delay, presumably due to lack of awareness of the disease. 
However, other factors are not easy to explain as the reverse is seen such as 
increasing severity of disease, or having haemoptysis associated with delay when 
they are expected to reduce delay. 
Table 2.2: Factors affecting patient delay 
No Category Factors associated with longer patient delay 
1 Gender " Mate: Penang, Malaysia[58] and Teheran, Iran[67] 
" Female: Mumbai, India[61] and Lusaka, Zambia[26] 
2 Age " > 33 years old: London, UK[60] 
" greatest delay in the 35-64 age group: Spain[62] 
" > 45 years old: Mwanza, Tanzania[73] and 
Ethiopia[75] 
" < 45 years old: South India[71] 
" 55- 64 years old: New York, USA[64] 
" Older age: Maryland, USA[59] and Hunan, China[83] 
3 Economic " Unemployed: California, USA[30] and Ukraine[82] 
" Poor economic status: Istanbul, Turkey[78] 
" Low income: South India[71] and Hunan, China[83] 
" Employed in private sector: Ukraine[82J 
4 Geography " Rural setting: Mwanza, Tanzania[73] 
" Distance from health facility: Lusaka, Zambia[18] and 
Hunan, China[83] 
" 2 km from health facility: South India[71] 
" >1 hour of walking from health facility: Ethiopia[66] 
" > 10 km from health facility: Mwanza, Tanzania[73] 
and Ethiopia[75] 
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No Category Factors associated with longer patient delay 
5 Education " Illiteracy: South India[71] 
" Lower than secondary education: Penang, 
Malaysia[58], Maryland, USA[59] and Luzaka, 
Zambia[26] 
" Lower than primary education: Mwanza, Tanzania[73] 
6 Social " Drug user: Penang, Mataysia[58] 
problem " Alcoholism: South India[71] 
" Those who felt ostracised because of illness: Manila, 
Philippines[84J 
7 Perception of " Poor perception of health service: Lusaka, Zambia[18] 
health service 
8 Symptoms " Haemoptysis: Ethiopia[66] and Hunan, China[83] 
" Cough and weight loss: Ukraine[82] 
" Increasing severity of illness: Lusaka, Zambia[18] 
" Self rate health as fair or good: Kweneng, 
Botswana[65] 
" No respiratory symptoms: Maryland, USA [59] 
" Presentation of constitutional symptoms: Spain[62] 
9 Health seeking " Visit to government facility as first provider: South 
behaviour India[71] 
" Seek folk therapy: Hunan, China[83] 
" Prior attendance to private clinic: Lusaka, Zambia[18] 
" Believe they could treat themselves: California, 
USA[30] 
" Visit to traditional healer: Mwanza, Tanzania[73] 
" Self treatment: Ethiopia [75] 
10 Knowledge " Uncertain about where to get care: California, 
USA[30] 
" Poor or no knowledge about TB: Ethiopia[66] and 
Mwanza, Tanzania[73] 
11 Others " Born in a low prevalence country: London, UK[60] 
" Have no index: Istanbul, Turkey[78] 
" Primary language other than English: New York, 
USA[64] 
" Migrant and stayed <3 years: Italy[77] 
b. Health service delay 
Risk factors for health service delay were almost similar to patient delay. (Table 
2.3) In addition, in terms of symptoms, those who presented with no cough[26] 
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or cough of shorter duration[71,77] had health service delay which is what one 
might expect. Repeated encounters would also result in delay. [26] In developed 
settings, again, those born in low prevalence country[60] and non migrant[70] 
would have health service delay due to low index of suspicion among the health 
care providers. 
Table 2.3: Factors affecting health service delay 
No Category Factors associated with longer health service delay 
1 Gender " Female: Zambia[26], Ghana[72], Hunan, China[83], 
Manila, Phitippines[84], India[79], South Africa[63] 
2 Age Increasing age: Queensland, Australia[70] and 
Maryland, USA[59] 
3 Geography " >5 km from health facility: South Africa[63] 
" >2 km from health facility: South India[71] 
" > 30 minutes walking distance to clinic: Ethiopia[66] 
" Rural residence: Ghana[72] 
" Village without hospital: Kweneng, Botswana [65] 
4 Education " Low level of education: Zambia[26], Yemen[80] and 
Hunan, China[83], India[79] 
5 Marital Status " Being married: Kweneng, Botswana[65] 
6 Social problems " Homelessness: New York, USA[64] 
" Alcoholism: South India[71] 
" Ever drank alcohol: South Africa[63] 
" Stigma of disease: Hunan, China[83] 
" Had been a migrant worker: South Africa[63] 
7 Symptoms " Positive smear: Zambia[26] 
" Absence of cough: Zambia[26] and New York[64] 
" Shorter duration of cough: South India[71] 
" Self rate health as poor or very poor: Kweneng, 
Botswana[65] 
" History of asthma: Maryland, USA [59] 
" Cough only: Southern Taiwan[76] 
" Cough of less than 1 month: Italy[77] 
8 Health seeking " Those who present to general practitioner(GP) than to 
behaviour others: Zambia[26], South India[71], London, UK[60] 
and Ethiopia[75] 
" Visit to traditional healer: Zambia[26] and Kweneng, 
Botswana[65] 
" First consultation with other than chest physician: 
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No Category Factors associated with longer health service delay 
Italy[77] 
" Women who visited traditional heater: Nepal[33] 
" First visit to health post: Ethiopia[75] and Kweneng, 
Botswana[65] 
" Village with no hospital: Kweneng, Botswana[65] 
" Those who presented to hospital rather than clinic or 
GP: South Africa[63] 
" Believed disease caused by bewitchment: South 
Africa[63] 
" Sought folk therapy: Hunan, China 83J 
9 Knowledge " Prior health education on TB: Hunan, China[83] 
" Believed TB caused by bewitchment: South Africa[63] 
10 Health service " >6 instances of encounter: Zambia[26] 
practice " Outpatient diagnosis of TB: Zambia[26] 
" No chest x-ray at first visit: New York, USA[64] 
" Those needing hospitalisation: Ghana[72] 
" Rural facility: Mwanza, Tanzania[73] 
11 Others " Born in low prevalence country: London, UK[60] 
" Increasing length of stay (Australia): Queensland, 
Australia[70] 
" Non migrant: Queensland, Australia[70] 
" Speak English: Maryland, USA [59] 
" Has insurance: Maryland, USA [59] 
" Migrant: Itaty[77] 
c. Total delay 
Most factors that were associated with longer patient and health service delay 
were also responsible for total delay. (Table 2.4) Again, the unexpected 
association between some of the symptoms such as haemoptysis and total delay 
is not easily explained. 
I/ 
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Table 2.4: Factors affecting total delay 
No Category Factors associated with longer total delay 
1 Symptoms " History of recurrence: Spain[62] 
" Presence of respiratory symptoms: Spain[62] 
" Presence of pulmonary and extra-pulmonary 
disease: Spain[62] 
" Clinical picture not fully manifested: Italy[85] 
" Those with toss of weight and haemoptysis: 
Pakistan[86] 
" Cough only: Southern Taiwan (Chiang) 
2 Age " 25 - 34 years old: The Gambia[69] 
3 Health seeking " GP as first provider: Itaty[85] and Pakistan[86] 
behaviour " First visit to health post: Kweneng, Botswana[65] 
" Visit to traditional healer: Kweneng, Botswana[65] 
4 Geography " Rural residence: Ghana[72] 
5 Others " STD treatment during the last 3 years: Kweneng, 
Botswana[65] 
" Registered on Out-patient card: Kweneng, 
Botswana[65] 
2.3 Perception of TB 
There are several studies on the perception of TB as shown in 
Table 2.5 which have provided useful insight into the `uniqueness' of TB compared 
with other infectious diseases. (Details in Appendix 2) Most of the findings 
revealed that TB is often perceived outside the bio-medical explanatory model 
that view TB as a disease caused by Mycobacterium tuberculosis and transmitted 
by aerosol droplets. The understanding of the perception of TB allows for 
negotiations and compromise for both health provider and patients and their 
families towards the success of care and control of the disease. For example, 
when patients do not believed that TB was caused by an infectious agent and 
insists on seeking traditional medicine, the compromise could be that they could 
still try other medicine but not to default taking the anti-TB drugs. 
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Table 2.5: Studies on perception of TB 
Country, First Ethnic group Findings 
author 
New York Vietnamese   TB is an infectious lung disease 
State. Carey refugees (non Risk factor for TB: 
JW, USA[87] TB " Hard manual labour, smoking, alcohol 
participants) consumption and poor nutrition. 
  All infection inevitable leads to disease 
Vietnam. Long Vietnamese " TB dangerous and contagious disease cause 
NH. [88] (TB and non by germs. 
TB Four main types of TB: 
participants) (1)'Lao trugen' (hereditary TB), handed down 
from older generations through 'family blood', 
regardless of sex 
(2) ''Lao luc' (physical TB), caused by hard 
work, more men are affected 
(3) 'Lao tom' (mental TB), caused by too much 
worrying, more women are affected 
(4) 'Lao phoi' (lung TB), dangerous, caused by 
TB germs, transmitted through the respiratory 
system and more men are affected. 
Ethiopia. Ethiopians   Do not regard tubercle bacilli to be the 
Vecchiato NL. (non TB cause of TB. Prefer to seek ethno-botanical 
[89] participants) remedies. 
Chiapas, Mexicans (TB Perceived causes of TB: contagion via food 
Mexico. patients) utensils, excess work, malnutrition and cold as 
Alvarez- well as other causes unrelated to person-to- 
Gordillo person contagion. 
GC. [9Q] 
South Africa. Rural South   TB is the result of breaking cultural rules 
Edginton Africans such as not abstaining from sex after the 
ME. [91] (TB patients death of a family member and after a 
and spontaneous abortion. Remedy can only be 
community) obtained from traditional healers. 
Aceh Province, Achehnese TB is represented by a semantic network of 
Sumatra, illnesses, partly transmissible, partly related 
Caprara A., to specific phenomena affecting the 
Indonesia[92] individual, such as 'terbuk' (poisoning) or 
'trouk' (fatigue produced by hard work) and 
are not considered contagious. " 
TB is attributed to (a) germ (b) socio- 
economic conditions; (c) transgression of 
social rules and (d) poisoning and the 
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Country, First Ethnic group Findings 
author 
influences of supernatural powers. 
Manila, Filipinos Perceived causes of TB: 
Philippines. (TB patients)   Drying sweat on the back, smoking, microbe, 
Auer C. [84] - semi drinking alcohol, dirty environment, sleeping 
structured on cold floor, fatigue, working too hard, 
interview frequent pneumonia, lack of food, poverty, to 
be near a TB case, inherited, many sex 
partners. 
Kenya, Kenyan tribes Perception of TB: 
Liefooghe (TB and non Dangerous disease, highly contagious and 
R. [93] TB difficult to cure. 
participants) 
West Malaysia, West Attributed symptoms to: 
Liam CK. [94] Malaysian   common cold 
(TB patients)   `weak' body 
  overwork 
  asthma, lung cancer, diabetes mellitus, 
pneumonia, TB, dengue fever, heart failure 
" cigarette smoking 
  effect of an abortion 
"a spell put on them by someone 
Orange Mexicans Symtoms associated with 
County, CA, (TB patients) -benign conditions gripe (grippe) or bronquitis 
Rubel AJ [3] (bronchitis) 
"a folk illness, susto 
" fatigue and weight loss due to hard work and 
lack of sleep 
As shown in Table 2.5, despite current knowledge on TB as to its cause and mode 
of transmission, in societies with linkages to their cultural roots, the 
understanding of TB is `richer' and diverse. Whether they are right or wrong is 
secondary to the fact that in order to engage TB patients and the community, 
such interpretations should be acknowledged. 
2.4 TB and stigma: untangling the web 
Stigma has often been seen as a barrier to seeking treatment and responsible for 
sending TB underground. Few researchers have tried to assess stigma and most 
have used qualitative approaches. Researches by Erving Goffman, a sociologist, 
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on face-to-face interaction or micro-sociology have made popular the concept of 
stigma. He defines stigma as "a process by which the reaction of others spoils 
normal identity. " He describes three different types of stigma as shown below: 
[95] 
a. Abomination of the body; the various physical deformities 
b. Blemishes of individual character perceived as weak will, domineering or 
unnatural passions, treacherous and rigid beliefs and dishonesty 
c. Tribal stigma of race, nation and religion; these being stigmas that can be 
transmitted through lineage and equally contaminate all members of a 
family. 
Although there were differences between the three types of stigma, the main 
concept was that of a "spoilt identity". Often the individual is blamed and yet in 
reality, other people such as the community, the state and global institutions are 
responsible in producing and ameliorating stigma. The concept of stigma should 
be discussed within a collection of concepts such as that of contagion, defect 
and disability and made relevant across many cultures and contexts. [96] TB is 
said to be a good example where the two concepts of stigma and contagion 
merge into each other thereby confusing the picture as to whether one fears TB 
because it is contagious or that it is a disease that sets one apart or both. In the 
absence of fear of contagion, stigma is lessened or nonexistent. Among the 
Vietnamese, one type of TB; 'Lao luc' (physical TB) is caused by hard work and 
not contagious and therefore families did not isolate the patients. [88] 
However, in general, the relationship between TB and stigma throughout the 
history shares a common thread running through; that of fear and isolation. It 
began with fear of its fatality as noted by Hippocrates around 460 BC. 
Hippocrates also warned his colleagues not to visit patients in the late stages of 
the disease, not because of anything but that the inevitable deaths would 
damage their reputations. [97] In `A New Theory of Consumption' by Benjamin 
Marten in 1702, he wrote "It may be therefore very likely that by an habitual 
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lying in the same bed with a consumptive patient, constantly eating and drinking 
with him, or by very frequently conversing so nearly as to draw in part of the 
breath he emits from the lungs, a consumption may be caught by a sound 
person...! imagine that slightly conversing with consumptive patients is seldom 
or never sufficient to catch the disease. "[97] This led to the avoidance of close 
and frequent contacts with TB patients. Sometimes, everyone in the family was 
inflicted and TB was thought to be hereditary. This led to a kind of 'familial 
stigma' which further led to isolation, separation and even divorce. 
Following the discovery of the tubercle, the early recommended treatment for 
TB was rest, fresh air and good food. As a result, sanatoriums mushroomed to 
make this treatment available. In fact, Styblo had suggested that isolation in 
sanatoria of highly infectious TB patients had reduced the risk of infection in the 
community. [22] The sanatoria have long gone but this form of isolation is still 
being replicated within families and communities even today. 
With the discovery of anti-TB drugs, TB patients can be cured and it is now 
possible to see the long term effects of TB on a person's life. During their illness, 
TB patients may lose a lot of weight, sometimes leaving just skin over the bones. 
After treatment, they can became a shadow of their former selves and never 
regain their former strength. This can be seen as a form of `deformity' or 
'disability' which could lead to stigma. Their quality of life can be compromised 
as noted by Chamla among the Chinese patients in his study. [98] Today, TB is 
feared for a familiar reason; the absence of cure, this time due to HfV, MDR-TB9 
and of late, XDR-TB h. Fear of TB has come full circle. 
& MDR-TB is a specific form of drug-resistant TB due to a bacillus resistant to at least isoniazid and rifampicin, the 
two most powerful anti-TB drugs. [99. http: //www. who. int/tb. 
h XDR-TB Is TB that is resistant to any fluoroquinolone, and at least one of three injectable second-line drugs 
(capreomycin, kanamycin, and amikacin), in addition to MDR-TB. This definition of XDR-TB was agreed by the WHO 
Global Task Force on XDR-TB in October 2006. [99. Ibid. 
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Macq et at have reviewed studies examining stigma and TB. [100] He defined 
studies as being about two classical types of stigma (enacted and perceived) and 
the potential negative impact of stigma on TB Control Programme. In addition, 
the determinants of TB stigma were often unfounded beliefs about transmission 
or health staff attitude. Finally, studies also found that TB stigma was often 
associated with patient's characteristics which were potential sources of 
discrimination such as gender, poverty and co-infection with HIV. [100] 
Understanding the features of stigma is invaluable as interventions can be 
focussed on each feature. For example, fear of TB can be allayed by convincing 
the community that TB is curable. Addressing the misconception that TB is a 
familial disease will lessen the effect of stigma. Counselling TB patients may 
improve the general health of the patients. However, in certain societies where 
discrimination towards certain groups such as the women or certain ethnic 
groups exists, merely unpacking the features of stigma wit( not be sufficient in 
influencing health and health care seeking behaviour. 
The understanding from the literature of factors, affecting delay, perceptions of 
TB and stigma were used to build a conceptual framework for this research. This 
conceptual framework on factors influencing health care seeking for possible TB 
symptoms is presented in the next chapter. 
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3 CHAPTER 3: A conceptual framework for health and 
health care seeking behaviour 
This chapter outlines the conceptual framework for health and health seeking 
behaviour among TB patients. The conceptual framework (Figure 3.1) was 
constructed using the following four models. These models of health-related 
actions, often constructed by social scientists, were developed to analyse how 
people view and react to health-related events. [101]. 
" Health Belief Model 
" Health Care Utilisation Model 
" The `four As' 
" Pathway model 
On their own, they are insufficient to explain the health and health care 
seeking behaviour among TB patients, hence the use of several models, the 
choice of which was informed by previous studies on health seeking behaviour, 
time period and delay. For example, studies from developing countries such 
as Tanzania[73,75] and Ethiopia[75] suggest that living far from health 
facility affect the time period between onset of symptoms and seeking 
treatment. As such, the health care utilisation model was included as the 
patient's perception of the severity of an illness as explained by the Health 
Belief model was insufficient to explain when and how the patient would seek 
care. Although the principles of the four As (Availability, Accessibility, 
Affordability and Acceptability) are already enshrined in the health care 
utilisation model, the specifics are important to consider when discussing 
health care access. The pathway model include the different options for 
action as well as the role of other people in the decision making process for 
seeking care. All models are explained and their usefulness and limitations 
discussed here. 
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3.1 Health Belief model (HBM) 
The core of the conceptual framework is derived from the HBM. This model, 
originally developed by social psychologists Hochbaum, Rosenstock and Kegels 
in the 1950s is a systematic method to explain and predict preventive health 
behaviour. The model was influenced by the theories of Kurt Lewin which 
states that it is the world of the perceiver that determines what an individual 
will and will not do. [102] 
This model hypothesised that the perceived susceptibility to a disease, 
perceive severity of that disease and perceived benefits of preventive actions 
minus the perceived barriers to taking those action explained the likelihood of 
an individual taking appropriate actions. [103] The HBM is popular in health 
education programmes even today but often its practical application did not 
yield the results or change in actions. Good, a medical anthropologist, is of 
the opinion that the main reason for this is because the HBM assumed a 
narrow conception of culture and human action. [103] Firstly, the assumption 
was that human behave rationally towards the goal of positive health; that he 
is able to weigh the benefits of particular behaviours and be able to act freely. 
Health culture was only as important as to the extent of its contribution to 
the decision-making process. The studies which revealed that those with 
increasing severity or haemoptysis tend to present late[66,83], suggests the 
first assumption may be incorrect. The second assumption is that lay medical 
culture was of a lower standard to that of biomedical knowledge. [103] These 
have been the limitations of the HBM and although it is relevant to TB in 
terms of outlining the various factors that influence decision to seek care, it 
does not identify what triggers a person to take action. [3] 
3.2 Health Care Utilisation Model 
This model, based on the works of sociologists Andersen and Aday, was 
included as it was specifically developed to investigate the use of biomedical 
health services. [104] This model provided a system perspective which 
integrates a range of individual, environmental and provider-related variables 
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associated with the decision to seek care. [105] It organizes factors related to 
health care service utilization into three categories: (1) predisposing factors 
such as attitudes toward service use; (2) enabling factors that promote or 
inhibit use; and (3) need factors of the patients which necessitates health 
care use. [104] By using this categorisation, the relevant factors in relation to 
health care seeking behaviour among TB patients were postulated and shown 
in Table 3.1. 
Table 3.1: Health care utilisation factors 
Predisposing factors Age, gender, education level, experiences , and 
attitudes towards health services, knowledge about 
illness, community pressure 
Enabling factors Financial resources, availability of health services, 
accessibility, social support 
Need factors Severity of illness, number of sick days, need for 
outside care 
One can see that this model complement the HBM by the addition of enablers 
and need factors which are important in the decision making towards health 
care use. 
3.3 The `four As' 
The 'four As' model has been widely used where distance (social and 
geographical) and economic aspects were emphasised as key factors for 
access to treatment. [106] The four As refer to availability, accessibility, 
affordability and acceptability. ( 
Table 3.2) 
Table 3.2: 4As factors in relation to access to health care 
Availability Refers to 'the geographic distribution of health facilities, 
harmaceutical products etc. 
Accessibility Includes transport, roads, etc. 
Affordability Includes treatment costs for the individual, household or 
family. A distinction is made between direct, indirect and 
opportunity costs. 
Acceptability Relates to cultural and social distance. This mainly refers to 
the characteristics of the health providers - health workers' 
behaviour, gender aspects (non acceptance of being treated 
by the opposite sex), excessive bureaucracy etc. 
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This model was included as it identified specific aspects of access to health 
care use. 
3.4 Pathway model 
This model, also known as the Kroeger's model is a variant of the Andersen 
model (health care utilisation model)[106] and starts with the recognition of 
symptoms and the path that people follow until they use the different types 
of treatment. It acknowledges the importance of 'significant others' in the 
decision making process. 'Significant others' are part of the 'therapy 
managing group' which include relatives and friends who play the pivotal role 
in illness negotiations and management. This concept was elaborated by 
Janzen for understanding decision making in therapeutic processes. [106] The 
inclusion of this model in the conceptual framework was in recognising that 
patients draw from the general knowledge and values shared by the wider 
social network in decision making regarding health care use. 
3.5 Hypothesis and Conceptual framework 
As a result of the amalgamation of the four models, a new model is produced. 
(Figure 3.1) The same predictive indicators in the HBM are shown on the left 
side of the model which has been further expanded to the right by including 
elements of the other three models. This progression from patients' 
perceptions on severity and benefits to therapy choices helps conceptualised 
what is currently known between health and health care seeking behaviour 
and time period. The enabling factors in section 3.2 have incorporated the 
elements of the four As. The roles of 'significant others' need factors and 
enabling factors provide cues to taking action for treatment. 
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Figure 3.1: Conceptual framework for health and health seeking behaviour 
among TB patients 
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This conceptual framework allows for clear thinking and planning on aspects 
that should be included in the research. For this research, the aim is to 
identify among others, the explanatory factors to delay and therefore having 
a framework which conceptualise the patient's behaviour in relation to illness 
is invaluable. For example, in assessing health care utilisation, one should 
consider all the elements of four As. Without a conceptual framework, only 
one or two elements might be considered in terms of access. Furthermore, a 
conceptual framework also helps in identifying appropriate research methods. 
Some concepts can be translated into operational variables such as 
accessibility by using proxy measures such as distance or travelling time to 
the nearest health facility. These data can be collected using structured 
questionnaire. In contrast, concepts on the role of `significant others' and 
social acceptability are better explored using in-depth interviews and focus 
group discussions. 
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3.2 Summary 
The development of the conceptual framework for health and heath care 
seeking behaviour was based on four models: the health belief model, health 
care utilisation, the four As and the pathway model. They were chosen based 
on the fundamental aspects of the models which explained in part the 
patient's behaviour in seeking care and also how they explained other 
important factors such as access and role of other people. The conceptual 
framework provided conceptualised variables which need to be translated into 
operational variables. This wilt be explained in Chapter 5. It also provided 
insight as to the appropriate research approach for data collection. 
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4 CHAPTER 4: Qualitative study 
This chapter documents the details of the first phase of the research which is 
a qualitative study to explore the health and health care seeking behaviour 
among the people of Sabah (Sabahans) with regards to TB. 
4.1 Objectives 
The specific objectives are: 
a. To assess knowledge and perception of TB among TB patients and the 
general community through in-depth interviews. 
b. To examine perceptions and experiences of health care services. 
c. To examine the impact of TB on the patients and families in terms of 
emotional, physical, social and life practices. 
4.2 Study population 
The people of Sabah include 32 indigenous groups with over 80 locally spoken 
dialects with a wide variation in traditions and cultures. For example, the 
Kadazandusun, the largest ethnic group in Sabah, are predominantly wet and 
hill rice cultivators. Although majority belong to one of the major religions 
such as Christianity and Islam, some still hold to the ancient beliefs and 
practice. One such practice is the annual state-level Harvest Festival to 
honour Bambaazon or Bambarayon, the rice spirit for yet another bountiful 
year. The Bajaus are great horsemen and commonly known as the famous 
Cowboys of the East. The Rungus reside in the northern districts of Sabah 
while the Muruts inhabit the interior and south eastern parts of Sabah. This 
group alone has 15 languages and 21 dialects and were, until the last century, 
head hunters and longhouse dwellers. Most practised shifting cultivations and 
are skilled hunters. [39] 
Even in these modern times when most Sabahans professed either, Christianity 
or Islam, there is still a well known belief amongst indigenous people that a 
person may fall ill due to the works of the evil spirit or from sickness `thrown' 
by someone else, a disease giver or the soul of the dead. 
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Ritual specialists or traditional herbalist are important persons in any village 
in Sabah. Their services are often sought 'to divine the nature of illness, to 
undo unfortunate events, to restore matters to original condition, to prevent 
sickness or to provide protection against impending harm. 
The relief of sickness may be attempted in two ways: to perform ritual to 
divine the nature of illness and to effect its cure or the use of a variety of 
plants substances to treat illnesses and to provide immunity to specific 
diseases. [107] Consultation with traditional heaters is not peculiar to the 
people of Sabah. It is an accepted practice in Malaysia. Among psychiatric 
patients in East coast of Peninsular Malaysia, 73% had consulted a bomoh 
(indigenous Malay medicine-man) prior to their visit to the government 
clinic. [108] Among the Semai tribe of 'Orang Asti' (indigenous people) in West 
Malaysia, the Tok Halaq (traditional heater) is the first person the community 
will sought advice from, even when health services are accessible. [109] 
This study was conducted in 7 districts; Kota Kinabalu, Penampang, Putatan, 
Tuaran, Kota Marudu, Kudat and Keningau. Kota Kinabalu is the state capital 
with a mixture of all ethnic groups. On the other hand, Penampang is a 
predominantly Kadazan area where a third of the population belongs to this 
ethnic group and the neighbouring district of Putatan is a predominantly 
Malay area (57%). [110] Around 45% of the population in Tuaran are the 
Dusuns followed by the Bajaus (28.9%). Similarly, around half of the 
population in Kota Marudu are the Dusuns. In contrast, two thirds of the 
neighbouring districts of Kudat are Rungus while in the interior district of 
Keningau, two thirds are of the Kadazan-Dusun-Murut ethnic goups. [110] 
4.3 Methods 
The methods employed for this study were a combination of methods 
summarised below: 
a In-depth interviews were performed on 17 TB patients from 7 districts. 
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a In-depth interviews were performed on 15 respondents who were 
either spouses, relatives or other people in the village. One of these 
was a village headman and two were traditional heaters. 
Feedback from health staff during 2 meetings. 
Feedback from staff in charge of the TB Clinics. 
Review of past documents including newspaper cuttings. 
Observations of patients in the hospital wards. 
4.3.1 Sampling methods 
a. Purposive sampling 
Purposive sampling to took for information-rich cases, with a mixture of 
extreme, typical and 'political sampling' as suggested by Patton was 
emp(oyed. [111] An `extreme' case would be someone who was 
underprivileged and perhaps marginalised and a `typical' case would be a self- 
employed person from a rural setting or an urban housewife. By using 
`political sampling', someone from very deprived areas with known problem 
of access could be identified. The sampling matrix for the purposive sampling 
used in this study is as tabulated below (Table 4.1). 
Table 4.1: Sampling matrix for identifying interviewee 
Group Income level Gender, -r 
and location Male Female 
Patients Low income 
Rural XXXX XXXX 
Urban XXX XXX 
come X 
Traditional heater xX 
Family member or relatives Rural XX XX 
or other key informants Urban XX XX 
Health staff XX XX 
Participants were identified by health staff working in the particular district 
based on the criteria outlined below. ( 
Table 4.2) 
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Table 4.2: Sample size, methods and criteria for eligibility 
Interviewee Methods Criteria for eligibility 
TB patients In-depth " Smear positive TB cases and still on 
interviews treatment at the time of research. 
Relatives In-depth " Has a family member or relative who 
interviews is/was a TB patient. 
" Actively involved in the care of the 
patient for example the spouse, parent 
and children. 
Traditional Key informant " Known to have treated TB 
healers interview patients 
Village Key informant " Village headman from high risk locality. 
headman interview 
Health staff Discussions, " From districts involved with the research. 
feedback, 
observation 
b. Theoretical sampling 
Theoretical sampling was also done because during the course of the 
interviews, there were interesting findings such as on stigma and effects of TB 
which needed to be explored. Therefore, the interviews were extended to 
specifically include more people who could provide such information. These 
findings were also supported by reviewing materials such as reports and 
newspaper cuttings. 
c. `Opportunistic' sampling 
Information was also obtained from relatives who accompanied patients who 
seemed eager to be involved in the interviews. They often have more to say 
than the patients or were quite strong in stating their stand that patients may 
not want to express their views in their presence. It was helpful to bring these 
relatives aside and interview them separately. This was also to maintain 
patient confidentiality. Sometimes, an opportunity presents itself when 
people knew that I was conducting a research on TB. In the second phase 
(quantitative) of the study, some patients were more than willing to narrate 
their experiences and such patients were interviewed separately on these 
63 
Chapter 4: Qualitative study 
issues. Similarly, some discussions and feedbacks from health staff at the 
clinic levels were often opportunistic in nature. 
4.3.2 Data requirement 
The data needed for the conceptual variables which were outlined in the 
guide for in-depth interview (Appendix 3) were: 
a. Local terminology with regards to TB 
b. Recognition of symptoms 
c. Perception of illness 
d. Health seeking and health care seeking behaviour 
e. Knowledge of TB 
f. Perception of care 
g. Effect of disease on the patient and family 
h. Community perception of TB 
4.3.3 Data collection methods 
a. Interviews 
Interviews were carried out as agreed by the interviewees in terms of time 
and place. It became apparent early during the interview phase that 
respondents residing in urban areas prefer to be interviewed at the clinics 
while those in the rural areas did not mind being interviewed at home. 
Oftentimes, interviews conducted at home attracted the interest of more 
than one person, Family members seemed interested to sit in during the 
interviews and most respondents said that they did not have any problems 
with that. Only 7 respondents were interviewed in the health clinics, the rest 
were done at the respondents' home. After identification of respondents by 
the health staff of the TB Unit in the districts, verbal agreement was obtained 
prior to the interview. This may be through the phone or more often, a visit 
to the interviewees' homes. This was followed by another visit for the 
interview, often with the same health staff who on several occasions also 
acted as a translator. Translators were needed for 5 interviews. Alt interviews 
except for the first two were tape recorded with verbal permission from the 
participants. 
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b. Feedback and discussions 
Most responses from the feedback and discussion sessions with health staffs 
were handwritten. Feedbacks from health staffs were available during two 
important meetings where I presented the earlier findings on knowledge of TB, 
perception of illness, heath seeking behaviour and also the effects of TB on 
their lives. The two meetings were: 
i. A meeting organised by the Sabah Health Department on the 23rd November 
2005 which was attended by around 25 senior public health officers. 
ii. A meeting for all health inspectors and medical assistants involved in the 
TB Control programme throughout the state of Sabah on the 3rd December 
2005. About 100 staffs were in attendance. 
Many issues were also discussed with the health staff at the clinic's and 
hospital level throughout the entire research period which was from 15` August 
2005 to 30th April 2006 (9 months) especially on the reasons for patients 
coming late for treatment. 
c. Review of relevant studies and documents 
As part of data collection, I have also reviewed other documents such as 
anthropological studies in Sabah and newspaper cuttings to complement the 
findings from interviews and discussion. 
d. Observations 
Observations on the patients' experiences in the clinic and wards were also 
included in the findings. 
4.3.4 Ethical issues 
Informed consent was prepared and completed before the interview process. 
(Appendix 4) 
a. Autonomy 
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The respondent could at any point before or during the interview refuse to 
proceed with the interview. In addition, he/she could indicate questions 
which he/she was not happy answering and the questions would be passed 
over. None of these occurred during the interviews. 
b. Confidentiality 
All information obtained was kept confidential. In instances where 
translators and other assistants were involved, they were also asked to 
keep the information confidential. The choice of translator was also 
important. He/she should not be recruited from the same village as that of 
the , respondent. This again was to ensure confidentiality. Only two 
translators were needed throughout the research and they were not from 
the same village as the respondents. 
c. Anonymity 
This was maintained by avoiding any reference to the actual name or any' 
other circumstances that might be easily connected to the respondents. 
Due to the small number of respondents, village or place of residence and 
even the districts were not referred to in the results. The same approach 
was used with health staff. 
This research had the ethical approval both from the London School of 
Hygiene and Tropical Medicine and the Ministry of Health Malaysia. There was 
no external financial assistance for this phase of the research. 
4.3.5 Analysis 
Alt in-depth interviews except for the first two were taped and took between 
one to one a half hours to conduct. Transcription of interviews was performed 
immediately and in the language in which interview was conducted. Each 
transcription took between 4 to 6 hours. Then they were translated to Bahasa 
Malaysia (national language). Data analysis was done in several stages 
throughout the research in the national language using thematic content 
analysis. 
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a. First stage: Finding common themes 
The first stage was to inform on the questionnaire which was to be used for 
the quantitative research. As such, general themes with regards to symptoms, 
causes, health care seeking behaviour and perception of care were identified. 
b. Second stage: Looking for emergent categories 
This was a more rigorous process of analysing the content for the emergence 
of new categories and subcategories. This was particularly important in 
identifying the various categories of effects of TB and stigma. 
c. Third stage: Synthesising findings 
This process involved looking for relationship between the various themes in 
an attempt to create a clearer understanding of TB as seen from the patients 
and community perspective. 
d. Triangulation 
Wherever possible, supporting data in various forms were added to the 
conceptual variables so as to present a more holistic picture. Often this 
included notes from short interviews, feedback and discussion. Other times, 
related published documents were used. 
4.4 Findings 
The findings presented are analysis of the interviews and where relevant, 
input from other sources such as from newspaper cuttings and observations 
are included. 
4.4.1 Characteristics of participants 
A total of 17 patients (P)' and 15 others (NP)i who were spouses, relatives, 
villagers and traditional heaters were interviewed in the seven districts and 
'In the text, the letter `P' after the excerpt refers to that taken from the interview with patients and 
J 'NP' to that taken from interview with non-patient participants. 
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they were mostly women. However, among the TB patients, seven were 
women and the remaining were men. The age ranges from 18 to 66 years old. 
Almost all participants have either no formal education or only completed 
primary education. Most of them were unemployed or self employed such as 
housewives and farmers. The ethnicity of the respondents varied; mostly were 
Rungus and Bajaus but there were also Kadazans, Dusuns, Muruts, Brunei, 
Indian and Chinese. Among the non-patient respondents, two thirds were 
women. The age ranged from 27 to 65 years old. Similar to the previous group, 
most were unemployed or self employed. 
The above mentioned were those involved in the in-depth interviews. There 
were many others who have participated by giving short descriptions, 
responses and feedback who are not listed. They include 10 other patients 
from the quantitative study, 5 relatives and 11 health staff. 
4.4.2 The community perspective of TB 
"in 1960s, dwellings were sprayed for the control of Malaria. When the spray 
team came to a house in our village, they heard someone in the house 
coughing and saw a very thin and ill-looking man coughing out blood. He told 
the members of that household that the man might be suffering from TB. It 
was the first time the villagers heard of such name. Not long after that, 
health staff came from the state capital to treat those with TB and in those 
days, injections were used. They put up beds in open spaces for the patients. 
I noticed the adults were frightened of the injections. I was just a kid then 
and had never seen adults running or hiding away from the medical team. It 
was so funny (laughs). " (As told by a patient, NM, farmer, 55 yrs old) 
The above illustrated the relatively 'unknown' TB as a disease entity in the 
1960s. In most places in Sabah, `TB' is a name introduced by the health staff 
to the locals in the early 1960s. Since then, TB once a nameless disease but 
often described by its symptoms (chronic cough, coughing out blood and being 
very thin) became well-known as 'TB' or 'batuk keying' (dry cough) or 
'mengurus' (becoming thin). 
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In a report in the local newspaper, The North Borneo Herald of November 
1883, a medical doctor in Sabah (then known as North Borneo) wrote that 
`consumption' (as TB was known then) was rare[112] and indicated that TB 
was relatively unknown at the turn of the century. Such lack of knowledge on 
TB resulted in many misconceptions on the care of TB patients such as the 
fear of injections. In a TB prevalence study conducted among the Muruts of 
rural Pensiangan in 1969, many participants did not return for the Mantoux 
test reading because they were apprehensive about the syringes. Many 
thought that evil may enter the body through injections. [113] This fear of 
injection may also be the reason for the 'funny' incident in the narration 
above. 
As little was known of TB, it was not regarded as `the works of the evil spirit' 
and thus the role of spiritualist was minimised. Two traditional healers were 
interviewed and both said that they were not taught on how to treat TB. 
According to them such disease did not exist when they started their training 
at the tender age of 10 years old. One had been a traditional healer for 20 
years and the other for 15 years. Instead, they believed that TB was due to 
hard tabour and eating contaminated food and could be treated through 
traditional rituals such as sacrificing pigs. 
Traditional medicinal plants were also used by the natives for generations in 
relieving symptoms of many diseases and the cure for various 
infections. Knowledge of medicinal plants has been the key for their survival 
especially among those who live in the interior. Nowadays, people who live 
far from towns still rely on traditional cures handed down to them through 
their ancestors. For example, the stem barks of Caesalpinia sappan of the 
leguminosae family, when boiled and drank has been used for treating 
TB. [114] Even the traditional healers interviewed used specific plants to try 
to relief the symptoms of cough. Whether this was the same plant mentioned 
earlier, it could not be ascertained during the interview. 
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Q. Have you ever treat anyone who has cough for a long time? 
A: Yes. 
Q: How do you treat them? 
A: There is this root of a plant which he has to put in water and drink. 
Q: What do you think is the cause of his cough? 
A: There was some food that he has eaten. 
Q. What sort of food? 
A: lt can be anything. It is like food poisoning. 
Q: So if he drink the water with the roots, can he get better? 
A: Sometimes. (NP3) 
Most health beliefs surrounding the cause of TB were formulated from within 
the community. There is also a fusion of cause and transmission forming a 
hazy picture of how one gets TB. When the patients were asked as to the 
cause of TB, most answers revealed the way TB occurred or got transmitted. 
The prevailing notion is that there was a 'tear' inside the body which 
eventually became 'rotten' making it possible for 'something' to enter the 
'tear' and caused TB. The 'tear' could have been due to several reasons; 
chief among these is hard work. Still, there are others who believed that TB 
started off as gastritis (inflammation of the stomach lining). 
"According to the people here, the origin of TB, number one is gastritis. 
Firstly, because he did not look after his food (nutrition). You know how it is 
with this village people.... sometime when they go to work...... they have not 
eaten, not taken any drinks. Hah, that is the cause. " (NP5) 
Some patients do not believe in this `a tear inside the body' notion but felt 
that they got the disease due to work condition such as exposure to rain and 
sweat. Others believed that TB was caused by eating or drinking contaminated 
food, food that have been exposed to dirt, dust or even the saliva of TB 
patients. Another patient recalled the day when he had continued farming as 
there was stilt plenty of daylight but had ran out of drinking water and he 
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decided to drink the water seeping from the rocks. He thought maybe that 
was how he got TB. 
There were some who agreed that TB was caused by germs but according to 
them, that did not explained how one got the disease. One patient thought 
that TB was hereditary because all his family members were affected with TB 
except for him and his sister. When he was told that he had TB, he was not 
surprised. 
The traditional belief of sickness being `thrown' by someone else proved to be 
more prevalent than the belief that TB was the work of the evil spirit. One 
patient believed that she was weakened by TB; as a result of which, it was 
easy for her to get `charmed'. 
A: In May, I felt this sharp pain just below my ribs. It felt painful when I 
cough, like being sliced by a knife. My uncle took me to see a 'bomoh' 
(traditional healer). You see, last year someone cast a charm on me. I had to 
be treated by 4 different 'bonroh'. Before I went to see the traditional 
healer, 1 went to a private doctor and asked for a scan over the area. 
Q: When you saw the 'bomoh', did you tell him that you have TB and are still 
on treatment? 
A: Yes, I told my family and the 'bonroh' but they told me to get treatment 
anyway, because l may have two illnesses. 
Q. What medicine did the 'bonroh' give you? 
A: Well, just water that has been `blessed' and told me to avoid some food. 
Q. Do you think that you have TB because someone has 'charmed' you? 
A: No, but maybe because I am already weakened and sick by TB, then he 
sent another illness to me. (P1) 
In another interview, an ex-TB patient related his experience of having TB 
some five years ago. He was getting thinner by the day and had been 
examined by doctors several times; had sputum examination repeatedly and 
also had a chest x-ray or two. However, it was apparent that he was getting 
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worse and thought that the end was near. His mother-in-law decided to seek 
an experienced heater who told him that someone has 'charmed' him. He was 
treated by the healer and about a week later went to the clinic again for his 
review. The sputum examination returned positive and a repeat x-ray 
revealed damage in the right side of his lungs. He believed that the 'charm' 
has masked his disease. 
Most respondents agreed that TB is infectious and can spread through sharing 
eating utensils and through face to face interaction. Among some cultures in 
Sabah, many social gatherings involved drinking local rice wine often served in 
a jar and sipped through bamboo straws. Many people of this culture were of 
the opinion that sharing cups and eating from the same plate as well as 
sharing the bamboo straws were routes of TB transmission. Due to this belief, 
TB patients do not share utensils or meats with family members and others. 
This belief that sharing bamboo straws can spread TB is quite wide spread 
even among local leaders. In a speech by a local assemblyman at a district 
level World TB Day celebration, he said "TB is caused by a virus which can be 
spread through saliva. The people should be aware that among the ways that 
the virus can be spread in our culture is through sharing of glasses and 
"monsiop tapai" (rice wine sipping). " (Reported in Daily Express (local Sabah 
paper), 25th June 2004. ) 
4.4.3 Health seeking and health care seeking behaviour 
The commonest symptom was cough. This was followed by loss of weight. 
Continuous coughing usually affected sleep and difficulty in breathing 
sometimes forced patient to sleep in a semi recumbent position for relief. The 
other respiratory symptoms experienced were hemoptysis (coughing out 
blood), shortness of breath and chest pain. The most commonly feared 
symptoms were persistent cough and coughing out blood. The commonest 
constitutional symptom was loss of weight followed by fever. The other 
constitutional symptoms were loss of appetite, difficulty in sleeping and 
lethargy. 
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Some patients knew they had TB because they have heard of the disease or 
have experienced the disease in their family. Other patients thought they 
were suffering from other diseases but had no idea what they were. Others 
thought they had diseases such as diabetes, asthma, gastritis, breast cancer 
and common cold. One patient thought she had been `charmed' white another 
two were not concerned with their symptoms and did not sought treatment 
until much later. Among the non-patient participants, cough and/or coughing 
out blood and loss of weight were identifiable with TB. 
Almost all patients sought treatment due to worsening of symptoms. If cough 
did not get worse such as by becoming productive and persistent, this 
symptom would be ignored for a tong time. However, if cough was 
accompanied with blood or difficulty in breathing or lethargy, treatment was 
sought promptly. One patient sought a traditional heater first before getting 
treating from a government clinic. This was because she and her family 
thought she was poisoned. Her husband told us, "Yes..... for about a month 
(she took the traditional medicine). After that ...... when there was no 
improvement, my father-in-law said.... let us bring her to the hospital. First 
time we went, they could not find what was wrong with her, they just 
examined her and said that she had common cough. My father-in-law was not 
happy. Let us bring her back to the hospital and ask for an x-ray. That is why 
the second time 1 took her, she had an x-ray done and then we were told she 
has TB. " 
The first choice of treatment was related to the understanding on the cause 
of illness. In most instances, patients rely on modern medicine for cure. 
However, other options were considered when modern medicine failed to 
provide complete cure. More than half of the patients did subscribe to 
multiple forms of treatment especially when they did not find complete 
recovery with the treatment provided by the doctors. One patient said he 
bought numerous medicines before being diagnosed with TB. He began by 
buying some medicine through direct selling agents. 
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Q: This medicine, what does it do? 
A: I don't know what it does. These two bottles, 5 drops from each. 
Q. Is it any good? 
A: ! think it is quite OK. But this is what I am thinking now, this is RM40 
(-USD10) each bottle, I am thinking when the doctor told me that 1, have scars 
in my lungs; I think this medicine can heat the wound but the germs don't die. 
They make the germs go and hide, making them more difficult to be detected. 
Q. This is what you believe? 
A: This is what I believe now. 
Q. Did you take anything else, herbs, for instance? 
A: Oh, different types of herbs, cannot be counted, whatever i hear: roots, 
saplings, everything, / have tried. 
Q: How did you get them? 
A: I look for them myself. Someone just showed me what they look like and 
where to get them. (P10) 
This patient would not seek a traditional healer due to his religious faith, a 
decision which many Sabahans Christian would be able to relate to. In fact, 
some people may not admit that they sought traditional heaters as this was 
considered a pagan practice. 
Most patients admitted to making their own decisions regarding treatment 
although this is often influenced by advice from family members and relatives. 
Most families in Sabah are still close-knitted and in some communities such as 
the Rungus of Kudat, many families reside in a `long house'. 
In the past, village headmen were highly respected individuals in the 
community. They served under the Native Chiefs who were responsible for 
preserving law and order in their districts. [115] Native Law is still being 
practiced in Sabah and village headmen are experienced in this law. They are 
even allowed to perform marriages according to the natives' culture. No 
activities should proceed unless permitted by the village headmen. In the past, 
villagers even sought the opinions of the village headmen regarding illnesses 
and forms of treatment. However, in present days, this is no longer the case. 
74 
Chapter 4: Qualitative study 
Upon being diagnosed with TB, patients were offered health education at the 
start of treatment. An examination of the health education materials at the 
clinics revealed that they only dealt with facts about the disease and 
treatment. Often, this form of providing health education may not be 
effective as little could be absorbed by the patients then as they reflect on 
how they could have contracted the disease and how their lives would be 
affected. At such an early stage in the treatment phase, patients may be 
embarrassed to discuss some sensitive issues such as whether TB was 
transmitted through sexual intercourse. Proper counselling sessions to TB 
patients has not been offered by the health provider due to lack of resources. 
This may attribute to poor knowledge of TB patients as revealed earlier. 
In terms of patient care, most TB patients were treated on an ambulatory 
basis. However, one hospital routinely warded their TB patients for the first 2 
months. It was distressing at first to find TB patients wandering around or 
idling about in the wards. Most patients said that they were bored and wished 
to be home. The only apparent advantage was in the physical improvement in 
terms of weight gain. Those warded seemed to gain weight much faster than 
those on ambulatory care. One patient said this was because in the hospital, 
they eat 6 times a day, 3 more meals than what they would have at home. 
4.4.4 Impact of . TB 
Most patients told their family members about their disease. One did not; a 
bachelor who lived on his own. One patient told her relatives about the 
disease and another two informed other people such as church members, 
superior and close colleagues at the office. The reasons for not telling other 
people outside the family circle were mainly due to worry about other 
people's reaction, felt that others did not need to be told and considered TB 
as an embarrassing disease. One respondent was worried that people might 
equate TB with AIDS and distanced themselves from him. 
The support that the patients received from their families in general, was 
good. There were various ways in which support was advanced such as 
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agreement to supervise medication, accompanied the patient for treatment 
or volunteered to get the medicine for the patient from the clinic or took over 
some of the patient's responsibilities such as tending the farm and cooking for 
the family. Family support is vital in helping the patients cope with everyday 
living throughout their illness period as the effects of TB on the patients' lives 
are substantial for example in terms of emotional and social aspects as shown 
below. 
Despite good support from their families, some patients often felt that they 
were not able to discuss aspects of their disease openly. Oftentimes they 
were preoccupied with what others thought of them and this preoccupation 
affected them emotionally and psychologically. They also worry about the 
future; after the completion of treatment. 
Judging from the depth of emotions such as worry, sadness and preoccupation, 
it seemed that women tend to be more affected emotionally while men tend 
to worry over financial and physical aspects. This is because, most mate 
patients found it difficult to work because of the need to go to the clinic 
regularly for treatment and therefore became dependent on others. 
Sometimes, they have to borrow money from relatives and friends for bus 
fares. Sometimes, patients may not be able to keep their appointments as 
they have to earn the money for the bus fares. 
"This time, it (the medication) was for 2 weeks. He gave me medicine supply 
for every 2 weeks. Earlier on, he asked me to come every day but 1 told him, 
am a poor man; I do not have my own transport. Everyday'I have to spend 
RM 12 (about USD 3) for transportation, how can I bear this financial burden, 
told the doctor. We discussed for quite some time and he agreed to supply 
the medicine for 2 weeks. I said, if for every 2 weeks, I can afford to bring 
my wife here (for treatment) but if every day, I said, how can I go out to sea 
(to fish). " (NP7) 
As a result of TB, patients often felt weak and never fully recover to their 
pre-illness physical state. In most instances, the patients mainly the men 
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could not carry on with their daily work due to physical weakness. Many 
patients who were farmers find it difficult to continue farming due to residual 
weakness. 
"Of course it is difficult. Before I had this disease, I was only old. But 
whatever 1 want to do, I did it on my own. But now that I have this disease, 
even though I am almost cured, according to the doctor and my own feelings, 
definitely 1 will not recover completely as before. So, definitely it is difficult 
because before this illness, whatever work, I did it myself. But now, even 
near the house, even when 1 see all the plants withered away, 1 cannot do 
anything. "(P10) 
Almost all the patients mentioned the need to make changes in their everyday 
living as a result of TB. These include separation of utensils, making new 
steeping arrangement and reducing social contacts and activities. The need to 
separate utensils was most often initiated by the patients. Making new 
sleeping arrangement could cause problems between husband and wife. 
"Ah, when my husband had TB, if 1 am not mistaken, I did not steep with him 
for 7 months. He had to steep on the floor while I slept with our second child 
in the bed. I think for the first 3 months he was hurt by that but 1 told him It 
is not that I am neglecting his needs but this is for our own good. "(P3) 
Many'patients took the initiative to distance themselves from their families by 
keeping separate utensils, eating separately or sleeping separately. There 
were two extreme cases in which the patients moved out of the house 
temporarily during the treatment period. It was their decisions even though 
their family was against it. One patient rented another flat not far from his 
family during his treatment period. His wife came everyday to bring him food. 
His reason for moving out was that he was worried of infecting his baby son. 
Another patient moved to a small barn which also served as a store for the 
family's paddy stock. It was quite ironic because instead of being left on his 
own, his children and grandchildren and relatives never left him in peace. 
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Whoever brought food for him would sit and eat together with him. His 
grandchildren would play in the barn to keep him company. One patient was 
isolated by his family. He was asked to live in their farm house and looked 
after their farm. He sold the farm produce for money and when there was 
none to sell, he begged for money from friends and the public. 
Besides support from their families, TB patients had little support from others. 
In Sabah, the only known non-governmental organisation which supports the 
fight against TB is the Sabah Anti-Tuberculosis Association (SABATA). It was 
founded some five decades ago and receives an annual grant from the 
government to run its activities. However, most district branches of SABATA 
are not active. Some respondents did receive some form of financial 
assistance from SABATA. However, this financial assistance differs 
considerably between districts. In some districts, a sum of RM15 (-USD4) was 
given out every month to all patients. In other districts, the patients were 
reimbursed for their travelling fares. At one time, some patients were given 
money to buy lunch while waiting for the research team to arrive. Such 
financial assistance, though small in sum, was important to some patients and 
to TB control programme as it lessened the patients' financial burden 
especially in terms of transportation fares. In Sabah, anti-TB drugs and 
hospitalisation are free. For government servants, 2-weeks medical leave is 
granted or longer according to the patient's medical need. Unfortunately, the 
same has not been offered to those working in the private sectors. 
As mentioned, most patients did not tell other people outside the family 
circle mainly for fear of isolation or fear of negative reactions from others. 
This could be due to perceived stigma on the part of the patients rather than 
the experience of enacted stigma. In some situation, the latter may be true. 
One such case involved a temporary health worker who passed remarks about 
a couple who both had TB (P12 Et P13). The couple operates a small grocery 
stall in the village. 
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Wife: We don't take our medicine from the clinic here. (Laughs) 
Q: So, where do you get your medicine? 
She mentioned another clinic, about 20 km from the village. 
Q: Why? 
Wife: We are embarrassed, because a lot of people have been talking, they 
said we are infectious. We had a tiff with some of them. We did not ask for 
this disease, we told them. 
Q: Who did you quarrel with? 
Wife: With the health worker. He told the villagers, don't go and buy from 
their stall. I 
Husband: Don't play with their children. Don't go near them or you will get 
infected. He called us the "TB grocer". 
Q. He is working at the clinic here? 
Husband: Yes but now he has stopped working there. 
Q: So it was just him or the other staff as well? 
Wife: Just him. 
Husband: He is the only one but he told many people. 
Q: What about the other villagers? 
Wife: They are OK. 
Husband: They treat us the some as before. 
Q. Did anyone come to buy things from your stall? 
Wife: Not at the beginning. (Laughs) 
Q: How long did that last? 
Wife: Maybe 3 days. 
Husband: Not 3 days, more like a month. 
Q. Why is that? 
Wife: Well, they were scared. 
Husband: They were scared until I told them, although we are sick like this, 
we have never brought our plates and beg for food from you. I maybe sick 
but I can feed myself, 1 told them. They said we are 'TB grocer' and that 
hurts. If someone had said that 1 have TB, l am not ashamed, I did not ask for 
this. And I am not the only one with TB here. 
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In the above mentioned case,, perhaps there was more than enacted stigma on 
the part of the health staff. He may have resented the couple as they were 
not originally from the village and also of a different race. In general, there is 
a great tolerance for multi-ethnic existence within a village in Sabah. 
However, the above incident suggested that hostility may not be attributed 
solely for having TB. It also revealed how easily the villagers could be 
`frightened' into keeping their distance and just as easily, changed their 
reactions when one appealed to them sensibly. 
Stigma was also assessed from the community's perspectives represented by 
views from non-patient respondents. It was disturbing to find that in some 
communities, TB patients who are single faced a poor prospect of marriage. 
A: For example, when he comes to our house, so as usual, during meal time, 
we feed him too. After that, we separate his bowl and plate. When he has 
left, we wash his bowl and plate, first with soap water then with hot water. 
That is what we have been told. 
Q: In your opinion, if someone has TB, can he get married? 
A: If according to our custom, he can't, because he is like, physically 
deformed. After all he cannot look for job. It means that he can no longer be 
responsible for his family. (NP14) 
It also appeared that stigma did not disappear after cure. One elderly patient 
when asked how she could have contracted the disease narrated a family 
gathering which was attended by a relative who was known to have TB. 
Although that relative had completed treatment, she was not sure whether he 
was cured and seemed to be under the impression that she could have got the 
disease from him. This could be due to inadequate knowledge on the 
curability of TB or an underlying belief that a TB patient would always 
remained one. This might explain the reason why some people do not want to 
marry someone who had TB. It seemed that stigma (perceived and enacted) 
might be deeply rooted within all the communities. However, there are some 
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evidence that stigma has lessened over the years as shown as observed by a 
patient. 
"This disease, it is like a disgrace. Last time (in 1987), when my husband was 
sick, so we went to the hospital, when they know that my husband has TB, 
they were afraid to come near my husband. This, from hospital staff, from 
nurses. Maybe now, this disease is like normal, not like before, too 
embarrassing to tell others. "(P3) 
It is difficult to hide one's disease from the other villagers. In our experience, 
it seemed that once a person gets TB, almost everyone in the village would 
know. The extent to which one would hide his/her disease reflected the 
stigmatising effect of TB. Most patients especially in urban areas and those 
who did not have financial difficulties preferred to be interviewed in the 
clinic. However, one lady who lived in a rural village would rather walk for 2 
hours to her brother's village to be interviewed rather than have us visit her 
at her village. 
4.4.7 Patient and health care provider views of TB care 
The patients' and relatives' perception of care provided by government and 
private clinics was generally fair; most respondents said that the care was 
good or that they did not encounter any problems during their consultations 
with doctors. However, two did not wish to comment and another two were 
frustrated with the doctors who could not diagnose their disease early. 
Many health staff did not realised the impact TB has on the patients' lives as 
there were very little discussion regarding these effects between health staff 
and the patients. Also surprising was on the lack of knowledge on TB among 
the patients and community despite several decades of efforts in health 
education on TB. It is likely that in the past, the emphasis was more on case 
identification and completion of treatment. Little was done in understanding 
the socio-cultural dimensions of the disease. Health education materials were 
factual and standardised without addressing some of the misconceptions 
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surrounding TB. A senior officer related how a phone call to a patient's office 
from the Health Department resulted in the patient's fury as she did not want 
anyone in the office finding out that she has TB. Another staff related how 
health staffs were sent off when they made a home visit in full uniform and 
using the department vehicle. This sort of behaviour poses difficulty for the 
team as they have to conduct case investigations which involve visiting close 
contacts. In this study, since it was hard to predict the participants' reaction 
to being interviewed, the choice of place for interview was left entirely to the 
participants. 
The summary of this study was also presented to health personnel in two 
meetings as already mentioned. It was felt that the study highlighted 
misconceptions and stigma surrounding TB that should be communicated to 
the health providers which cannot wait until the completion of the research. 
Based on the responses during the two meetings, it was clear that the 
patients' and community's perspectives were quite different from that of the 
health providers'. Most health staff did not realised that the patients' and 
community's knowledge were poor and that the effects were considerable. 
Most health staff expressed these opinions as to why patients present late; 
r4 Patients live far from health facilities and public transportation 
is 
scarce. 
6 They face financial difficulties especially for transportation as most 
patients are poor. 
69 Patients think that their illness is not serious and that they may 
recover through their own effort such as buying medicine from medicine shops. 
8 For mothers, they may find difficulty in leaving their small children. 
s Farming activities made patients postponed an intended visit to seek 
treatment as there was nobody to tend to their farm in their absence. 
ep Not able to get away from work; among estate workers or those on 
daily wages, taking the day off to go to the clinic may mean no income for the 
day. 
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While the reasons given are valid and reflected in some of the answers 
provided by the patients and community, the clearer understanding among 
the health staff of the health and health care seeking behaviour of the 
community is lacking. There was no mention that patients might be 
embarrassed about the potentiality of being diagnosed as TB or that negative 
attitudes of health staff may deter patients to seek treatment early. 
4.5 Discussion 
From this study, greater understanding of the patients' and community's 
perspectives was made possible and will be discussed here. To my best 
knowledge, this is the first documented perspectives of patients and 
communities regarding TB in Sabah. 
4.5.1 Health culture in relation to TB 
Most health beliefs surrounding the cause of TB were formulated from within 
the community. In terms of the cause of TB, the germ theory is not well 
known. Most respondents associated TB with something that they have done 
such as hard work, eating contaminated food or exposure to extreme 
conditions. Some patients still believe that they were 'charmed' and thus 
vulnerable to TB. There is a parallel in the belief that hard work causes TB 
between the Sabahans and other communities such as the Vietnamese[88], 
Mexican[3,90], Achenese[92] and Filippino[84]. 
Most respondents believed that TB is infectious regardless of the cause. This is 
in contrast to the belief among Vietnamese where if TB was due to hard work 
(Lao luc), it is considered not contagious. [88] Some people still believed that 
TB was hereditary while most believed that it is spread through means in 
which droplets or saliva or breathing space was shared. 
Secondly, most patients did not attribute their symptoms to TB. This is not 
surprising as the symptoms are not specific to TB and can wax and wane. This 
finding is not different from the study done in West Malaysia in which only 
1.5% of the respondents attributed their symptoms to TB. [94] As TB was not 
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due to the works of evil spirit, the natural course of action was to seek 
modern medicine. Even the few patients who sought traditional healer later 
sought modern medicine when they did not get better, perhaps after re- 
interpreting their symptoms. . 
One of the reasons for the inadequate knowledge on TB in the community is 
due to the unavailability of information and insufficient publicity surrounding 
TB. Majority of the participants obtained information from other people and 
only a handful mentioned getting information from health staff or health 
education materials distributed by the Health Department. Information on TB 
in the media was sketchy and infrequent. A review on a local newspaper, 
Daily Express which is widely distributed and published in 3 languages (English, 
Malay and Kadazan language) revealed only 6 articles on TB between 2003 and 
2006. 
However, the wide distribution of this newspaper may still be ineffective in 
disseminating facts on TB as illiteracy in Sabah is still high; in 2000,21% of the 
population of 6 years and above have never attended schools and this ranges 
from 7% among the Chinese to 21% among the Bajaus. [116] The use of other 
sources of information such as television and radio might be just as 
ineffective. Electricity coverage for households especially in rural Sabah was 
reported to be 65% prior to 2004. [117] Even in health facilities, education 
materials on TB were hard to come by. For those who seek information 
through the internet, information on TB on the website of local medical and 
health departments or Anti-TB organisations is basic and not adapted to 
address local interpretation. It is therefore not surprising that the community 
continued to formulate their own understanding as to the cause and mode of 
transmission of TB. 
Since TB was not suspected by most patients, being diagnosed as having TB 
created more negative feelings. However, my suspicion is that the degree of 
negativity might be compounded by underlying fear of isolation and 
discrimination. This is suggestive of deep rooted stigma towards TB patients, 
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the nature of which were expressed through certain -acts such as using 
separate utensils and reducing social contacts. Studies in other countries also 
strike similar patterns such as the use of separate utensils among TB patients 
in Amazon Peruvian community[118], Zambia[18], Kenya[93] and 
Thailand[56]. Subsequently, this could have contributed to the psycho-social 
effects on TB patients which resulted in low self-esteem and withdrawal from 
society thus creating a vicious cycle. 
Family support during the treatment process of TB patients is needed. At least 
two patients who live with their families but did not involve them in the 
treatment process have defaulted treatment. There was a patient who was 
warded for almost 2 months before our interview which was considered a long 
period. This was because none of his family members were able to supervise 
his medication-taking. Prior to hospitalisation, he lived on his own. After 
missing his daily treatment several times, he was warded. He has four 
children, all with their own families. His son said that he was busy with his 
work and he could not take care of his father or supervise his treatment. Many 
a morning, the nurses would find him in his own clothing claiming that his son 
would take him home that day. Eventually the son would turn up in the 
afternoon only to say that he would not be taking him home that day. This 
experience was traumatic for him and also the staff. 
There was also suggestion that discrimination of TB patients persisted even 
after cure. This seemed to contradict the admission by most respondents on 
their belief in the curability of TB. Discrimination could persist because TB 
patients sometimes do not recover to their pre-illness physical state thus 
considered as permanently weakened or deformed. For single patients, TB 
may affect their prospect of marriage; similar to findings in Pakistan[119] and 
Gambia[18]. The persistent of stigma after completion of treatment noted in 
this study was also described among South Indian patients. [120] 
It is not clear from this study the extent to which health staff contribute to 
the perpetuation of stigma although during observation in the clinic, one 
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health staff was overheard advising a patient to use separate utensil. Whether 
such advice was given by other health staff is uncertain. In a study in 
Pakistan, stigma was perpetuated by health staff who recommended 
`voluntary social isolation', to cover their mouth when coughing and to use 
separate eating utensils. [119] In Kenya, stigma was perpetuated by the 
health staff by isolating TB patients and the use of special measures such as 
doormats being impregnated with chemical and the use of gloves before 
entering TB ward. [93] 
Female TB patients did not suffer increased enacted stigma compare to men. 
This could be due to the complementary role women play in family and social 
functions among most ethnic groups in Sabah. In Northern Thailand, female TB 
patients were not stigmatised any more than men due to women's hold to the 
inheritance of authority. [56] 
4.5.2 Strengths and limitations of the study 
This study contributed considerably to aspects of TB particularly on the health 
culture and health seeking behaviour among TB patients and the community 
where previously there was so little documentation. The strength lies in it 
being first hand information of patients' own experiences and from other 
members of the community. In addition, it covered the opinions expressed by 
different ethnic groups in seven districts and from all walks of life. 
Wherever secondary data was available, they were added to build a more 
complete construct. Although the findings could not be generalised to the 
whole population of Sabah, it added several more pieces of understanding to 
the current understanding of TB. It also exposed potentials for future research 
such as in the measurement of stigma using psychometric testing and 
intervention studies on improving awareness and knowledge on TB. 
As mentioned above, one of the limitations of the study is that the findings 
are confined to only several ethnic groups mainly the Kadazandusun, Bajau 
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and Rungus. It is possible that other ethnic groups have different health 
seeking behaviour for TB. 
Assessing the internal validity of the findings is difficult as the truth is often 
subjective. There is also some bias when the interviewer is connected to the 
Health Department. Perhaps patients may not reveal their true health seeking 
behaviour for various reasons despite the assurance of confidentiality and 
anonymity. However, the use of triangulation methods such as getting 
information from spouses and relatives and sometimes through published 
materials helped in improving the validity of the findings. The findings were 
also considered reliable as all interviews used a topic guideline and where 
feedbacks and discussions were concerned, the similar guideline was used 
throughout. 
4.5.3 Contribution to the questionnaire development 
The qualitative study was instrumental in the development of questionnaire 
for the quantitative phase. Earlier contributions to the formation of the 
questionnaire were from WHO (personal communication with Dr. Jane 
Cunningham, WHO Geneva), work done by Paul Pronyk (personal 
communication with James Hargreaves, lecturer, LSHTM) and the 
questionnaire used by MOH Malaysia for the TB prevalence survey. A draft of 
the questionnaire was already available prior to the start of the research. The 
qualitative study helped the development of questionnaire in the following 
areas. 
a. Terminology 
Attempts were made to ensure that certain terminologies were understood by 
the community. It was found that "TB" was a known and accepted name of 
the disease. 
b. Explore the ways to get a date for the onset of symptoms. 
It was obvious from this study that getting the dates for the onset of 
symptoms would prove difficult. The participants as with the majority of 
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population did not have a keen sense of time. The strategy was to identify 
certain occasions commonly known to the public such as festivals and public 
holidays. In addition, the dates should be asked in a systematic manner; 
beginning with year, followed by the month and then the day. 
c. Exploration of the possible range of answers 
This study allowed for the exploration of the possible range of answers 
especially on causes and symptoms of TB among others. 
d. Identify sensitive areas 
All patients in the qualitative study were more than willing to relate their 
illness in terms of symptoms. It was a good way to start the interview. Views 
on what they thought were the causes of their illness and their perceptions 
needed to be approach in an understanding manner as most patients wanted 
to appear rational in their thinking. For example, some respondents may be 
wary about saying that TB was caused by evil spirits as that may seem 
'ridiculous' to health staff. Similarly, the lowered tone and the change in the 
expression such as sadness and hurt suggested how TB has affected their lives. 
Personal behaviour of smoking, consuming alcohol or substance abuse was 
asked at the end of the interview, in a 'by the way' manner. Often, the 
patients were comfortable after relating their illness that it was easy to probe 
the sensitive questions after that. 
4.5.4 Recommendations 
Although WHO has provided very generic means in reducing TB incidence such 
as increasing case detection and ensuring high cure rate, the lack of 
understanding on the community perspectives, cultural practices and 
attitudes towards TB may be a reason why TB remains a threat. 
Based on this study, there is a need to discuss some of the misconceptions and 
the lack of knowledge on TB. Patients need to recognise the symptoms of TB 
early so that treatment can start early. A reinforcement of the message 
"cough of two weeks or more - think TB unless proven otherwise" need to be 
conveyed to the community. In addition, the curability of the disease must 
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remain as one of the key points; aptly summarised in the words of a patient, 
"I would rather have TB than HIV because TB is curable and HIV is not. " 
Finally, the whole concept should be `sold' as a package since fragmentary 
information will allow the public to create their own understanding to replace 
the missing pieces. This information package needs to be channelled through 
various means to cater for the different needs of the population. More support 
from various groups needs to be garnered for those affected by TB; the 
patients and their families. By taking such action, TB will be brought out into 
the open so that the stigma surrounding it will soon fade. 
Future research can explore health and health care seeking behaviours among 
other ethnic groups and also among immigrant population. In addition, in- 
depth analysis of stigma and TB would assist in reducing its effect on health 
seeking behaviour and on the lives of TB patients. 
4.6 Summary 
The objective of the study was to understand the socio-cultural dimensions of 
TB in the Sabah context using qualitative approaches such as interviews, 
observations and discussions. Although information from individual 
participants was fragmentary, by using triangulation methods, a broader 
picture of disease recognition, perception of illness, knowledge on TB and 
health seeking behaviour in relation to TB in Sabah has emerged. 
Knowledge on TB was generally unsatisfactory. Most participants did not know 
the cause of TB and some misconceptions such as TB being hereditary still 
prevail. Most patients did not perceive the symptoms they had as that of TB. 
However, the prevailing practice among the respondents was to seek modern 
medicine for cure. Other forms of treatment such as traditional medicine 
were also sought if modern medicine failed to provide cure. 
TB is still a stigmatising disease and the expression of this was in both 
perceived and enacted ways. TB also affects the patients in various aspects of 
their lives such as psycho-social, physical, financial and life practice. The 
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findings from this study served as eye-openers for most health staff. The 
extent to which these socio-cultural factors affect the time lapse in the 
process of care among TB patients are the objectives of the next phase of the 
research. 
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5 CHAPTER 5: Methodology for quantitative study 
The quantitative study is a progression from the qualitative study and builds 
on earlier understanding on health and health care seeking behaviour for 
possible TB in the Sabah context. This chapter presents the objectives and 
methodology used. 
5.1 Aims and objectives 
The aims of the study is to describe the various time periods in the 
management of TB and identify explanatory factors for patient and doctor 
delay using pre-determined cut-off points. 
5.1.1 Specific objectives 
a. To document the time period from onset of symptoms to start of TB 
treatment amongst smear positive PTB cases. This includes the patient, 
non-government practitioner, doctor and total time period. 
b. To identify explanatory factors for patient delay, defined as > 30 days, 
from onset of symptoms to presentation at any health provider. 
c. To identify explanatory factors for doctor delay, defined as > 14 days from 
seeking treatment from a doctor to start of treatment. 
5.1.2 Secondary objectives 
a. To identify explanatory factors for patient delay of > 90 days. 
b. To identify explanatory factors for doctor delay of > 60 days. 
5.2 Outcome measures 
a. Patient delay (in days) from onset of symptoms to first consultation (first 
presentation with a health care provider which include pharmacy and 
traditional healers) is defined as > 30 days as a primary outcome and then 
greater than 90 days as secondary outcome. 
Chapter 5: Methodology for quantitative study 
b. Doctor delay (in days) from consultation to a doctor (government or private) 
to start of treatment is defined as >14 days as a primary outcome and then 
greater than 60 days as secondary outcome. 
5.2.1 Definition of a patient with TB 
The definition of a new smear positive TB patient for this research adopted 
that used for the National TB Information System (TBIS), Ministry of Health, 
Malaysia. [121 ]A new TB case is: 
a. One who had just been diagnosed as having TB and has not received any 
anti-TB treatment prior to the diagnosis OR 
b. A TB patient who had been put on anti-TB drugs within the past 4 weeks OR 
c. One who claimed to have been treated with anti-TB drugs but had no 
record of being registered as a TB patient. 
A smear positive TB patient is: 
a. one who had at least 2 smear positive slides OR 
b. had I smear positive slide AND chest x-ray suggestive of PTB OR 
c. had 1 smear positive slide AND sputum culture positive of Mycobacterium 
TB 
5.2.2 Inclusion and exclusion criteria 
The inclusion criteria were: 
" Newly diagnosed smear positive TB patients 
" 18 years of age or older 
" Malaysians 
" Registered with TB at one of the 10 districts (see section 5.5.1 for 
" 
further description) 
92 
Chapter 5: Methodology for quantitative study 
The exclusion criteria were: 
" Those too ill to participate. However, those hospitalised for whatever 
reason but were able to be interviewed were included. 
" Patients identified through contact investigation. This was because the 
period from onset of symptoms to first consultation was not relevant. 
However, contacts of patients that eventually become patients 
themselves and sought treatment on their own were included. Although, 
one can argue that having a TB patient in the family or within a 
community can alter health seeking behaviour through raised 
awareness, it may not always follow that awareness and knowledge get 
translated into action. 
" Non Malaysians were excluded due to their mobility. From my own 
experience, they are fairly mobile as most are in the country for job 
opportunities and often came illegally and thus maybe suspicious of any 
study done by government agencies. This issue was difficult to deal 
with within such a tight research schedule and so was outside the scope 
of this study, important though it is. 
5.3.3 Definitions of time period and delay 
For the purpose of the research, time period in the management of TB is 
divided into a number of intervals as shown in Figure 5.1. 
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Figure 5.1: Time period milestone in the management of TB 
Onset 
of 
symptoms 
Presentation 
at any 
health care 
provider 
Presentation 
at government facilities 
(for those who seek treatment 
other than government clinic 
prior to this) 
Patient time period 
Doctor time periodl 
Non-governmental 
practitioners time period Doctor time period2 
Total time period 
Definitions of total time period 
This period is defined from the onset of symptoms to the initiation of 
treatment. This is made up of patient time period and doctor time period 
(doctor time periodl or non-governmental practitioners time period and 
doctor time period2) as shown in Figure 5.1. 
Definitions of patient time period and patient delay 
The patient time period is defined as the interval between patient's onset of 
signs and symptoms suggestive of TB (restricted to cough, fever, loss of 
weight and blood stained sputum) to the first presentation at any health care 
providers. Any health care provider is defined as medical practitioners (both 
government and private), pharmacists or traditional herbalist or heater. 
A cut-off point of 30 days was used to dichotomise the respondents into 2 
groups. Those with a patient time period of 30 days or less were considered to 
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have `no patient delay'. This acceptable delay is based on the Malaysian 
guideline (Practice Guideline for the Control and Management of TB, 2002) 
and by catering for reasonable time lapse in 'normal' circumstances. 
According to the national guideline, patients with cough of more than 2 weeks 
duration should-have their sputum examined. [122] In some cases, patients 
may not come immediately after coughing for 2 weeks. However, not to seek 
treatment for a cough that has been bothering a patient for I month is 
probably not 'acceptable' from a Malaysian health care perspective. In 
addition, a cut-off point of 90 days was used to determine the explanatory 
factors for 'extreme' patient delay. 
Definitions of non-governmental practitioners and non-governmental 
practitioners time period 
For the purpose of this research, the working definition of "non-governmental 
practitioners" has been broadened to include private doctors, pharmacists, 
medicine shop owners and traditional practitioners. This is because in 
Malaysia, traditional practitioners and other form of therapy are being 
registered and regulated. The Traditional and Complementary Medicine Unit 
in the Ministry of Health was set up some years back to coordinate and 
implement various activities on traditional and complementary medicine in 
relation to practice, training and policy. 
The non-governmental practitioner time period is defined as the interval 
between presentation to any non-governmental practitioner and to 
consultation at a government clinic. 
Definitions of doctor time period and doctor delay 
The period between the presentations to any doctors (either government or 
private clinics) and the commencement of treatment defines the doctor time 
period and is illustrated in Figure 5.1 by doctor time periodl and doctor time 
period2. For those whose first visit to a health care provider was at 
government or private clinic, the period is doctor time period 1. For those 
whose first visit to a health care provider was not at a government or private 
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clinic, this period refers to when they are eventually seen by a government 
doctor and is illustrated as doctor time period2. 
For participants who first attended a health care provider other than a doctor, 
a government doctor was the next health care provider visited for all except 
for one patient. This patient saw a private doctor who referred him and was 
seen by a government doctor on the same day. Therefore, in this case, the 
period is stilt doctor time period 1. 
A cut-off point of 14 days was used to dichotomise the respondents into 2 
groups. Those with a doctor time period of 14 days or less were considered to 
have 'no doctor delay'. An acceptable period for both diagnostic and 
treatment time period is one week for each. One week is more than enough to 
determine whether a patient has TB in a straight forward case. According to 
the national guideline, at least 3 sputum samples are needed: spot, morning 
and spot specimen are collected over a period of 2 days. In the absence of 
chest x-ray, 2 positive smears can be justified for starting treatment. Patients 
are started on treatment by medical officers almost immediately after 
diagnosis. However possible delay in starting treatment may occur if there is 
no medical officer in the health facility (often manned by medical assistants) 
which is common in Sabah. This 'delay' has been taken into account in the 
construction of acceptable delay from consultation to start of treatment. 
Similar to patient delay, a cut-off point of 60 days was used to determine the 
explanatory factors for 'extreme' doctor delay. 
5.4 Study population 
The population under study is the same as that described in section 5.2. Ten 
districts in Sabah were selected for phase 2 of the research based on the 
following criteria: 
a. Logistics 
As shown on in Map 2, all the districts are accessible from the state capital, 
Kota Kinabalu where the research team was based. 
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Map 2: Study sites in Sabah 
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Source: [123] 
b. Smear positive TB notification rate 
All the districts have considerably high notification rates ranging from 50 to 
135 cases per 100 000 population. (Table 5.1) 
c. Balance in ethnicity and sex 
Most of the ethnic groups in Sabah were represented by the 10 districts with 
almost equal number of men and women in each district. (Table 5.1) 
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Table 5.1: Population composition (1998) and smear positive TB 
notification rates (2000) for selected districts 
District % of total 
population# 
. Ethnic group# %`female of 
population# 
Smear 
positive TB 
notification 
rate (2000)** 
Kota 
Kinabalu 
12.1 27.6% Chinese, 11% Bajau, 
9% Malay, 7.5% Kadazan, 
7.4% Dusun 
48.9 50.0 
Penampang 5.0 30% Kadazan, 16% Chinese 48.6 55.0 
Paar 3.4 25.2% Malay, 24.5% Kadazan 48.8 73.9 
Beaufort 2.8 21% Malay, 12.9% Kadazan 48.6 77.8 
Tuaran 3.7 44.7% Dusun, 28.9% Bajau 49.2 83.9 
Ranau 2.8 80% Dusun 48.1 135.9 
Keningau 5.1 40% Dusun, 13.7% Murut 46.8 126.2 
Kudat 3.2 61.7% Other indigenous 
Run us , 8.7% Ba'au 
48.3 82.1 
Pitas 1.4 68.7% Other indigenous group 
Run us 
48.2 132.9 
Kota Marudu 2.5 53% Dusun, 12.5% Bajau 48.3 110.5 
"" per 1 oO o0o population. Source: [124] 
#Total population (1998): 1,734,685. Source: * [125] 
5.5 Methodology: Sampling 
5.5.1 Sampling and recruitment process 
In all the districts, the flow chart for the management of TB patient is as 
illustrated diagrammatically in Figure 5.2. A patient with cough who 
presented to the health facility could either be treated symptomatically or 
subjected to sputum examination. This depends on various factors including 
the general health of the patient and also the duration of cough. For patients 
with cough of 2 or more weeks in duration, sputum specimen for examination 
should be requested as stated in the Practice Guideline for the Control and 
Management of TB (2002). [122] At least 3 specimens would be needed and 
sometimes more if the quality of specimens provided were unsatisfactory. The 
criteria for a diagnosis of smear positive pulmonary TB has been outlined in 
5.2.1. 
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Once a patient is diagnosed as having TB, a standardised regime of treatment 
commenced. As required by the law the case should be notified by the 
attending doctor to the nearest health office for registration in the District 
Registry (IBIS). (Figure 5.2) This Registry is maintained by Health Inspectors. 
At the same time, the patient is also registered in the Treatment Registry 
which is kept at the treatment centre and maintained by the Medical 
Assistant-in-charge of the treatment centre. It was from this Treatment 
Registry that respondents for the research were identified. 
The Treatment Registry is kept at health centres where diagnosis and 
treatment are available. They are known as PR1 (treatment centre 1) while 
the rest, usually smatter health centres and community clinics are known as 
PR2. PR1 are often bigger health centres with medical officer, laboratory 
support and sometimes with x-ray facilities. In a district, there may be more 
than one PRI. PR2 serves as treatment centres only and these are health 
facilities with no medical officer but may have diagnostic facilities. If patients 
sought treatment at PR2, they would have to be referred to PRI and may be 
referred back to PR2 to continue treatment if they wished. 
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Figure 5.2: Flow chart for the management of TB patients in a government 
health facility 
f 
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Starttreatment 
Registration In 
Treatment 
Registry 
Reg IslrgionIn 1 Contact Tracing 
TBIS 
Recruitment into 
research stud 
Participants were recruited into the study based on their entry into the TB 
Treatment Registry in the 10 districts involved. Prior to the start of the study, 
all staff in the TB Control Units from the 10 districts attended a meeting in 
which they were briefed on the inclusion criteria, how to identify potential 
respondents and on the procedure for arranging interviews. In the districts of 
Kota Kinabalu and Penampang, I identified the respondents. In the other 
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districts, either the Medical Assistants-in-charge of the TB Clinics or the 
Health Inspectors-in-charge of the TB Unit would assist in the recruitment to 
save travelling time. This was done by identifying eligible respondents based 
on the inclusion criteria and then asked the respondents whether they were 
willing to participate in the study. Verbal consent was obtained at this stage 
and a list of eligible respondents was prepared. I would then reconfirm the 
recruitment when the team visited the district for the interviews to ensure 
that the inclusion criteria have been adhered to. I also went through the TB 
Treatment Registry again to ensure that all eligible patients have been 
identified. The visits were often as weekly for neighbouring districts of Kota 
Kinabalu but never more than three weeks for the other districts. Before 
interview, an explanation of the study and the content of the consent form 
would be read to the respondents and interview would only proceed after 
written consent was obtained. 
5.5.2 Sample size calculation 
The calculation for the sample size for this study was based on the Penang 
study in 1994. In that study, being mate, having below secondary education 
level, drug users and those who have seek private practitioners prior to 
government doctors tend to have longer patient delay. [58] The situation in 
Sabah is somewhat different in term of the availability of private clinics. 
Private clinics are mainly found in city or town centres and scarce in rural 
areas. In that study, the odds ratio for those with lower education was 3.3 for 
delay longer than 30 days where the percentage with delay (defined as > 30 
days) in the `unexposed' (high education level) is approximately 20%. However, 
bearing in mind that more than half of the population in Sabah reside in rural 
areas, the expected percentage of delay among the same education group 
was expected to be higher than 20%. 
For this research, a sample size based on a type I error of 5%, 80% power and 
an odds ratio of 2.0. The ratio between the unexposed and exposed was also 
explored in terms of 1: 1,1: 2 and 2: 1 as shown in Table 5.2. Assuming that the 
percentage with delay in the unexposed group was 30%, an OR of 2.0 and a 
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ratio of unexposed to exposed of 1: 2, the total sample size was 347. 
Allowance of a 10% refusal rate, including missing values and other factors, 
the estimated size for this study was 386. The calculation for sample size was 
carried out using Epi Info 6.04d. 
Table 5.2: Estimation of sample size 
Ratio of 
unexposed % in % in 
Sample size (not taking into account 
10% refusal rate 
to exposed unexposed exposed OR unexposed exposed Total 
1: 1 20 33.3 2.0 186 186 372 
25 40 2.0 165 165 330 
30 46.2 2.0 153 153 306 
1: 2 20 33.3 2.0 142 284 426 
25 40 2.0 125 250 375 
30 46.2 2.0 116 231 347 
2: 1 20 33.3, 2.0 274 137 411'.: 
25 40 2.0 244. 122 366 :.. 
30 46.2 2.0 '226 113 339 
5.5.3 Field preparation 
Prior to the commencement of the research, the following activities took 
place (Table 5.3). 
Table 5.3: Field preparation for the quantitative study 
Activity Participants Purpose Duration 
Meeting " State TB team Briefing on the purpose of 1 day 
" Area Medical Officer the research and on the 
of Health research protocol 
" Coordinator of District 
TB team 
Meeting " Health Inspectors Briefing on the purpose of 1 day 
and " Medical Assistants the research and on the 
training research protocol 
Training " Research assistants Interview technique 3 days 
(RA) Questionnaire 
Data entry 
I was responsible for gaining access to the health facilities and the community 
involved, recruitment and training of research assistants, recruitment of 
participants, arrangement of work and travelling schedules and analysis of 
data. Three research assistants (RAs) were employed for this study. Their 
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education was at the diploma level. They were responsible for conducting 
interviews, completing questionnaires and data entry. Their training involved 
interview techniques and to gain familiarity with the details on the 
questionnaire such as the techniques for asking specific questions, prompts 
and also local terminologies of certain aspects. The RAs also practised doing. 
interviews with each other and then observed when I did a participant 
interview before performing interviews on their own. I sat in almost all the 
interviews and was with them all the time as the team travelled together. I 
was therefore able to supervise them throughout the study period. At the end 
of each day, all completed questionnaires were checked to ensure the 
completeness and also aided in the learning process for the RAs. 
5.5.3 Contact procedure 
An attempt at first contact with respondent took place almost immediately 
upon confirmed eligibility based on the inclusion criteria. The health staff 
that provided treatment to the patient were asked to inform the patient that 
a research study was going on and asked the patient whether he/she was 
willing to be interviewed. If the patient agreed, the health staff would inform 
the research team. An appointment date would be set which was 
communicated to the patients by the health staff. In the event that a patient 
was not interested in the study (refused), this was noted together with the 
reason for declining. 
Before the interview, the patient's eligibility in terms of the inclusion criteria 
would be verified again. During the interview, the patient information sheet 
and consent form was read to the patient. Some respondents were wary about 
putting down their signature but agreed to give verbal consent. In these few 
instances, the consent form was fitted by the RA and another witness, often 
the health staff, would testify to the verbal consent. 
Every attempt was made to contact the patients who did not turn up for their 
appointment. Due to the movement of the team between 10 districts, often it 
was not possible to reschedule the appointment to the next day. However, 
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such cases were given priority and every attempt was made to interview them 
within the next 14 days. In cases where attempts to contact a patient did not 
result in an achieved contact, the individual was defined as non contactable. 
However, this status was only accorded after a minimum of 3 attempts. This 
was done to minimise selection bias. 
The details of interviews in terms of district, dates and numbers interviewed 
are tabulated in Appendix 6. 
5.6 Data collection and entry 
5.6.1 Data description 
The descriptions of data that were collected are listed below. 
Table 5.4: Data descriptions 
Conceptual Level of, ",. Operational variables 
variables determinants 
Socio- Distal Sex, age, race, education level, income, 
demographic ownership (house, transport, land, 
livestock, TV, radio), marital status, 
geographic location, 
Symptoms Proximal Cough, chest pain, shortness of breath, 
(doctor delay) hemoptysis, loss of weight, loss of 
appetite, fever, lethargy, insomnia 
Medical and Intermediate Problem with mobility, co-morbidity, 
family history family history of TB, 
Social history Distal Smoking, alcohol consumption and 
substance abuse 
Knowledge Not shown in Ever heard of TB, cause of TB, Is TB 
analysis infectious?, Is TB curable? 
Heath care Intermediate Ever use health facility, number of times 
utilisation used over past year, travelling time, mode 
of transportation, usual first place for 
treatment 
Heath care Proximal Current choice for treatment 
utilisation (patient delay) 
but 
intermediate 
(doctor delay) 
Examination Proximal Sputum at first visit, repeat visit, referral, 
(doctor delay) number of days for chest x-ray, number of 
days for sending sputum, hospitalisation 
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Conceptual Level of Operational variab(es',, ý'I' 
variables determinants 
Effect of Not shown in Physical, emotional, financial, social and 
disease analysis change in life practice 
Stigma Not shown in TB is embarrassing, isolation, not tell 
analysis others of disease or treatment, work 
prospects and lifelong effect 
5.6.2 Pilot study 
A pilot study was conducted in Kota Kinabalu to test the questionnaire for the 
following: length of time taken for completion of interview, ambiguous 
questions, and clarity of instruction, to eliminate questions that did not yield 
desired information. 
Twenty TB patients (both smear positive and negative) who were already on 
treatment were chosen from several PR1 (health clinics where diagnostic and 
treatment facilities are available). Minor alterations were made to the 
questionnaire as a result of this pilot study. The final version of the 
questionnaire used was in Bahasa Malaysia and an English version is inserted in 
Appendix 7. 
5.6.3 Interviews and data abstraction 
The structured questionnaire was administered in face to face interviews by 
the RAs. An interview took 45 minutes to an hour to conduct, longer if 
translation into local dialects was required. A maximum of 4 interviews a day 
for each RA was manageable. 
Participants were identified by a unique study number. All data collected 
from the patients (questionnaires) were stored in a locked cupboard when not 
in use. Computers used for the study were password protected with limited 
access. In addition to data collected from interviews, abstraction of 
laboratory results was also conducted from patients' case notes. A copy of the 
abstraction form in shown in Appendix 5. These include results of sputum 
microscopy, chest x-ray and date of starting treatment. 
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5.7 Data processing and analysis 
5.7.1 Data management 
At the completion of the interview, manual checking of the information 
obtained was performed by the interviewers. This was repeated at the end of 
the day by the research team. Incomplete answers were treated as missing 
data. The information was then coded and double-entered into Microsoft 
Access database by the RAs. Comparison of the double data entry and data 
cleaning was also performed before analysis. Data analysis was performed 
using the statistical package STATA version 9.1. 
5.7.2 Descriptive analysis of variables 
Categorical data were summarised using frequency tables. Continuous data 
were grouped into 3-5 levels. For example, age was grouped into 5 groups of 
10 years interval except for the first and fifth groups. Regrouping of ethnic 
groups was also made; other indigenous races, beside Kadazan-Dusun-Murut 
and Bajau were grouped together and other non-Sabahans as one group. Data 
were illustrated using frequency tables or bar charts. 
Variables were also cross-tabulated to explore association between 
explanatory variables for e. g. sex and education. Hypothesis tests for 
associations between the explanatory variables were done using the chi- 
square test. Comparison of median was done using the Wilcoxon rank-sum test 
when normality of the data could not be assumed. 
5.7.3 Calculation of time period 
Four dates were needed to calculate the various time periods in this study; 
date of onset of symptoms, date of first presentation at any health care 
provider, date of presentation at a government health facility (for those who 
did not consulted a doctor as the first health provider) and date of starting 
treatment. There were difficulties in determining the date of onset and this is 
described in more detail in this section. 
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Patient time period was calculated as the interval between the onset of 
symptoms and the date of first presentation at any health care provider. Both 
dates for onset of symptom and seeking treatment were asked during the 
interview. 
The respondents were first asked whether they remember the exact date of 
onset or seeking treatment (see questions 31 in Appendix 7). If they could not 
recall the exact date, they were asked in stages beginning with the year, then 
the month and followed by the day of the month. If they could not recall the 
exact day, they were asked whether it was in the beginning, middle or end of 
the month. 
When data for the year or month unavailable, no date could be generated and 
so coded as missing. In situations where the year and month were available 
but the day of the month was recorded as either 'early', 'middle' or 'end', 
recoding was done; 'early' was coded as the 5th, 'middle' as the 15th and 
'end' as the 25th of the month. Where the day was reported as 'cannot 
remember', it was coded as the 15th. 
In addition, during the interview, the duration (in days) of each of the nine 
symptoms (in days) experienced was also obtained and respondents were also 
asked how tong they waited after realising the symptoms before seeking 
treatment. 
To calculate the patient time period, the date of onset of symptoms and date 
of first presentation with any health care provider are required. However, due 
to missing values for the date of symptoms onset (32 respondents), the 
decision was to use the maximum duration of four symptoms (cough, 
hemoptysis, fever and loss of weight) to generate the date of onset. 
Data on maximum duration of symptoms was available for 275 respondents. 
For 21 respondents, the maximum duration of symptoms was not available. 
For 11 of these respondents, the period between when the patient first 
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realised the symptoms to the time of seeking treatment was used. Using these 
periods, 286 dates of onset of symptoms could be generated. 
Data on time period were summarised and presented by showing the median 
and inter-quartile range (IQR). The Kaplan-Meier plot was used to show time 
from onset of symptoms to first contact with a health provider for patient 
delay and from first contact with a doctor to the start of treatment for doctor 
delay. 
5.7.4 Outcome measurement 
Time periods were recoded into binary outcomes defining no delay and delay, 
using a pre-determined cut-off point. For the primary outcomes, cut-off 
points of 30 days and 14 days for patient and doctor delay respectively, were 
chosen. A secondary analysis, investigating factors associated with 'extreme' 
delay, used the cut-off points of 90 days and 60 days for patient and doctor 
delay respectively. 
5.7.5 Univariate analysis 
Univariate analyses were conducted to assess the association between 
explanatory variables with the outcome (delay). Odds ratios and 95% 
confidence interval (Cis) were calculated using logistic regression. Hypothesis 
testing was carried out using the likelihood ratio test (LRT). For ordered 
categorical variables such as age group, tests for linear trend and departures 
from linearity were performed using the LRT. 
5.7.6 Multivariate analysis 
Conceptual frameworks (Figure 5.3 and Figure 5.4) were formulated for both 
patient and doctor delay prior to analysis. They were the simplified version of 
the conceptual framework in 3.5 for use during the analysis phase. 
1 
a. Conceptual framework for patient delay 
This conceptual framework is based on previous studies and the current 
knowledge on risk factors for TB. There are three levels to the framework; 
distal, intermediate and proximal level. 
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The direct measure of time period is in relation to the choice of treatment by 
the patients or in other words, the health care utilisation. This category forms 
the proximal determinant. Health care utilisation in turn is a reflection on the 
understanding of the illness based on many factors and the mental process of 
where, how, when, what and from whom treatment should be sought. Socio- 
demographic factors influence health and health seeking behaviour directly; 
several studies have highlighted the differences between genders with regards 
to health and health care seeking behaviour. These factors are in the distal 
level. However, they also have an indirect influence through intermediate 
determinants such as the elements of the four As. For example, income and 
education may decide accessibility and affordability. The presence of co- 
morbidity indirectly affects health and health care seeking behaviour as part 
of the `past experience' phenomena. Co-morbidity is related to socio- 
demographic and social factors; certain disease has predilection for certain 
sex, age or ethnic groups. Diagrammatically, the levels are shown in Figure 
5.3. 
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b. Conceptual framework for doctor delay 
This framework (Figure 5.4) is an extension of the one for patient delay. In 
this framework, additional variables are included such as sputum request at 
first consultation, referral, and repeat visit which are grouped under the 
category of health provider factors. This category was considered proximal 
determinants for the time from consultation with doctor and starting TB 
treatment. Symptoms experienced by the patients were also included as 
proximal determinants as they influence the decision by the health provider 
to consider a diagnosis of TB. A patient with cough of more than 2 weeks is 
supposed to be subjected to sputum examination. 
Past experience, the four As and some socio-demographic factors affect 
`uptake' of health service recommendations. For example, a positive past 
experience encourages a' patient to comply with request for further 
examination. Again, based on previous studies, low education level and 
increasing age tend to increase doctor delay. This could act by affecting 
directly the uptake of health service recommendations or indirectly through 
the intermediate determinants. 
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Multivariate analysis based on a hierarchical approach of the conceptual 
framework as described by Victora et al[126] was performed with logistic 
regression. Only variables in the hierarchical model are considered for the 
multivariate analysis. As such, variables describing knowledge of TB and 
symptoms were not included in the multivariate analysis for patient delay as 
they are not in the model (Figure 6.3). Two strategies were adopted for 
selecting variables to be included in the multivariate analysis and the steps 
described below were similar to the steps by Thomas. [127] Firstly, variables 
which have significance levels of p<O. 2 in the univariate analysis were 
considered for the multivariate analysis. Secondly, variables considered a 
priori confounders were also included such as sex and age. 
The distal determinants were entered first in the model one at a time 
beginning with age and sex. If they did not reach a significance level of p< 0.1, 
they were dropped. Potential confounders were however stilt retained if they 
changed any of the effect estimates (OR) of interest by > 10%. This decision 
was consistent throughout all the stages in the modelling process. However, 
known confounders such as age and sex were retained in the model 
throughout. 
Then, intermediate determinants were added to determine their effects after 
adjusting for the distal determinants and a priori confounders. Finally, 
proximal determinants were added to assess their effects after adjusting for 
distal and intermediate determinants. 
Those distal and intermediate level variables which have been dropped at an 
earlier stage were added back to the model one at a time and retained if they 
reached a significance level of p< 0.1 in the presence of the other variables or 
if OR changed by > 10%. 
The analysis was performed under the a priori assumption that there was no 
interaction between the variables. 
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5.8 Resources and time frame 
This research received financial support through the submission of a 
successful grant application to the Ministry of Health (MOH), Malaysia during 
the second year of the DrPH programme. The grants were under the MOH 
Allocation for Research Development and awarded yearly. The grant allowed 
payment for the salary and traveling allowances for the 3 research assistants. 
The field work was conducted from 1st November 2005 to 30th April 2006. 
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6 Chapter 6: Descriptive analysis of cross sectional 
study 
This chapter presents the descriptive analysis of the quantitative study. The 
recruitment process is described and the age and sex distribution of 
respondents and non respondents is compared. The study sample is 
summarised, TB symptoms experienced by respondents are described and the 
total time period summarised. 
6.1 Numbers identified in the recruitment centres 
As mentioned in section 5.5, PRI are health facilities which serve as 
diagnostic and treatment centres where the Treatment Registry is kept and 
from which potentially eligible respondents were initially identified. In every 
district, there is at least one PR1 but in districts with relatively dense 
population such as Kota Kinabalu, Penampang and Tuaran, there are more 
than one (Table 6.1). 
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Table 6.1: Number of respondents and recruitment centre 
District & PR1 " No. ' of patient No. of smear No. of No. of No. 
Chest Clinic (CC) registered positive 'patients patients who interviewed 
from 1aß patients eligible for died before (actual 
Oct, 2005 
to 
interview Interview, '' number. 
3181 March, refused or not Interviewed 
2006 contactable for the 
district) 
Kota Kinabalu 
" CC Luyang 169 92 48 9 39 
CC Inanam 44 33 20 7 13 
CC Menggatal 53 36 23 4 19 
" CC QE Hospital 
115 43 28 15 13 (84) 
Penampang 
CC Penampang 45 28 22 3 19 
CC Putatan 31 22 5 2 3 (20) 
Papar 
CC Paar 39 34 28 1 27 (27) 
Beaufort 
" CC Beaufort 43 35 23 4 19(17) 
Tuaran 
" CC Tuaran 63 42 38 6 32 
" CC Tamparuli 6 5 4 1 
3 (35) 
Ranau 
" CC Ranau 45 23 18 3 15(15) 
Keningau 
" CC Keningau 79 56 36 5 31 
" CC Sook 26 20 13 6 
7(37) 
Kudat 
" CC Kudat 57 49 32 6 26 (25) 
Pitas 
" CC Pitas 25 18 12 2 10 (9) 
Kota Marudu 
CC Kota Marudu 59 48 32 4 28 (27) 
Total 899** 584 382 78 3041296 
-- ne numders inctuae aupucates. 
In some instances, duplicates were found during the verification of eligibility 
and confirmed by the national identification card number. These were 
patients who may have sought treatment at another health facility, diagnosed 
and started on treatment there but after some time, chose to continue 
treatment at a different clinic nearer his/her home. Patients who were 
transferred from other districts which were not included in the study were not 
processed for interviews. Whereas, patients from the districts included in the 
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study but who had transferred to another district which was not included 
were traced for interview (2 respondents). 
Of the 858 patients registered between 1St October 2005 and 31St March 2006, 
65% were smear positive. Of these, 66% fulfilled the inclusion criteria. (Figure 
6.1) For those who did not fulfil the criteria, the reasons were non Malaysians 
(108), less than 18 years old (30), detected through active case finding (4), 
restarted treatment or relapse (24) and extra-pulmonary cases (8). Ten 
respondents were from districts not included in the study while 7 started 
treatment before the 1st October 2005 but only registered after that date. 
6.2 Response percentage 
A total of 296 (80.2%) respondents were available and consented for interview. 
(Figure 6.1) The response percentage across districts ranged from 70.6% for 
Kota Kinabalu to 96.4% for the district of Papar. 
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Figure 6.1: Flow chart for identifying eligible respondents 
11 Total number in registry (ist Oct 
2005 - 31S` Mar 2006), n=899 
Total excluding duplicates 
n=858 
11 
Number of non smear 
positive, n=300(35%) 
11 
Number of smear positive that did 
. not fulfil criteria, n=189(33.9) 
11 
II Number who died before 
interview, n=14(3.8%) 
Number of smear 
positive, n=558 (65%) 
Number of smear positive that 
fulfilled criteria", n=369(66.1%) 
Number refused (n=9) or non contactabte 
(n=50); (16%) Number consented and 
interviewed 
n=296(80.2%) 
**Eligibility criteria: Newly diagnosed smear positive PTB, 18 years and above and Malaysians 
A comparison between the non-respondents (death, refused or non 
contactable; n=64) and respondents in terms of age and sex revealed little 
difference except for those in age group of 50 though overall data were 
compatible with no association of age and responding. (Table 6.2) 
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Table 6.2: Comparison between respondents and non-respondents in terms 
of sex and age group 
Variable Respondents 
n=296 
Non-respondents 
n=73 
p-value 
(X) 
No % col No 
Mate 189 63.9 48 65.8 0.25 
Female 107 36.1 25 34.2 
18 - 29 yrs 87 29.4 23 31.9 
30 - 39 yrs 57 19.2 14 19.4 0.86 
40 - 49 yrs 59 19.9 13 18.0 
50 - 59 yrs 41 13.8 5 6.9 
> 60 yrs 52 17.6 17 23.6 
6.3 Time lapse from start of treatment to interview date 
In most PR1 centres, registration of patients into the Treatment Registry was 
often made on the same or following day. However, in some PR1 centres, it 
was longer especially, when there was only one staff manning the Registry. 
Interviews were attempted as soon as patients were registered in the 
Treatment Registry though sometimes, there was some delay due to logistics 
reasons. 
The median duration between date of commencement of treatment and date 
of interview was 37 days (IQR: 18 - 67, range 0- 185 days). There was no 
difference in interview duration between the mate and female (for male: 
median: 37 days, IQR: 17 - 68 days; for female: median: 37 days, IQR: 19 - 65 
days, p-value=0.89). One fifth (20.3%) of the respondents were interviewed 
within 2 weeks of starting treatment and almost two fifths within 30 days. 
Almost a third (31.1%) was interviewed 60 days or more after starting 
treatment. 
The highest percentage of those interviewed 60 days or more after the start 
of treatment was in the district of Pitas (Table 6.3). This town of Pitas is 
about 210 km from the state capital, Kota Kinabalu and involved a 3-hour 
drive from the state capital. It is relatively underdeveloped compared to 
other districts in terms of infrastructure. A total of 8 visits were made over 
the period of 6 months. The town of Beaufort is just over 100 km from the 
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state capital and took about 1-2 hours driving time. Most patients opted to be 
interviewed at the clinic. 
Table 6.3: Time lapse from start of treatment to interview date (> 60 days) 
by district 
Variable Total number 
interviewed 
Frequency (row's) with 
time tapse > 60 days 
Kota Kinabalu 84 24 (28.6) 
Penampang 20 6 (30) 
Papar 27 7 (25.9) 
Beaufort 17 9 (52.9) 
Tuaran 35 8 (22.9) 
Ranau 15 5 (33.3) 
Keningau 37 10 (27) 
Kudat 25 8 (32) 
Pitas 9 7 (77.8) 
Kota Marudu 27 8 (29.6) 
Total 296 92 (31.1) 
Patients were given the option for place of interview. Overall, approximately 
75% opted for interviews at the TB clinic, health office or health centre. The 
other places for interview were hospital wards (11.8%) and patients' homes 
(13.5%). 
6.4 Descriptive analysis 
This section describes the study population in terms of socio-demographic, 
medical, family and social history and the health care utilisation pattern in 
terms of frequency and distribution between men and women. 
6.4.1 Characteristics of study population 
Table 6.4 summarises socio-demographic, medical, family and social history 
and health care utilisation of the 296 respondents. Of the 10 districts involved 
in the study, almost a third (28.4%) of the respondents resided in Kota 
Kinabalu which is the state capital followed by Keningau (12.5%) from the 
largest town in the interior division of Sabah. 
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Table 6.4: Description of respondents 
Urban 63 (21.3) 35 (18.5) 28 (26.2) 
Rural 233 (78.7) 154 (81.5) 79 (73.8) 0.12 
Sex 
Male 189 (63.8) 
Female 107 (36.2) 
Age group (years) 
18 - 29 87 (29.4) 50 (26.4) 37 (34.6) 
30 - 39 57 (19.3) 38 (20.1) 19 (17.7) 
40 - 49 59 (19.9) 40 (21.2) 19 (17.8) 
50-59 41 (13.8) - 26(13.8) 15(14) 
> 60 52 (17.6) 35 (18.5) 17 (15.9) 0.66 
Ethnic group 
Kadazan-Dusun-Murut 141 (47.6) 90 (47.6) 51 (47.6) 
(KDM) 
Bajau 56 (18.9) 36 (19.1) 20 (18.7) 
Other Sabahans 75 (25.3) 47 (24.9) 28 (26.2) 
Chinese 15 (5.1) 12 (6.3) 3 (2.8) 
Other Malaysians 9(3.0) 4(2.1) 4(4.7) 0.52 
Education 
None 61 (20.6) 25 (13.2) 36 (33.6) 
Primary 104 (35.1) 71 (37.6) 33 (30.9) 
Secondary 106 (35.8) 79 (41.8) 27 (25.2) 
Form 6 and above 24(8.1) 13 (6.9) 11 (10.3) 
"Unknown 1 (0.3) 1 (0.5) 0 <0.001 
Marital status 
Single 68 (23.0) 52 (27.5) 16 (14.9) 
Married 201 67.9) 127(67.2) 74 (69.2) 
Others (separated, 27 (9.1) 10 (5.3) 17 (15.9) 0.001 
divorced, widowed) 
Respondent income** 
No fixed income 148 (50) 68 (36) 80 (74.8) 
< USD 132 63 (21.3) 50 (26.5) 13 (12.1) 
USD 132 - USD263 53 (17.9) 45 (23.8) 8 (7.5) 
USD 264 - USD 789 30 (10,1) 24 (12.7) 6 (5.6) 
> USD 789 1 (0.3) 1 (0.5) 0 
'Refused 1 (0.3) 1 (0.5) 0 <0.001 
Household income** 
No fixed income 18 (6.1) 11 (5.8) 7 (6.5) 
< USD 132 83 (28) 47 (24.9) 36 (33.6) 
USD 132 - 263 89 (30.1) 59 (31.2) 30 (28) 
USD 264 - 789 84 (28.4) 55 (29.1) 29 (27.1) 
> USD 789 13 (4.4) 9 (4.8) 4 (3.7) 
"Don't know 8 (2.7) 7 (3.7) 1 (0.9) 
"Refused 1 (0.34) 1 (0.5) 0 0.68 
k The definitions of urban and rural were based on the availability of services provided by the 
city or town council such as garbage collection rather than the usual population density. This 
is because there is no record of localities (villages or housing areas) that are designated as 
urban or rural based on population density. 
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Variable, Frequency -,. Male - Female- , p-value 
(col %) (col %) (col %) (X2) 
Owner ship" 
Own house 189 (63.8) 123 (65.1) 66(61.7) 0.56 
Own transport 101 (34.1) 70 (37) 31 (29) 0.16 
Own land (nmiss=1) 153 (51.7) 99 (52.7) 54 (50.5) 0.72 
Livestock 104 (35.1) 71 (37.6) 33 (30.8) 0.24 
TV 230 (77.7) 155 (82) 75 (70.1) 0.02 
Radio (n, n, ss=5) 213 (72) 145 (77.5) 68 (64.8) 0.02 
Type of housing@ 
`Village' house 236 (79.7) 159 (84.1) 77 (72) 
Residential area 26 (8.8) 12 (6.4) 14 (13.1) 
Squatters 4 (1.3) 3 (1.6) 1 (0.9) 
Quarters 10(3.4) 4(2.1) 6(5.6) 
Long house 3 (1) 3 (1.6) 0 
Others 17 (5.7) 8 (4.2) 9 (8.4) 0.04 
Asthma 21 (23.1) 15 (28.8) 6(15.4) 
Diabetes mellitus 16 (17.6) 9 (17.3) 7 (17.9) 
Hypertension 32 (35.2) 17 (32.7) 15 (38.5) 
Heart problem 8(8.8) 5 (13.5) 3(7.7) 
Family history of TB 
(nmiss=l) 
No 140 (47.5) ' 99 (52.7) 41 (38.3) 
Yes 155 (52.5) 89 (47.3) 66 (61.7) 0.02 
Alcohol intake (nmjss=1) 
Never 105 (35.6) 41 (21.8) 64 (59.8) 
Past intake (ex) 153 (51.9) 117 (62.2) 36 (33.6) 
Current 37 (12.5) 30 (16) 7 (6.5) <0.001 
History of smoking 
(nmiss-l) 
Never 123 (41.7) 40 (21.3) 83 (77.6) 
Ex-smoker 130 (44.1) 108 (57.4) 22 (20.6) 
Current 42 (14.2) 40 (21.3) 2(1.9) <0.001 
History of drug misuse 
(nmiss=l) 
No 276 (93.6) 169 (89.9) 107 (100) 
Yes 19(6.4) 19 (10.1) 0 <0.001' 
Health care utilisation 
Ever use government 
facility 
No 47 (15.9) 38 (20.1) 9 (8.4) 
Yes 249 (84.1) 151 (79.9) 98 (91.6) 0.01 
Number of times used 
in the past year 
(nmiss-4) 
Never 47 (16.1) 38 (20.4) 9 (8.5) 
None 51 (17.5) 35 (18.8) 16 (15.1) 
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No 258 (87.2) 170 (89.9) 88 (82.2) 
Yes 38 (12.8) 19 (10.1) 19 (17.8) 0.06 
Co-morbidity (nm, ss=2) 
No 203 (69.1) 136 (72.3) 67 (63.2) 
Yes91 (30.9) 52 (27.7) 39 (36.8) 0.10 
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Variable Frequency, .d° Male Female p-value (Co( %) ' (Co[ %) -> cot %) X2 
1-2 times 67 (22.9) 43 (23.1) 24 (22.6) 
More than 3 times 127 (43.5) 70 (37.6) 57 (53.8) 0.01 
Usual first place for 
treatment 
Government clinic 215 (72.9) 130 (69.1) 85 (79.4) 
Private clinic 52 (17.6) 35 (18.6) 17 (15.9) 
Pharmacy 15 (5.1) 11 (5.9) 4 (3.7) 
Others 13 (4.4) 12 (6.4) 1 (0.9) 0.09 
Mode of transportation: 
To the nearest clinic 
Public transport 136 (45.9) 85 (45) 51 (47.7) 
Own transport 105 (35.5) 75 (39.7) 30 (28) 
Walk 55 (18.6) 29 (15.3) 26 (24.3) 0.06 
To the nearest 
hospital 
Public transport 183 (61.8) 117 (61.9) 66 (61.7) 
Own transport 106 (35.8) 67 (35.5) 39 (36.4) 
Walk 7 (2.4) 5 (2.6) 2 (1.9) 0.91 
To the treatment 
choice for current 
illness (TB) 
Public transport 149 (50.3) 93 (49.2) 56 (52.3) 
Own transport 117 (39.5) 79 (41.8) 38 (35.5) 
Walk 30 (10.2) 17 (9) 13 (12.2) 0.48 
Travelling time: 
To the nearest clinic 
Less than 15 min 153 (52) 103 (55.1) 50 (46.7) 
15 - 29 min 99 (33.7) 61 (32.6) 38 (35.5) 
> 30 min 42 (14.3) 23 (12.3) 19 (17.8) 0.29 
To the nearest 
hospital 
Less than 15 min 51 (17.3) 30 (16) 21 (19.8) 
15 - 29 min 111 (37.8) 76 (40.4) 35 (33) 
> 30 min 132 (44.9) 82 (43.6) 50 (47.2) 0.42 
To the treatment 
choice for current 
illness (TB) 
Less than 15 min 105 (35.6) 72 (38.1) 33 (31.1) 
15 - 29 min 105 (35.6) 65 (34.4) 40 (37.7) 
> 30 min 85 (28.8) 52 (27.5) 33 (31.1) 0.48 
Treatment choice for 
current illness (TB) 
Government clinic 216 (73) 132 (69.8) 84 (78.5) 
Private clinic 73 (24.7) 52 (27.5) 21 (19.6) 
Pharmacy 5 (1.6) 4 (2.1) 1 (0.9) 
Others 2 (0.7) 1 (0.5) 1 (0.9) 0.37 
1 USD - Ringgit Malaysia 3.80 
Not included in X2 test. 
Ownership of each asset is not mutually exclusive. 
C Regrouped for X2 test; s quatters, quarters, long house and others combined into 
one group. 
++ The denominator for m ain co-morbidity (medical conditions) was the total number 
with medical conditions. 
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Fisher's exact test 
The youngest respondent was 18 years and the oldest was 88 years old with 
64% were men. Almost 80% were rural residents as the whole of Sabah is more 
rural than urban. Almost half of the respondents were of the Kadazan-Dusun- 
Murut ethnic group, the predominant ethnic group in Sabah. One third of the 
respondents had primary education and another third with secondary 
education. In term of respondents' income, half of the respondents did not 
have any fixed income but for household income, only 6% did not have fixed 
income. However, almost all households have some form of assets even those 
with no fixed income. 
Most respondents lived in `village' houses which are often individual dwellings 
with surrounding land area and built from wood, bricks or bamboo as in the 
rural areas. Less than 10% of the respondents lived in residential areas and 
the rest lived in `provided dwellings' such as government quarters or estate 
housing, squatter areas and long houses. A long house is a building on stilts 
which houses as many as 30 families in partitioned rooms. The respondents 
were also asked on the number of rooms used as bedrooms in their homes. 
The number of bedrooms or 'sleeping area' ranged from 1 to 12 while the 
number of occupants (adults and children) ranged from 1 to 21. The median 
ratio between occupants and bedroom/ sleeping area is 1.8 (IQR: 1.2 - 2.5, 
range: 0.1 - 7). (Data not tabulated) 
Slightly more than half gave positive family history of TB. The median for the 
time lapse between the last episode in the family and the current episode was 
48 months (IQR: 1- 312 months). 
Nearly 6% of respondents, all men, had history of substance misuse prior to 
diagnosis. About a fifth currently consumed alcohol. Among those who 
currently consume alcohol, three respondents drank several glasses daily, 
white the rest reported consuming 3 glasses on a weekly or monthly basis. 
More men smoked compared to women. One to 20 cigarettes were smoked a 
day (median of 5 cigarettes per day and IQR: 3- 10) by current smokers. 
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Health facilities' are fairly accessible and in most cases, travelling time to the 
nearest health facility took less than 30 minutes. Health clinics are also 
accessible where around 24% of the respondents walked to the nearest health 
clinics. Most rural respondents had to depend on the public transport to get to 
the nearest health facility or health provider. For those living in urban areas, 
more than half used their own transport for the same purpose. (Data not 
presented) Approximately 84% of the respondents have used a government 
health facility in the past. Approximately 73% preferred government facilities 
while around 17% preferred private practitioners. There were slight variations 
in health utilisation among men and women. Slightly more women preferred 
government clinic than men. In relation to household income, the higher the 
income level, the stronger, the preference for private practitioners. (Data not 
presented) 
Respondents who usually go to government clinic for treatment would also do 
the same for their current illness (TB). Almost 90% of the respondents who 
usually sought treatment at government clinic had continued to do so for 
current illness (TB) while the remainder chose private practice. (Data not 
presented) 
The perception among TB patients of government health facilities was good; 
13.5% said the services were `good', 63.2% agreed they were `very good' and 
about 18.9% said `excellent'. 5 patients (all of whom had patronised the 
facilities) perceived the services as not satisfactory and 7 chose not to make 
any comments. 
6.4.2 Symptomatology 
The commonest symptom was cough (reported by 92.2%), followed by loss of 
weight (84.8%), lethargy (80.4%), fever (75.3%) and loss of appetite (70.6%). 
Almost half of the respondents had coughed out blood. 
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More than half of the respondents have 3 to 4 respiratory symptoms. Almost 
40% have all the constitutional symptoms of loss of weight, loss of appetite, 
fever, lethargy and insomnia. (Table 6.5) 
Table 6.5: Frequency of respiratory and constitutional symptoms 
Number of 
Symptoms 
Respiratory symptoms 
(Co[ %) 
Constitutional symptoms 
(Co[ %) 
None 9 (3) 9 (3) 
1 -2 123 (41.6) 44 (14.9) 
. 
3-4 164 (55.4) 125 (42.2) 
5 NA" 118(39.9) 
kuiiry iuur reapirawry Symptoms) 
The commonest symptom for which treatment was sought was cough while 
the least common was hemoptysis. The shortest median duration for 
symptoms before treatment was sought was hemoptysis followed by fever. 
(Table 6.6) 
Table 6.6: Frequency and median durations for symptoms 
Symptoms: sought 
treatment for 
Frequency 
No (row %) 
Frequency 
Yes (row %) 
Median duration 
IQR da s 
Cough 39 (14.9) 222 (85.1) 30(14-90) 
Chest pain 165(63) 97 (37) 30 (14 - 90) 
Shortness of breath 147 (56.3) 114 (43.7) 30(7-90) 
Hemoptysis 183 (70.1) 78 (29.9) 7(3-60) 
Loss of appetite 133 (51) 128 (49) 30(7-60) 
Loss of weight 130 (49.8) 131 (50.2) 30(14-60) 
Fever 120(46) 141 (54) 14 (7 - 30) 
Lethargy 114 (43.7) -147(56.3) 30(7-60) 
Results of sputum examination were available for 169 respondents and the 
`maximum' reading of three or more specimens are tabulated in Table 6.7. Of 
these, almost two thirds had reading of more 50 bacteria per line. Only 157 
chest x-ray results were available in the patient's case notes. Of these, 
almost 85% had moderate to advanced lesions. 
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Table 6.7: Results of sputum examination and chest x-ray 
Variable Frequency 
col %) 
Male 
col %) 
Female 
cot %) 
p-value 
X2 
Results of sputum 
examination* (n=169) 
I- 49/3L (1+) 37 (21.9) 24 (22) 13 (21.7) 
50/> 1L (2+) 6 (3.6) 1 (0.9) 5 (8.3) 
11 - 49/L (3+) 20 (11.8) 15 (13.8) 5 (8.3) 
> 50/L (4+) 106 (62.7) 69 (63.3) 37 (61.7) 0.07 
Results of chest x-ray* 
(n=1 58) 
No lesion 1 (0.6) 0 1 (1.8) 
Minimal 23 (14.6) 15 (14.6) 8 (14.5) 
Moderately advanced 116 (73.4) 74 (71.8) 42 (76.4) 
Far advanced 18 (11.4) 14 13.6) 4(7.3) 0.36 
Ltassitncatlon Dasea on the National Guideline [1ZZJ 
6.5 Total time period 
This time period is defined as the interval from the date of onset of symptoms 
to the date of starting treatment. Dates of symptoms onset have been 
calculated as described in 5.7.3. The dates of starting treatment were 
obtained from the patients' treatment cards. The median for total time 
period for 269 patients is 90 days, IQR: 38-176 days, range 1- 1281 days 
(Figure 6.2). 
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Figure 6.2: Kaplan Meier plot of total time period (days) 
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The time period comprise of 2 components: patient and doctor time periods. 
(Figure 5.1) 
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7 Chapter 7: Results of cross sectional study on 
explanatory factors for patient delay 
This chapter presents the quantitative results of the study of explanatory 
factors for patient delay. The putative explanatory variables are described 
and then analysed for association with patient delay. Finally, multivariate 
analysis is performed for these explanatory factors for patient delay based on 
a hierarchical approach using the conceptual framework discussed in Figure 
5.3. 
7.1 Patient time period 
The duration for each TB symptom were asked during the interview. The 
median for the maximum duration was 60 days, IQR: 21 -90 days, range; 1- 
1095 days. The maximum duration of one or more of the 4 major symptoms 
(cough, hemoptysis, fever and loss of weight) was used in the calculation for 
patient time period. For 90 respondents, although all 4 symptoms were 
reported, only one symptom contributed to the calculation of patient time 
period for half of this number while two symptoms contributed for a quarter 
of them. (Table 7.1) 
There were 21 missing value for duration of symptoms as shown by the total 
number in Table 7.1. For 11 of these respondents, the period between when 
the patient first realised the symptoms to the time of seeking treatment was 
used. Using these periods, date of onset of symptoms could be generated. 
However, due to missing data for the date of seeking treatment, only 273 out 
of 296 respondents had both date of onset of symptoms and date of seeking 
treatment. One respondent was excluded because TB was an incidental 
finding when he sought treatment for accidental injuries, which made 
available data on patient time period for 272 respondents for further analysis. 
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Table 7.1: Number of symptoms reported and contribution to calculation 
of time period 
Number of Number of t he symptom s* reported 
symptoms* 
contributing to 
calculation of 
patient time 
period 
One 
symptom 
(col %) 
Two 
symptoms 
(col %) 
Three 
symptoms 
(cot %) 
Four 
symptoms 
(col %) 
Total 
(cot %) 
One symptom 9 (100) 33 (67.3) 77 (60.6) 49 (54.4) 168 (61.1) 
Two symptoms 0 16 (32.7) 34 (26.8) 22 (24.4) 72 (26.2) 
Three symptoms 0 0 16 (12.6) 12 (13.3) 28 (10.2) 
Four symptoms 0 0 0 7 (7.8) 7 (2.5) 
Total 9 49 127 90 275 
"- cough, hemoptysis, toss of weight and fever 
Among these 272 respondents, 200 of them (73.5%) first sought treatment at 
government clinics, 66 (24.3%) at private clinics, 4 (1.5%) bought medicine 
from pharmacies and one respondent each first used traditional medicine or 
traditional herbalist. 
The distributions of sex, age and race were similar for respondents where a 
patient time period could be defined (n=272) compared with respondents 
where a patient time period could not be defined (n=24). 
The median for patient time period was 60 days (IQR: 14 - 90 days, range 1- 
1095 days). (Figure 7.1) 
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Figure 7.1: The Kaplan-Meier plot of patient time period (days) 
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Note: 2 respondents with patient time period of 1095 days were not shown in the graph above. 
The Kaplan-Meier plot of patient time period shows large steps at 30 (n=50, 
18.4%), 60 (n=39,14.3%) and 90 (n=32,11.8%) days indicating clustering of 
patient time periods at these times. 
Thirty two respondents had patient time period exceeding 15 months (456 
days), three quarters were men. Approximately 80% of them resided in the 
rural area and just over half had a household income of more than USD132. 
Almost three quarters of them sought government health facility for this 
current illness (TB) for which the main presenting symptom was cough. 
The respondents were also asked how long it took them from deciding to seek 
treatment to actually go to the place for treatment for any of the symptoms 
which prompted them to seek treatment. Approximately 84% took a day 
following decision to actually seek treatment while the longest period was 14 
days (9 respondents). 
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7.2 Patient delay 
This section will present analysis of explanatory factors for patient delay for 
two cut-off points: those who took more than 30 days from onset of symptoms 
to seeking treatment from any health providers and those who took more than 
90 days will be described. Firstly, univariate analysis of the various variables 
will be presented followed by the multivariate analysis and finally the analysis 
of the secondary outcome which is patient delay of more than 90 days will be 
described. 
7.2.1 Univariate analysis for patient delay of more than 30 days 
Among the 272 respondents, 51.8% had patient delay (95% Cl: 45.9 - 57.8) of 
more than 30 days. Univariate analysis was performed to assess the 
association of distal, intermediate and proximal variables with patient delay 
and the results are shown in Table 7.2 to Table 7.4. 
a. Soclo-demographic factors and social history 
These factors formed the distal determinants in the conceptual framework 
described in Figure 5.3. 
Table 7.2: Univariate analysis of socio-demographic and social history 
factors (distal determinants) and patient delay 
Variable n No Patient OR -Confidence, ' ° p- , 
( col %) delay delay interval (CI) vaiue* 
(r`ow%) 
Location 
Urban 59 (21.7) 30 29 (49.1) 1 
Rural 213 (78.3) 101 112 (52.6) 1.15 0.64-2.04 0.64 
Sex 
Mate 172 (63.2) 85 87 (50.6) 1 
Female 100 (36.8) 46 54(54) 1.15 0.70- 1.88 0.59 
Age group (years) 
18 - 29 82 (30.1) 46 36 (43.9) 1 
30 - 39 51 (18.8) 18 33 (64.7) 2.34 1.14-4.82 
40 - 49 55 (20.2) 29 26 (47.3) 1.14 0.58-2.27 
50 - 59 38 (14.0) 16 22 (57.9) 1.76 0.81 - 3.82 
> 60 46 (16.9) 22 24 (52.2) 1.39 0.68-2.88 0.16 
Race 
KDM 128 (47.1) 65 63 (49.2) 1 
Bajau 48 (17.6) 27 21 (43.8) 0.80 0.41 - 1.56 
Other indigenous 73 (26.8) 28 45 (61.6) 1.66 0.92-2.98 
Chinese 14 (5.1) 6 8 (57.1) 1.37 0.45-4.19 
Others 9 (3.3) 5 4 (44.4) 0.83 0.21 - 3.21 0.31 
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Variable n No Patient OR Confidence p- 
( col %) delay delay interval (Cl) value* 
(row%) 
Marital status 
Single 62 (22.8) 33 29 (46.8) 1 
Married 186 (68.4) 86 100 (53.8) 1.32 0.74-2.35 
Others 24(8.8) 12 12(50) 1.13 0.44-2.92 0.62 
Education 
(nmiss-l ) 
None 56 (20.7) 25 31 (55.4) 1 
Primary 96 (35.4) 50 46 (47.9) 0.74 0,38-1.44 
Secondary 99 (36.5) 45 54 (54.6) 0.97 0,50-1.87 
Tertiary ft 20 (7.4) 10 10 (50) 0.81 0.29-2.24 0.76 
above 
Household 
income (amiss=8) 
No fixed income 17 (6.4) 9 8 (47.1) 0.75 0.26-2.11 
< USD 132 73 (27.7) 38 35 (48) 0.77 0.42-1.43 
USD 132 - 263 82(31.1) 39 43 (52.4) 0.93 0.51 - 1.68 0.84 
> USD 263 92 (34.8) 42 50 (54.4) 1 
Own house 
No 98 (36) 48 50 (51) 1 
Yes 174 (64) 83 91 (52.3) 1.05 0.64-1.73 0.84 
Own transport 
No 179 (65.8) 92 87 (48.6) 1 
Yes 93 (34.2) 39 54 (58.1) 1.46 0.88-2.43 0.14 
Own Land(nmiss=1) 
No 131 (48.3) 62 69 (52.7) 1 
Yes 140 (51.7) 69 71 (50.7) 0.92 0.57-1.49 0.75 
Livestock 
No 175 (64.3) 87 88 (50.3) 1 
Yes 97 (35.7) 44 53 (54.6) 1.19 0.72-1.96 0.49 
TV/radio(nmiss=4) 
No 41 (15.3) 19 22 (53.7) 1 
Yes 227 (84.7) 108 119 (52.4) 0.95 0.49-1.85 0.88 
Type of house 
`Village' 215 (79) 99 116 (53.9) 1 
Residential 29 (10.7) 12 17 (58.6) 1.21 0.55-2.65 
ntherc# . 2800-31 20 8 (28.6) 0.34 0.14-0.81 0.03 
Alcohol intake 
(nmiss=l) 
Never 98 (36.2) 51 47 (48) 1 
Past intake 140 (51.6) 65 75 (53.6) 1.25 0.75-2.10 
Current 33 (12.2) 15 18 (54.5) 1.30 0.59-2.87 0.65 
History of 
smoking (nmiss=1) 
Never 114 (42.1) 58 56 (49.1) 1 
Ex-smoker 121 (44.6) 55 66 (54.5) 1.24 0.74-2.07 
Current 36 (13.3) 18 18 (50) 1.03 0.49-2.19 0.69 
History of drug 
abuse 
(nmiss=l) 
No 254 (93.7) 123 131 (51.6) 1 
Yes 17 (6.3) 8 9 (52.9) 1.06 0.39 - 2.83 0.91 
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" p-value from likelihood ratio test 
11Refers to squatters, quarters, long house and others in Table 6.4 
Household income was used in the univariate analysis instead of individual 
income as this was a better measurement of wealth. For most socio- 
demographic variables, the data were compatible with no association with 
patient delay. Although there was variation across the different age group, 
there appeared to be no trend in the odds ratios for age group. 
b. Medical and family history 
Based on the conceptual framework (Figure 5.3), these variables are the 
intermediate variables. As with socio-demographic variables, the data were 
also compatible with no association with patient delay. 
Table 7.3: Univariate analysis of medical, family and social history factors 
(intermediate determinants) and patient delay 
Covariate n (col %) No Patient OR Confidence 
' 
p- 
delay: delay interval value" 
(row%) (CI)` 
Mobility 
problem 
(nmiss-l) 
No 239 (87.9) 114 125 (52.3) 1 
Yes 33 (12.1) 17 16 (48.5) 0.86 0.41 - 1.78 0.68 
Co-morbidity 
No 184 (67.6) 94 90 (48.9) 1 
Yes 88 (32.4) 37 51 (57.9) 1.44 0.86-2.41 0.16 
Family history 
of TB 
(rlmiss-l ) 
No 132 (48.7) 58 74 (56.1) 1 
Yes 139 (51.3) 72 67 (48.2) 0.73 0.45 - 1.18 0.20 
* p-value from likelihood ratio test 
c. Health care utilisation 
Some of the variables in this group formed the intermediate determinants 
while treatment choice for current illness (TB) and those related to this 
variable (travelling time and mode of transportation) formed the proximal 
determinants. (Figure 5.3) 
There is an association between usual first place for treatment and patient 
delay. Those who preferred non-government health facility had double the 
odds of patient delay compared to those who preferred government health 
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facility. However, this association was not replicated in relation to choice of 
facility for the current illness (TB) although the pattern is similar. Although, 
there was no linear trend for frequency of use of government facility over the 
past year, those who had used the government clinic once or twice over the 
past year had reduced odds ratio compared to those who had never used 
government facility before. However, this was not true for three or more 
usage of government facilities over the past year. 
Table 7.4: Univariate analysis of health care utilisation factors 
(intermediate and proximal determinants) and patient delay 
Covariate :n( col %) No Patient, OR Confidence p- 
delay delay interval value* 
(r'ow% (CI) 
Ever use 
government 
health facility 
Yes 230 (84.6) 114 116 (50.4) 1 
No 42 (15.4) 17 25 (59.5) 1.44 0.74-2.82 0.28 
Number of 
times used 
government 
health facility 
over past year 
(nmiss-3 ) 
Never use 42 (15.6) 17 25 (59.5) 1 
None 49 (18.2) 19 30 (61.2) 1.07 0.46-2.49 
1-2 times 65 (24.2) 41 24 (36.9) 0.40 0.18-0-88 
3 or more 113 (42) 52 61 (54) 0.80 0.39- 1.64 0.03 
Travel time to 
the nearest 
clinic (nmiss=2) 
< 15 min 144 (53.3) 71 73 (50.7) 1 
15 - 29 min 89(33) 40 49 (55.1) 1.19 0.70-2.02 
> 30 min 37 (13.7) 19 18 (48.7) 0.92 0.45-1.90 0.74 
Transport to 
the nearest 
clinic 
Public 123 (45.2) 57 66(53.7) 1 
transport 
Own transport 101(37.1) 47 54 (53.5) 0.98 0.58 - 1.68 
Walk 48(17.7) 27 21 (43.8) 0.24 0.34- 1.31 0.47 
Travel time to 
the nearest 
hospital 
(nmiss-l) 
< 15 min 49(18.1) 21 28(57.1) 1 
15 - 29 min 98 (36.2) 44 54 (55.1) 0.92 0.46-1.84 
> 30 min 124 (45.7) 65 59 (47.6) 0.68 0.35-1.33 0.39 
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Covariate n"( col %) No Patient OR Confidence p- ;, 
delay delay interval value* I 
(row%) (CI) 
Transport to 
the nearest 
hospital 
Public 164 (60.3) 81 83 (50.6) 1 
transport 
Own transport 102 (37.5) 47 55(53.9) 1.14 0.69-1.87 
Walk 6(2.2) 3 3 (50) 0.97 0.19-4.98 0.87 
Usual first 
choice for 
treatment 
(amiss=l ) 
Gov facility 198 (73.1) 104 94 (47.5) 1 
Others 73 (26.9) 27 46 (63.0) 1.88 1.08-3.29 0.02 
Treatment 
choice for 
current illness 
(TB) 
Gov clinic 200 (73.5) 102 98 (49.0) 1 
Others 72 (26.5) 29 43 (59.7) 1.54 0.89-2.67 0.12 
Travel time to 
treatment 
choice 
< 15 min 96 (35.3) 41 55 (57.3) 1 
15 - 29 min 95 (34.9) 48 47 (49.5) 0.73 0.41 - 1.29 
> 30 min 81 (29.8) 42 39 (48.2) 0.69 0.38 - 1.25 0.41 
Transport to 
the treatment 
choice 
Public 134(49.3) 62 72 (53.7) 1 
Transport 
Own transport 112(41.2) 56 56(50) 0.56 0.52 - 1.42 
Walk 26(9.6) 13 13 (50) 0.73 0.37-1.99 0.83 
" p-value from likelihood ratio test 
7.2.2 Multivariate analysis for patient delay of more than 30 days 
Sex and age group were considered a priori confounders and retained in all 
the models. Given their expected importance, education level and household 
income were included and examined for their rote as potential confounders 
despite the fact that their association with the patient delay in the univariate 
analysis gave p-values greater than 0.2. 
In addition to these variables, all variables with p-value < 0.2 in the univariate 
analysis were considered in the multivariate analysis. At the distal level of 
these were types of house. Co-morbidity, family history of TB, number of 
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times government facility was used over the past year and usual first place for 
treatment were variables at the intermediate level. There was only one 
variable at the proximal level: treatment choice for current illness (TB). 
a. Multivariate analysis with distal determinants - modelling stage 1 
As shown in Table 7.5, odds ratios for sex, age group (those 60 and above) and 
for those with secondary education and above showed more than 10% change 
in the point estimates. Household income was dropped from the model as its 
inclusion did not change much the other point estimates and the p-value for 
its association with patient delay, using likelihood ratio test, was 0.64. The 
decision was to retain the other variables and the type of house for the next 
step which would include the intermediate variables. 
Table 7.5: Multivariate analysis for patient delay by including distal 
determinants (n=271) 
Univarlate analysis Multivariate analysis . 
Variable Unadjusted 95% Cl Adjusted 95%"CI p-value" 
ORS OR 
Sex 
Male 11 
Female 1.15 0.70-1.88 1.29 0.74-2.24 0.37 
Age group 
(years) 
18-29 1 1 
30 - 39 2.34 1.14-4.82 2.39 1.12-5.08 
40 - 49 1.14 0.58-2.27 1.13 0.54-2.34 
50 - 59 1.76 0.81 -3.82 1.91 0.80-4.59 
> 60 1.39 0.68-2.88 1.59 0.62-4.07 0.15 
Education 
None 1 1 
Primary 0.74 0.38-1.44 0.86 0.39- 1.89 
Secondary & 0.97 0.50-1.87 1.46 0.60-3.51 0.25 
above 
Type of house 
'Village' 1 1 
Residential 1.21 0.55-2.65 1.06 0.45-2.46 
Others' 0.34 0.14-0.81 0.28 0.11-0.71 0.01 
p-value from likelihood ratio test 
' Refers to squatters, quarters, long house and others in Table 6.4 
b. Multivariate analysis with distal and intermediate determinants - stage 2 
By adding the intermediate variables into the model one at a time, co- 
morbidity was excluded as the p-value did not reach the predetermined value 
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of 0.1. Family history of TB was retained although the p-value was 0.32 as it 
changed the point estimates of female and age group of 30 - 39 years by 
about 10%. Number of times government facility was used was retained as its 
inclusion increased the odds ratio of usual first choice of treatment and some 
of the age group despite the p-value exceeding 0.1. 
Table 7.6: Multivariate analysis for patient delay, including distal and 
intermediate determinants (n=266) 
Age group (years) 
18-29 1 1 
30 - 39 2.34 1.14-4.82 2.62 1.17-5.87 
40 - 49 1.14 0.58-2.27 1.02 0.47-2.22 
50 - 59 1.76 0.81 - 3.82 1.57 0.62-3.99 
> 60 1.39 0.68-2.88 1.38 0.51 - 3.76 0.14 
Education 
None 1 1 
Primary 0.74 0.38- 1.44 0.74 0.33-1.67 
Secondary Et 0.97 0.50-1.87 1.13 0.44-2.85 0.40 
above 
Type of house 
'Village' 1 1 
Residential 1.21 0.55-2.65 0.86 0.36-2.08 
Others 0.34 0.14-0.81 0.27 0.11-0.71 0.02 
Family history of 
TB 
No 1 1 
Yes 0.73 0.45-1.18 0.77 0.45-1.32 0.32 
Usual first choice 
for treatment 
Gov facility 1 1 
Others 1.88 1.08-3.29 2.28 1.03-5.06 0.04 
Number of times 
used government 
health facility 
over past year 
Never use 1 1 
None 1.07 0.46-2.49 1.45 0.51-4.10 
1-2 times 0.40 0.18-0.88 0.65 0.24-1.75 
3 or more 0.80 0.39-1.64 1.30 0.47-3.58 0.16 
* p-value from likelihood ratio test 
c. Multivariate analysis using distal, intermediate and proximal 
determinants - stage 3 
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Sex 
Mate 11 
Female 1.15 0.70-1.88 1.41 0.78-2.53 0.25 
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Including the only proximal variable identified in the univariate analysis 
(treatment choice for current illness (TB)) into the multivariate model did not 
change any of the point estimates. In addition, the variable was not 
associated with patient delay at the 0.1 significance level and therefore was 
not retained in the model. The variables that were not retained earlier were 
introduced again one at a time to see whether they were associated with 
patient delay after adjusting for other variables. 
The final model is as shown in Table 7.6 above. After adjusting for 
confounders and mediating factors, only the usual first choice for treatment 
remained associated with patient delay. Patients whose usual first place for 
treatment was non-government health facilities had more than double the 
odds of patient delay than those whose first choice was government clinics. In 
addition, those aged between 30 to 39 years old were 2.6 times more likely to 
have patient delay compared to the baseline group of 18 to 29 years old (CI: 
1.17 - 5.87). However, no increase of odds ratio in older age group was seen. 
Those who lived in 'other' type of house (not 'village' and not residential) 
were less likely to have patient delay compared to those who lived in 'village' 
houses (adjusted OR: 0.27, Cl: 0.11 - 0.71) but not in those living in 
residential housing. No important association was seen in this dataset with 
education level or with female sex though there was a tendency for a U- 
shaped relationship with no education and higher than secondary education 
and being female having a higher odds of delay. 
The duration for 4 symptoms (cough, hemoptysis, fever and loss of weight) 
was used in the calculation of patient time period. For 168 respondents (Table 
7.1), only one of the 4 symptoms contributed to the calculation and 
hemoptysis was the one contributing symptom for 12 of these respondents. 
Since hemoptysis was associated with patient delay in 2 studies[66,83], it was 
included in the final model to see whether it was associated with patient 
delay after adjusting for confounding effects and found that it was not. (Data 
not shown) 
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7.2.3 Analysis of patient delay of more than 90 days 
The secondary outcome for patient delay uses a different cut-off point of 90 
days. This section presents the univariate analysis and multivariate analysis 
which uses the same methods as explained for patient delay of more than 30 
days. Of the 272 respondents, 23.5% (95% CI: 18.4 - 28.6) had patient time 
period of more than 90 days. 
a. Univariate analysis 
The socio-demographic variables were compatible with no association with 
patient delay of more than 90 days. Those with co-morbidity had double the 
odds of patient delay of more than 90 days; OR of 1.92,95% Cl from 1.07 to 
3.44) compared to those without. Modes of transportation to the nearest 
clinic and treatment choice for current illness (TB) had weak association with 
patient delay of more than 90 days. Those who used own transport or walk to 
the nearest clinic or treatment choice for current illness were less likely to 
have patient delay of more than 90 days; p-value of 0.05 for both. The 
detailed results of this analysis are summarised in Appendix 8. 
b. Multivariate analysis for patient delay of more than 90 days 
For the multivariate analysis, the variables at the distal level were sex, age 
group, educational level, household income, own livestock and type of house. 
At the intermediate level were co-morbidity, transport to the nearest clinic 
and usual place for treatment. Transport to treatment choice for current 
illness (TB) was the only variable at the proximal level that was retained in 
the model because the p-value was < 0.1. As with multivariate analysis for 
patient delay of 30 days, sex and age group were retained in all models while 
education and household income was included one at a time as they were 
considered potential confounders. Since transport to the nearest clinic and 
transport to treatment choice for current illness (TB) was correlated, the 
former was not included in the multivariate analysis. 
In the multivariate analysis (Table 7.7), usual first choice of place for seeking 
treatment was found to be associated with patient delay of more than 90 days. 
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Those who usually sought treatment at non-government facilities were 2.3 (CI: 
1.11-4.68) times more likely to have patient delay of more than 90 days 
compare to those who usually preferred government clinics. This finding is 
similar to the multivariate analysis for patient delay of more than 30 days. 
Those aged 30 to 39 years also had double the odds (CI: 0.91-4.68) of patient 
delay of more than 90 days compared to the baseline age group of 18 - 29 
years old. Finally, there was weak evidence that those who owned livestock 
and had other medical conditions were also almost twice more likely to have 
patient delay of more than 90 days (adjusted OR: 1.88, CI: 0.98 - 3.63 and 
adjusted 'OR: 1.95, CI: 0.97 - 3.91). It was found that gender and education 
level were compatible with no association with `extreme' patient delay. 
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Table 7.7: Multivariate analysis for patient delay of more than 90 days 
(n=262) 
'ý - Univariate analysis Mültiväriäte anälysis Variable Unadjusted 95% CI Adjusted ý . 95% Cl p- OR OR value 
Sex 
Mate 1 1 
Female 1.13 0.64-2.02 1.18 0.59-2.34 0.64 
Age group (years) 
18 - 29 1 1 
30 - 39 1.86 0.82-4.24 2.27 0.91 - 5.69 
40 - 49 0.99 0.41 -2.40 1.02 0.38-2.75 50-59 2.60 1.10-6.19 1.92 0.65-5.62 
> 60 1.24 0.51 -3.04 0.91 0.24-3.43 0.23 
Education 
None 1 1 
Primary 0.76 0.36 - 1.64 0.69 0.25-1.87 Secondary Et 0.84 0.41-1.74 0.90 0.28-2.90 0.66 
above 
Household 
income 
No fixed income 1 1 
< USD 132 0.78 0.24-2.53 0.86 0.23-3.20 
> USD 132 0.67 0.22-2.02 0.73 0.20-2.71 0.86 
Location 
Urban 1 1 
Rural 1.93 0.89-4.21 1.17 0.41 - 3.29 0.77 
Own livestock 
No 1 1 
Yes 1.57 0.88-2.78 1.85 0.96-3.56 0.06 
Type of house 
`Village' 1 1 
Others 0.39 0.17-0.90 0.55 0.19-1.64 0.29 
Co-morbidity 
No 1 1 
Yes 1.92 1.07-3.44 1.90 0.95-3.79 0.06 
Usual first choice 
for treatment 
Gov facility 1 1 
Others 1.60 0.87-2.94 2.28 1.11-4.68 0.02 
Transport to 
treatment choice 
Public transport 1 1 
Own transport 0.51 0.28-0.94 0.48 0.24-0.96 
Walk 0.43 0.14-1.32 0.28 0.07-1.09 0.03 
p-value from likelihood ratio test 
"Type of housing was regrouped: residential and others were grouped into one due to the 
small numbers in one of the cells. 
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8 Chapter 8: Results of cross sectional study on 
explanatory factors for doctor delay 
Variables related to health provider such as sputum examination at first visit 
to government clinics and repeat visit to first provider will be described in 
this chapter. These variables were also analysed for association with doctor 
delay as with all the variables listed in Table 6.4. In the multivariate analysis, 
variables related to health provider and symptoms were defined as proximal 
determinants. Socio-demographic and social history remained as distal 
determinants while the other variables in Figure 5.4 were defined as 
intermediate determinants. This multivariate analysis, based on the 
conceptual framework in 5.7.6, was performed for both doctor delay of more 
than 14 days and 60 days. 
8.1 Diagnosis by health provider 
As revealed in this study, almost all respondents sought treatment from either 
government or private clinics where diagnosis of TB was possible. However, 
most diagnoses made at private clinics were based on clinical presentations 
and/or chest x-ray. Smear results were also used for diagnosis, though rarely. 
Following such diagnosis, patients would be referred to the government clinic 
for treatment. Patients who had not had sputum examinations or whose 
examinations were incomplete i. e. only one specimen, the test would be 
initiated or repeated. Patients may choose to be treated at private clinic, in 
which case, they would have to pay for treatment. As required by the law, 
the case would be notified to the nearest district health office and registered 
in the TB Registry for the district. This TB Registry was also checked during 
the recruitment process to ensure that even those who were on treatment at 
private clinics were recruited in the study. During the study period, there 
were no such cases. 
In this study; 30% of respondents (87/289) were diagnosed at their first visit to 
a doctor (either private or government). Almost a third of those who sought 
treatment at government clinics were diagnosed at their first visit while only 
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approximately 22% of those who went to private clinics were diagnosed at 
their first visit. (Figure 8.1) 
Figure 8.1: Flow chart of case diagnosis by health provider 
Total respondents 
n=296 
Treatment 
choice for 
current 
illness 
(TB) - first 
provider 
Government clinic 
n=216 (73%) 
Diagnosed Yes 
at first n=71 
visit (32.9%) 
No 
(n=145) 
Private clinic Others 
n=73 (24.7%) n=7 (2.3%) 
Yes No No 
n=16 (n=57) 
(21.9%) 
Almost 35% of the respondents had more than one visit to the same provider. 
There is association between repeat visit and sex; more women had repeat 
visit to the first provider compared to men. (Table 8.1) 
Data on sputum examination at the government clinic was collected. Almost 
72% of the respondents were requested to provide sputum samples at the first 
consultation at a government facility. (Table 8.1) 
According to the national guideline, those with cough of more than 2 weeks 
should be subjected to sputum examination and therefore should be more 
likely to be diagnosed than those with cough of shorter duration. An analysis 
of the 296 respondents revealed that 190 respondents (64%) had cough of 
more than 14 days. Of these, 132 respondents first went to a government 
doctor and 53 went to a private doctor. Only a third was diagnosed at the first 
visit to a government doctor and approximately 23% by a private doctor. (Data 
not presented) 
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Table 8.1: Health provider factors 
Variable Frequency,., Mate Female p-value 
col % cot % col %" ý X2 
Diagnosis at first visit 
(n=87) 
Government clinic 71 (81.6) 49 (79) 22 (88) 
Private clinic 16 (18.4 13 (21) 3 (12) 0.33 
Repeat visit to first 
provider 
Diagnosed at first visit 87 (29.4) 62 (32.8) 25 (23.4) 
Yes 98 (33.1) 54 (28.6) 44 (41.1) 
No 111 (37.5) 73 (38.6) 38 (35.5) 0.06 
Sputum examination at 
first visit to government 
facility 
Yes 213 (72) 143 (75.7) 70 (65.4) 
No 83 (28) 46 (24.3) 37 (34.6) 0.06 
Of the 296 respondents, thirty two stated that they had problem sending the 
sputum specimens. Ten respondents cited financial constraints white 5 
respondents gave physical reasons such as inability to walk, bodily pain and 
breathlessness as the problems in sending the specimens. Four said they had 
transportation problems and 8 respondents had financial or other problems 
such as inability to leave work or family. Overall, 11 respondents had to 
submit more than 3 samples and only one of them was in this group who had 
problems sending specimen. 
Despite the problems mentioned by the respondents, 98% managed to send 
their specimens in less than 4 days. Of the 4 respondents who submitted their 
specimens between 4 to 7days after the request, one was due to 
transportation problem and another had family problem during the period. For 
the remaining two, no reason was given for the delay. 
All respondents had a chest x-ray examination; almost 96% chest x-rays were 
performed at the government health facility while the rest were done at 
private clinics. Nearly all (98%) chest x-rays were carried out within 48 hours 
after they were ordered. One respondent whose chest x-ray was performed 
after 4 days said that the reason was because the technician has gone on 
leave. 
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Almost a fifth were hospitalised prior to treatment, a third in the district of 
Kudat and 15% at Queen Elizabeth Hospital, the State referral hospital in Kota 
Kinabalu. 
8.2 Non-governmental practitioner time period 
Non-governmental practitioner time period was calculated as the interval 
between the first presentations to any provider to the consultation at a 
government clinic. This analysis is initially restricted to 80 respondents whose 
first consultation was not at a government facility. However, dates of seeking 
treatment at government clinic were only available for 72 respondents. 
Another 6 respondents had missing data for date of seeking treatment at first 
provider and one respondent had a date of seeking government clinic which 
was earlier than date of seeking first provider and therefore excluded. Thus, 
65 respondents were available for analysis. 
The median period was 15 days with IQR of 5- 68 days and ranges from 0- 780 
days (Table 8.2). 
Table 8.2: Treatment choice among those whose first visit was to a non- 
government health facility 
Treatment choice of 
first visit 
Number of 
respondent 
Median 1QR 
(days) (days) 
Range 
(days) 
Private clinic 59 13 3-69 0- 550 
Pharmacy 4 22.5 21 - 29 
Traditional healer 1 780 
Traditional herbalist 1 15 
8.3 Doctor time period 
The doctor time period is the time lapse between the first consultations with 
a medical doctor (government or private) to the start of treatment. Data for 
date of seeking treatment was missing for 19 respondents (13 for those who 
sought government clinics and 6 for those who sought private clinics). In 
addition, 17 had dates of seeking treatment that were after the date of 
starting treatment (14 for those who sought government clinics and 3 for 
those who sought private clinics) thus leaving data for 260 respondents for 
further analysis. 
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The median doctor time period for the 260 respondents was 20 days (IQR: 7- 
59 days, range 0- 551 days). (Figure 8.2) 
Figure 8.2: Kaplan Meier plot of doctor time period (days) 
Proportion of ... .. 
rlb%ndents 
0.75 
0.50 
0.25 
0.00 
8.4 Doctor delay 
Doctor delay is defined as those who were put on treatment more than 14 
days after seeing a doctor for their symptoms. Of the 260 respondents, 57.3% 
had doctor delay (95% CI: 51.2 - 63.3). 
8.4.1 Univariate analysis for doctor delay of more than 14 days 
This section presents results of the univariate analysis to assess the 
association of distal, intermediate and proximal variables with doctor delay 
based on the conceptual framework described in Figure 5.4. 
a. Socio-demographic factors and social history 
There was no pattern across age group with doctor delay. Those who owned 
transport were almost twice as likely to have doctor delay compared to those 
who did not own transport. In addition, those who owned land had 1.5 the 
odds of doctor delay compared to those who did not. 
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Table 8.3: Univariate analysis of socio-demographic and social history 
factors (distal determinants) and doctor delay 
Variable n(col %) No Doctor OR 95% Cl p 
delay delay value* 
(row %) 
Location 
Urban 60(23.1) 29 31 (51.7) 1 
Rural 200 (76.9) 82 118 (59) 1.35 0.78-2.41 0.31 
Sex 
Male 166 (63.8) 74 92 (55.4) 1 
Female 94 (36.2) 37 57 (60.6) 1.24 0.74-2.08 0.41 
Age group (years) 
18 - 29 77 (29.6) 37 40 (51.9) 1 
30 - 39 50 (19.2) 20 30 (60) 1.39 0.67-2.85 
40 - 49 54 (20.8) 21 33 (61.1) 1.45 0.72 -2.95 
50 - 59 37 (14.2) 18 19 (51.3) 0.98 0.45-2.14 
> 60 42 (16.2) 15 27 (64.3) 1.67 0.77-3.61 0.60 
Race 
KDM 122 (46.9) 46 76 (62.3) 1 
Bajau 46 (17.7) 22 24 (52.2) 0.66 0.33 - 1.31 
Other indigenous 69 (26.5) 32 37 (53.6) 0.70 0.38- 1.27 
Chinese 14 (5.4) 8 6 (42.9) 0.45 0.15-1.39 
Others 9 (3.5) 3 6 (66.7) 1.21 0.29- 5.07 0.46 
Marital status 
Single 60 (23.1) 28 32 (53.3) 1 
Married 181 (69.6) 74 107 (59.1) 1.26 0.70-2.28 
Others 19 (7.3) 9 10 (52.6) 0.97 0.34-2.73 0.67 
Education 
(nmiss=l) 
None 52 (20.1) 25 27 (51.9) 1 
Primary 90 (34.7) 38 52 (57.8) 1.27 0.64-2.52, 
Secondary 99 (38.2) 37 62 (62.6) 1.55 0.79-3.06 
Tertiary It above 18 (6.9) 10 8 (44.4) 0.74 0.25-2.18 0.39 
Household income 
(nmiss=7) 
No fixed income 15 (5.9) 5 10 (66.7) 1 
< USD 132 71 (28.1) 28 43 (60.6) 0.77 0.24-2.48 
USD 132 - 263 77 (30.4) 37 40 (51.9) 0.54 0.17-1.73 
> USD 263 90 (35.6) 37 53 (58.9) 0.72 0.23-2.27 0.61 
Own house 
No 93 (35.8) 44 49 (52.7) 1 
Yes 167 (64.2) 67 100 (59.9) 1.34 0.80-2.23 0.26 
Own transport 
No 169 (65) 81 88 (52.1) 1 
Yes 91 (35) 30 61 (67) 1.87 1.10-3.18 0.02 
Own Land(nmiss=l) 
No 126 (48.6) 61 65 (51.6) 1 
Yes 133 (51.4) 50 83 (62.4) 1.56 0.95-2.56 0.08 
Livestock 
No 170 (65.4) 74 96 (56.5) 1 
Yes 90 (34.6) 37 53 (58.9) 1.10 0.66 -1.85 0.71 
TV/radio(nmjss=4) 
No 37 (14.5) 20 17 (45.9) 1 
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variame n (col 76) No Doctor, ' m, 95% GI P. 
delay delay value" 
(row %) 
Yes 219 (85.5) 90 129 (58.9) 1.69 0.84-3.39 0.14 
Type of house 
`Village' 204 (78.4) 87 117 (57.3) 1 
Residential 28 (10.8) 10 18 (64.3) 1.34 0.59-3.04 
Others 28 (10.8) 14 14 (50) 0.74 0.34-1.64 0.56 
Alcohol intake 
(nmjss=1) 
Never 93 (35.8) 45 48 (51.6) 1 
Past intake 133 (51.1) 51 82 (61.6) 1.51 0.88-2.58 
Current 34 (13.1) 15 19 (55.9) 1.19 0.54-2.61 0.32 
History of 
smoking 
(nmºss=1) 
Never 109 (41.9) 46 63 (57.8) 1 
Ex-smoker 116 (44.6) 50 66 (56.9) 0.96 0.57-1.63 
Current 35 (13.5) 15 20 (57.1) 0.97 0.45-2.10 0.99 
Past history of 
drug abuse 
No 243 (93.5) 105 138 (56.8) 1 
Yes 17(6.5) 6 11 (64.7) 1.39 0.50-3.90 0.52 
* p-value from likelihood ratio test 
b. Medical and family history 
There is weak evidence to suggest that those with co-morbidity were more 
likely to have doctor delay (OR: 1.58, Cl: 0.92 - 2.71). (Table 8.4) 
Table 8.4: Univariate analysis of medical and family history factors 
(intermediate determinants) and doctor delay 
` Väriab(e n (%) No Doctor OR '95% C1, p- 
delay delay value". 
(row %) Problem with 
mobility 
No 228 (87.7) 98 130 (57) 1 
Yes 32 (18.3) 13 19 (59.4) 1.10 0.52-2.34 0.80 
Co-morbidity 
No 175 (67.3) 81 94 (53.7) 1 
Yes 85 (32.7) 30 55 (64.7) 1.58 0.92-2.71 0.09 
Family history 
of TB (rime: s=1) 
No 126 (48.6) 59 67 (53.2) 1 
Yes 133 (51.4) 52 81 (60.9) 1.37 0.83-2.25 0.21 
* p-value from likelihood ratio test 
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c. Symptoms 
Those with chest pain, loss of weight and fever had more than double the 
odds of doctor delay. (Table 8.5) 
Table 8.5: Univariate analysis of symptoms experienced by respondents 
(proximal determinants) and doctor delay 
Variable n No- Doctor. "OR 95% CI p-' 
(co( %) May delay value* 
(row, %) 
Cough 
No 21 (8.1) 8 13 (61.9) 1 
Yes 239 (91.9) 103 136 (56.9) 0.81 0.32-2.04 0.66 
Chest pain 
No 123 (47.3) 65 58 (47.2) 1 
Yes 137 (52.7) 46 91 (66.4) 2.22 1.33-3.70 0.002 
Shortness of 
breath 
No 96 (36.9) 45 51 (53.1) 1 
Yes 164 (63.1) 66 98 (59.8) 1.31 0.79-2.18 0.30 
Hemoptysis 
No 132 (50.8) 53 79 (59.9) 1 
Yes 128 (49.2) 58 70 (54.7) 0.81 0.49-1.33 0.40 
Loss of appetite 
No 76 (29.2) 36 40 (52.6) 1 
Yes 184 (70.8) 75 109 (59.2) 1.31 0.76-2.24 0.33 
Loss of weight 
No 36 (13.8) 23 13 (36.1) 1 
Yes 224 (86.2) 88 136 (60.7) 2.73 1.30-5.75 0.006 
Insomnia 
No 88 (33.8) 38 50 (56.8) 1 
Yes 172 (66.2) 73 99 (57.6) 1.03 0.61 - 1.73 0.91 
Fever 
No 59 (22.7) 34 25 (42.4) 1 
Yes 201 (77.3) 77 124 (61.7) 2.19 1.20-3.99 0.009 
Lethargy 
No 50 (19.2) 25 25 (50) 1 
Yes 210 (80.8) 86 124 (59.1) 1.44 0.77-2.68 0.25 
p-value from likelihood ratio test 
d. Health care utilisation 
Those who have used government health facilities were less likely to have 
doctor delay. Those who had to travel longer than 30 minutes to the nearest 
clinic were less likely to have doctor delay. However, there was no trend 
across the travel time to the nearest clinic. For the current illness (TB), those 
who went to other provider other than government clinic were twice as likely 
to have doctor delay. Those who walked to the treatment choice for current 
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illness (TB) had thrice the odds of doctor delay compared to those who used 
public transport. (Table 8.6) 
Table 8.6: Univariate analysis of health care utilisation factors 
(intermediate determinants) and doctor delay 
Variable n No Doctor OR 95% CI p- 
(cot %) delay Delay value* 
(row %) 
Ever use 
government 
health facility 
Yes 220 (84.6) 100 120 (54.6) 1 
No 40 (15.4) 11 29 (72.5) 2.19 1.04-4.61 0.04 
Number of 
times used over 
past year 
(nmiss=3) 
Never use 40 (15.6) 11 29 (72.5) 1 
None 50 (19.5) 21 29 (58) 0.52 0.21 - 1.28 
1-2 times 61 (23.7) 32 29 (47.5) 0.34 0.15-0.81 
3 or more 106 (41.2) 46 60 (56.6) 0.49 0.22- 1.09 0.09 
Travel time to 
the nearest 
clinic (nmiss'-2) 
< 15 min 140 (54.2) 57 83 (59.3) 1 
15 - 29 min 83 (32.2) 32 51 (61.5) 1.09 0.63-1.91 
> 30 min 35 (13.6) 21 14() 0.46 0.22-0.97 0.08 
Transport to the 
nearest clinic 
Public transport 116 (44.6) 53 63(54.3) 1 
Own transport 96(36.9) 37 59 (61.5) 1.34 0.77-2.32 
Walk 48(18.5) 21 27 (56.3) 1.08 0.55-2.13 0.57 
Travel time to 
the nearest 
hospital (nmiss=1) 
< 15 min 46 (17.8) 25 21 (45.7) 1 
15.29min 94(36.3) 34 60(63.8) 2.10 1.03-4.30 
> 30 min 119 (45.9) 51 68 (57.1) 1.59 0.80-3.15 0.12 
Transport to the 
nearest hospital 
Public transport 157 (60.4) 72 85 (54.1) 1 
Own transport 97 (37.3) 37 60 (61.9) 1.37 0.82-2.30 
Walk 6(2.3) 2 4(66.7) 1.69 0.30-9.52 0.43 
Usual first 
choice of 
treatment 
(nmiss=l ) 
Gov clinic 189 (73) 84 105 (55.6) 1 
Others 70 (27) 26 44 (62.9) 1.35 0.77-2.38 0.29 
Treatment 
choice for 
current illness 
(TB) 
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variaoie n No Doctor UK 95% GI p- 
(col %) delay Delay value* 
(row %) 
Gov clinic 189 (72.7) 89 100 (52.9) 1 
Others 71 (27.3) 22 49 (69) 1.98 1.10-3.56 0.02 
Travel time to 
treatment 
choice 
< 15 min 94 (36.1) 39 55 (58.5) 1 
15 - 29 min 88 (33.9) 33 55 (62.5) 1.18 0,65-2.14 
> 30 min 78(30) 39 39 (50) 0.71 0.39 - 1.30 0.26 
Transport to the 
treatment 
choice for 
current illness 
(TB) 
Public transport 128 (49.2) 63 65 (50.8) 1 
Own transport 107(41.2) 42 65 (60.8) 1.5 0.89-2.52 
Walk 25(9.6) 6 19 (76) 3.07 1.15-8.19 0.04 
* p-value from Likelihood ratio test 
e. Health provider factors 
At the first attendance to the government clinic (including those who had first 
seen private doctors), those who had sputum examination were less likely to 
have doctor delay compared to those who did not. (Table 8.7) A repeat visit 
to the first provider resulted in over 4 times the odds of doctor delay 
compared with those respondents who did not have repeat visit. Those who 
were satisfied with the services provided were less likely to have doctor delay. 
Table 8.7: Univariate analysis of health provider factors (proximal 
determinants) and doctor delay 
Variable n No Doctor OR 95% CI 
(col %) delay lay,, value* 
(row %) 
Sputum exam 
at 1St visit to 
government 
clinic 
Yes 181 (69.6) 91 90 (49.7) 1 
No 79 (30.4) 20 59 (74.7) 2.98 1.66-5.35 <0.001 
Repeat visit to 
first provider 
No 169 (65) 92 77 (45.6) 1 
Yes 91 (35) 19 72 (79.1) 4.53 2.43-8.45 <0.001 
Referral made 
by first 
provider 
No 233 (89.6) 98 135 (57.9) 1 
Yes 27 (10.4) 13 14 (51.9) 0.78 0.35-1.74 0.55 
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Hospitatised 
No 200 (76.9) 83 117 (58.5) 1 
Yes 60 (23.1) 28 32 (53.3) 0.87 0.44-1.72 0.68 
" p-value from likelihood ratio test 
8.4.2 Multivariate analysis of doctor delay of more than 14 days 
As with patient delay, all the variables in the univariate analysis with p-values 
< 0.2 and all those identified as a priori confounders were considered in the 
multivariate analysis. Several variables were at the distal level: sex, age 
group, education level, household income, owned transport, land and has TV 
or radio. Seven variables were at the intermediate level: co-morbidity, ever 
use government facility, number of times used government facility in past 
year, travelling time to nearest clinic, travelling time to nearest hospital, 
treatment choice for current illness (TB) and mode of transport to treatment 
choice for current illness (TB). Sputum examination at first visit to 
government clinic, repeat visit to first provider, chest pain, loss of weight and 
fever were at the proximal level. As before, sex and age group were a priori 
confounders and retained in all the models while education level and 
household income were included because they were considered potential 
confounders. 
Among the intermediate determinants, there were two variables; travelling 
times to the nearest health facility (clinic and hospital) that satisfied the 
criteria for consideration in the multivariate model. As almost all diagnosis 
could be made at the clinic level, only the travelling time to the nearest clinic 
was considered in the multivariate analysis. 
a. Multivariate analysis with distal determinants - multivariate modelling 
stage 1 
Education level and household income were included as they were potential 
confounders. Two variables at the distal level were not retained: owned land 
and own TV or radio as they did not attained the p-value of < 0.1. 
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Table 8.8: Multivariate analysis of distal determinants for doctor delay 
(n=252) 
Univariate analysis Multivariate analysis ° 
Variable Unadjusted 95% CI Adjusted 95% CI .; p- OR OR value* 
Sex 
Mate 1 1 
Female 1.24 0.74-2.08 1.60 0.90-2.85 0.11 
Age group 
(years) 
18-29 1 1 
30-39 1.39 0.67.2.85 1.27 0.59-2.74 
40 - 49 1.45 0.72-2.95 1.81 0.82-4.00 
50 - 59 0.98 0.45-2.14 1.39 0.55 - 3.52 
60 - 88 1.67 0.77-3.61 3.88 1.36-11.04 0.10 
Education 
None 1 1 
Primary 1.27 0.64-2.52 2.40 1.02-5.60 
Secondary Et 1.38 0.71 -2.66 3.44 1.30-9.11 0.04** 
above 
Household 
income 
No fixed 1 1 
income 
< USD 132 0.77 0.24-2.48 0.53 0.14-1.97 
> USD 132 0.63 0.20-1.92 0.33 0.09 - 1.21 0.12" 
Own transport 
No 1 1 
Yes 1.87 1.10-3.18 2.02 1.11 -3.66 0.02 
" p-value from likelihood ratio test 
ý" p-value for trend of odds=0.39 
p-value for trend of odds=0.83 
b. Multivariate analysis with distal and intermediate determinants - stage 2 
The variable `ever use government facility' showed high collinearity with 
`number use of government facility over past year' and so the latter was not 
retained in subsequent model. The variable 'co-morbidity' was also not 
included in the model because of its p-value of 0.28. 
Table 8.9: Multivariate analysis of distal and intermediate determinants for 
doctor delay (n=250) 
Univarlate analysis- nnuttivariate anaß sis 
Variable Unadjusted 95% C(" Adjusted 95% Cl p- 
OR. OR ,, value* 
Sex 
Mate 11 
Female 1.24 0.74-2.08 1.78 0.98-3.25 0.06 
Age group 
(years) 
18-29 11 
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Univariate, analysis .. Multivariate analysis, ',, Variable Unadjusted 95%0- Adjusted 95% Cl 
OR OR value*' 
30 - 39 1.39 0.67-2.85 1.17 0.52-2.63 
40-49 1.45 0.72-2.95 1.83 0.80-4.16 
50 - 59 0.98 0.45-2.14 1.46 0.55-3.90 
60 - 88 1.67 0.77-3.61 3.82 1.29-11.34 0.14 
Education 
None 1 1 
Primary 1.27 0,64-2.52 2.14 0.90-5.12 
Secondary Et 1.38 0.71 -2.66 2.97 1.09-8.09 0.09 
above 
Household 
income 
No fixed 1 1 
income 
< USD 132 0.77 0.24-2.48 0.63 0.16-2.43 
> USD 132 0.63 0.20-1.92 0.26 0.07-0.98 0.01 
Own transport 
No 1 1 
Yes 1.87 1.10-3.18 1.98 1.06 - 3.69 0.03 
Ever use 
government 
health facility 
Yes 
No 
1 
2.19 1.04-4.61 
1 
2.37 0.99-5.68 0.05 
Travel time to 
the nearest 
clinic 
< 15 min 1 1 
15-29 min 1.09 0.63-1.91 1.13 0.60-2.15 
> 30 min 0.46 0.22-0.97 0.42 0.17-1.03 0.09 
Treatment 
choice for 
current illness 
(TB) 
Gov clinic 1 1 
Others 1.98 1.10-3.56 1.78 0.90-3.50 0.09 
* p-value from likelihood ratio test 
c. Multivariate analysis with distal, intermediate and proximal 
determinants - stage 3 
In the final model, having sputum examination at the first visit to the 
government clinic was retained despite a p-value exceeding 0.1 as it 
decreases the odds ratio for repeat visit by more than 20%. The variable 
`fever' was not retained due to its p-value of 0.15. 
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After adjusting for distal, intermediate and confounding factors, those 
educated, those who had never used government facility, had chest pain and 
loss of weight were twice more likely to be associated with doctor delay. 
(Table 8.10) A repeat visit to the first provider resulted in approximately 4 
times doctor delay than those who did not (AOR: 3.88, CI: 1.79 - 8.39). Those 
who chose non-government clinic for current illness (TB) had almost twice the 
odds of having doctor delay. Those who had sputum examination done at the 
first visit to government facility were 1.6 times more likely to have doctor 
delay. In contrast, those with household income of > USD 132 were less likely 
to have doctor delay. 
Table 8.10: Multivariate analysis of distal, intermediate and proximal 
determinants for doctor delay (n=250) 
y Univýrlate anal sis Multivariate "ana ysis 
Variable Unadjusted 95% Cl Adjusted 95% CI 
OR OR va(" 
Male 1 1 
Female 1.24 0.74-2.08 1.36 0.70-2.64 0.37 
Age group (years) 
18-29 1 1 
30 - 39 1.39 0.67-2.85 1.12 0.47-2.71 
40 - 49 1.45 0.72-2.95 1.88 0.74-4.81 
50 - 59 0.98 0.45-2.14 1.05 0.33-3.29 
60 - 88 1.67 0.77-3.61 2.83 0.83-9.66 0.32 
Education 
None 1 1 
Primary 1.27 0.64-2.52 2.00 0.73-5.46 
Secondary a 1.38 0.71 - 2.66 2.69 0.85-8.54 0.36 
above 
Household 
income 
No fixed income I I 
< USD 132 0.77 0.24-2.48 0.51 0.10-2.49 
> USD 132 0.63 0.20-1.92 0.20 0.04 - 0.96 0.02 
Own transport 
No 1 1 
Yes 1.87 1.10-3.18 1.47 0.73-2.92 0.28 
Ever use 
government 
health facility 
Yes 1 1 
No 2.19 1.04-4.61 2.70 1.04-6.98 0.04 
Travel time to 
the nearest clinic 
<15min 1 1 
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Vniväriate"anal sis ,. Multivariate anal sis . °: i 
Variable Unadjusted 95% Cl Adjusted 95ßb Cl p- 
OR OR value'" 
15 - 29 min 1.09 0.63-1.91 1.20 0.60-2.40 
> 30 min 0.46 0.22-0.97 0.41 0.15-1.13 0.11 
Treatment choice 
for current illness 
(TB) 
Gov clinic 1 1 
Others 1.98 1.10-3.56 1.85 0.89-3.87 0.10 
Repeat visit 
No 1 1 
Yes 4.53 2.43-8.45 3.88 1.79-8.39 0.001 
Sputum exam at 
1't visit 
Yes 1 1 
No 2.98 1.66 - 5.35 1.66 0.76-3.62 0.20 
Chest pain 
No 1 1 
Yes 2.22 1.33-3.70 2.71 1.45-5-08 0.002 
Loss of weight 
No 1 1 
Yes 2.73 1.30-5.75 2.26 0.93 - 5.47 0.04 
* p-value from likelihood ratio test 
8.4.3 Analysis of doctor delay of more than 60 days 
The secondary outcome for doctor delay uses a different cut-off point of 60 
days. Of the 260 respondents, 24.2% (95% CI: 19 - 29.5) had doctor delay of 
more than 60 days. 
a. Univariate analysis 
As with doctor delay of more than 14 days, socio-demographic variables were 
compatible with no association with doctor delay of greater than 60 days. 
Similarly, medical, family and social history factors were also compatible with 
no association with doctor delay. 
However, those with shortness of breath and fever tended to have doctor 
delay of more than 60 days; OR: 2.49(CI: 1.28-4.87, p-value=0.006) and OR: 
2.87 (Cl: 1.21 - 6.78, p-value=0.01) respectively. Also, those who had used 
government health facilities in the past were less likely to have doctor delay 
of more than 60 days (OR: 0.46, Cl: 0.22 - 0.96, p-value=0.03). Choosing a 
non-government health facility for current illness (TB) was associated with 
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doctor delay of more than 60 days compared to those who chose government 
clinics. 
Those who did not have sputum examination done at the first visit to a 
government clinic had double the odds for doctor delay of more than 60 days 
than those who had sputum examination done. In addition, a repeat visit to 
the first provider resulted in approximately 4 times doctor delay of more than 
60 days. The detailed results for these univariate analyses are available in 
Appendix 9. 
b. Multivariate analysis for doctor delay of more than 60 days 
The variables listed below were included in the model for the multivariate 
analysis. At the distal level were sex, age group, education level and 
household income while ever use government facility, number of times used 
government facility in the past year and treatment choice for current illness 
(TB) were at the intermediate level. The variables at the proximal level were 
sputum exam at first visit to government facility, repeat visit to first provider, 
chest pain, and shortness of breath, toss of weight, fever and lethargy. The 
process for inclusion followed previous steps already described. 
Table 8.11 shows the, findings from multivariate analysis. After controlling for 
the effects of confounding and other variables, those who have never use 
government health facility were twice more likely to have doctor delay of 
more than 60 days compare to those who had (CI: 0.87 - 5.51). A repeat visit to 
the first health provider resulted in 6 times the odds of doctor delay of 
greater than 60 days. Those with fever had almost thrice the odds for doctor 
delay of more than 60 days (AOR: 2.98, CI: 1.13 - 7.83). Those with primary 
education, had chest pain and shortness of breath were approximately 1.7 
times more likely to have doctor delay of greater than 60 days that those who 
did not. Those with household income were less likely to have doctor delay of 
more than 60 days than those without income. 
158 
Chapter 8: Results of cross sectional study on explanatory factors for doctor delay 
univariate analysis Multivariate analysis 
Variable Unadjusted 95% Cl Adjusted '95% CI p-, 
OR OR, value*g 
Sex 
Mate 1 1 
Female 0.93 0.51 -1.69 0.77 0.37-1.61 0.49 
Age group (years) 
18-29 1 1 
30 - 39 1.00 0.44 2.25 0.95 0.37-2.43 
40-49 0.90 0.40-2.02 0.85 0.30-2.38 
50 - 59 0.92 0.37-2.27 0.63 0.18-2.18 
60 - 88 0.67 0.27-1.69 0.43 0.10-1.79 0.81 
Education 
None 1 1 
Primary 1.27 0.64-2.52 1.77 0.57-5.47 
Secondary Et above 1.38 0.71 -2.66 1.20 0.32-4.45 0.44 
Household income 
No fixed income 1 1 
< USD 132 0.77 0.24-2.48 0.24 0.06-1.03 
> USD 132 0.63 0.20-1.92 0.22 0.05-0.90 0.11 
Ever use 
government health 
facility 
Yes 1 1 
No 2.15 1.05-4.40 2.19 0.87-5.51 0.09 
Treatment choice 
for current illness 
(TB) 
Gov clinic 1 1 
Others 1.98 1.10- 3.56 1.54 0.68-3.46 0.30 
Sputum exam at 1s 
visit 
Yes 1 1 
No 2.29 1.27-4.13 0.93 0.40-2.17 0.87 
Repeat visit 
No 1 1 
Yes 4.13 2.21 - 7.71 6.04 2.61 - 14.00 <0.001 
Chest pain 
No I 1 
Yes 2.22 1.33-3.70 1.73 0.84-3.57 0.13 
Shortness of breath 
No 1 1 
Yes 1.31 0.79-2.18 1.74 0.82-3.69 0.15 
Fever 
No 1 1 
Yes 2.19 1.20-3.99 2.98 1.13-7.83 0.03 
p-value from likelihood ratio test 
The above completes the multivariate analysis of doctor delay and the 
discussion for the results is presented in the next chapter. 
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9 CHAPTER 9: Discussion 
This chapter discusses the findings of the quantitative study and the strength 
and limitations of the study, makes relevant comparisons with other studies, 
and suggests how the findings contribute to current knowledge and makes 
suggestions on how it could be improved and finally recommendations for 
future studies. 
9.1 Summary of findings 
The findings from this study revealed that only the usual first choice for 
treatment was associated with patient delay of more than 30 days. Patients 
whose usual first place for treatment was non-government health facilities 
had more than double the odds of patient delay than those whose first choice 
was government clinics. In addition, those aged between 30 to 39 years old 
were 2.6 times more likely to have patient delay compared to the baseline 
group of 18 to 29 years old. Those who lived in 'other' type of house (not 
'village' and not residential) were less likely to have patient delay compared 
to those who lived in `village' houses but not in those living in residential 
housing. No important association was seen in this dataset with education 
level or with female sex. 
For patient delay of more than 90 days, similar finding to the above was noted. 
Those who usually sought treatment at non-government facilities were 2.3 
times more likely to have patient delay of more than 90 days compare to 
those who usually preferred government clinics. Similarly, those aged 30 to 
39 years also had double the odds of patient delay of more than 90 days 
compared to the baseline age group of 18 - 29 years old. There was weak 
evidence that those who owned livestock and had other medical conditions 
were also almost twice more likely to have patient delay of more than 90 days. 
Again, it was found that gender and education level were compatible with no 
association with `extreme' patient delay. 
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For doctor delay of more than 14 days, those educated, those who had never 
used government facility, had chest pain and loss of weight were twice more 
likely to be associated with doctor delay. A repeat visit to the first provider 
resulted in approximately 4 times doctor delay than those who did not. Those 
who chose non-government clinic for current illness (TB) had almost twice the 
odds of having doctor delay. Those who had sputum examination done at the 
first visit to government facility were 1.6 times more likely to have doctor 
delay. In contrast, those with household income of > USD 132 were less likely 
to have doctor delay. 
For `extreme' doctor delay (more than 60 days), those who have never use 
government health facility were twice more likely to have doctor delay of 
more than 60 days compare to those who had. A repeat visit to the first health 
provider resulted in 6 times the odds of 'extreme' doctor delay while those 
with fever had almost thrice the odds. Those with primary education, had 
chest pain and shortness of breath were approximately 1.7 times more likely 
to have doctor delay of greater than 60 days that those who did not. Those 
household with income were less likely to have doctor delay of more than 60 
days than those without income. 
9.2 Strengths of the study 
The strength of this study is in making available a wealth of relevant data on 
factors affecting case finding for TB such as socio-demographic, health care 
utilisation and symptomatology following a relatively short period of research 
work. These data were useful in generating information on important 
elements of TB control efforts such as the journey or time period from illness 
to treatment. Such information on time periods was not available prior to this 
study. 
Despite this being a cross sectional study, the coverage was fairly broad as it 
covered 10 out of the 23 districts in Sabah. In addition, it covered most of the 
ethnic groups in Sabah and also urban and rural areas. The sample size was 
estimated based on previous study done in Penang, West Malaysia where the 
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sample size in that study was only 100. This sample size is comparable to 
many studies such as in the Philippines study (302 patients)[84], Italian study 
(271)[77], South Africa study (298)[63], Tanzanian study (296)[73] and 
California study (248)[30]. The smallest sample size was the Teheran study (50 
patients)[67] and the most was the Spain study (7037 patients)[62]. 
The analysis in this Sabah study was also rigorous especially in the 
multivariate analysis using a very detailed conceptual framework for analysis 
and in using 2 different cut-off points for both patient and doctor delay. Of 
the 38 studies in 29 countries reviewed, only five studies reported on results 
of multivariate analysis after control of confounding factors. 
The use of both qualitative and quantitative approaches proved invaluable in 
this research. The qualitative study provided information about health and 
health care seeking behaviour among TB patients and in the community. Such 
information was also valuable in informing the questionnaire development 
such that the questionnaire became relevant to the setting. 
9.3 Limitations of the study 
9.3.1 Generallsability 
The study was conducted in 10 out of 23 districts in Sabah and the sample was 
drawn from the TB Treatment Registry at the health centre. As TB is a 
notifiable disease under Act 342 and based on past knowledge, almost all TB 
patients received their treatment at government facilities, it is likely that the 
study had good representation of all PTB patients in the 10 districts. 
Although the study involved as many different races as possible, its 
confinement to the west coast made it not generalisable to the whole 
population of Sabah. There are many ethnic groups residing in the east coast 
which were not represented in the sample. As mentioned in 5.2.2, the 
immigrant populations were excluded due to their mobility and the tight 
research schedule. However, it is postulated that for various social reasons 
162 
Chapter 9: Discussion 
such as mobility and fear of authority due to their illegal status they would 
have different health and health care seeking behaviours such as that found 
among immigrants in the California study[30]. 
9.3.2 Selection bias 
There is bias due to the fact that the participants were patients who seek 
treatment at the health facilities including private clinics and ended up being 
diagnosed at government health facilities. There may be others who sought 
treatment elsewhere and never use the government or private health 
facilities. There is no way one can find out the reason why and when they 
seek treatment unless one does a community survey. In addition, patients 
with TB symptoms who died before being diagnosed were also excluded from 
the study. 
Selection bias was minimised by ensuring that sufficient attempts were made 
to interview all eligible respondents. Comparison between those consented 
and those not consented (due to death, refusal and not contactable) did not 
reveal any difference for gender and age and thus, a condition known as 
volunteer bias[128] may not be a major issue. 
9.3.3 Information bias 
Information bias occurred when determining the time period and delay and 
inlcude recall bias, interviewer bias and missing data. 
a. Calculation of time period and delay 
There were many difficulties in ascertaining past symptoms and onset of these 
symptoms by participant self-report. This has not been revealed in great 
details by those who have embarked on such research. Attempts to use similar 
approaches used by other studies such as by improving recall in relation to 
local events[69] did not prove successful in the context of Sabah. Although 
triangulation methods such as the use of clinical records, interviews with 
carers or close contacts may be useful, it does leave one with the dilemma of 
choosing a single date in the presence of discrepancies between reports. In 
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Sabah, once a patient is diagnosed, a clinical record of the current illness (TB) 
is created for the patient but information on the duration of illness or date of 
start of illness was not systematically recorded. They are kept in the Chest 
clinic for several years. The reason for this is because even after completing 
treatment, the patients are still reviewed on a regular basis for a period of 18 
months. The case notes for TB suspects prior to TB diagnosis are kept in the 
Out-Patient Department (OPD) of the clinics. Due to the difficulties in getting 
the OPD notes and the potential inconsistencies and incomplete information 
on symptoms and their durations, participant self-report for the date of onset, 
duration of symptoms and the date of seeking treatment was used. The date 
of starting treatment was the only date obtained from patients' clinical 
records. 
In the calculation of patient time period, date of first seeking treatment was 
used together with the maximum duration of the four symptoms (cough, 
hemoptysis, fever and loss of weight) to generate a date for the onset of 
symptoms. This is a departure from what other researchers have done such as 
Pronyk et al[63] and Salaniponi et al[129] who both used one symptom (cough). 
In the calculation of the doctor time period, the interval started from the 
date the patient consulted a medical practitioner in either government or 
private clinics. This is because all doctors even those in private practice 
should be able to diagnose TB clinically and managed accordingly. 
Errors in obtaining a correct time period are likely to have occurred in the 
following ways. 
a. Problems with recall may provide an inaccurate date for date of 
seeking treatment or for duration of symptoms. 
b. In cases, where respondents tried their best to provide a date or 
duration of symptoms, they often 'round' up the numbers such as '30 
days' or 'about a year' which was reflected in clustering around certain 
values on the graph on time period. 
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c. In the approximation of the term `early', `middle' and `end', assigning 
a fixed number also contributed to inaccuracies of the time period. 
It is therefore relevant to interpret the findings on time period and delay in 
view of these errors. In addition, it is just as important to identify such errors 
in order that steps could be undertaken to minimise such errors in future 
researches. 
b. Recall bias 
Another factor related to recall bias is one's ability to recognise symptoms as 
the expression of an illness. Patients may be more aware of a symptom when 
it became worse, persistent or affected their daily activities. In terms of 
seeking care, that may be sufficient but in the wider perspective of limiting 
transmission, inability to recognise the symptom is a public health problem. 
In addition, there was a delay from starting treatment and being interviewed; 
almost two fifths were interviewed within 30 days of starting treatment. This 
time lapse may have also contributed to recall bias. On the other hand, when 
a patient has just been diagnosed and started on treatment, it may not be 
beneficial to interview them on the same day. This study also noted that TB 
patients went through considerable psycho-social and physical stress which 
may be more disturbing at the early stage of the disease and when 
interviewed too early might also affect the ability to recall events. 
There was also potential for differential bias if the ability to recall dates 
differed between age, gender and ethnic groups and even between certain 
such groups such as smokers. This may have been contributed to different 
interpretation of symptoms. For example, smokers may interpret early 
symptoms of cough as being due to smoking rather than the onset of TB or 
patients with co-morbidity may regard earlier symptoms of loss of weight as 
due to pre-existing illness. 
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c. Interviewer bias 
All three RAs were sufficiently trained to conduct the interview in Bahasa 
Malaysia using similar approach and terminologies. Although, Bahasa Malaysia 
is the national language, it is often not the first language among Sabahans. 
When they do use Bahasa Malaysia, they speak in a variant of this language. 
Therefore, due to some diversity in dialects, there may be some 
misclassifications of the explanatory variables. 
d. Missing data 
The study also revealed the need to improve on the complete documentation 
of the results in the patients' case notes. Although the sputum examination 
and chest x-ray results were not used in relation to the outcome measurement, 
missing data in both these areas limited their use in the descriptive analysis. 
In almost half the cases, the results of some of the sputum examination were 
not in the notes and when they were in the notes, often the dates on which 
the reading was made were missing. All respondents have their chest x-rays in 
the case notes but in almost half of them, their results were missing. Missing 
data from questionnaires were very few and most missing data were with 
reference to date of seeking treatment or duration of symptoms. 
9.3.4 Other limitations 
The calculated sample size of 386 was based on the previous study in West 
Mataysia[58]. The percentage of patient delay among those with secondary 
education was much higher (53%) than that used in the estimation (30%) and a 
recalculation of required sample size based on this percentage revealed that 
the current sample size was sufficient to detect an odds ratio for delay 
exceeding 2.0 based on a type I error of 5% and 80% power. 
The other limiting factor is that this was a cross sectional study which may 
make it difficult to assess a clear cause and effect relationship. For example, 
in this study it was revealed that the explanatory factor for patient delay was 
because the patients sought non-government health services but it is possible 
that individuals may have been embarrassed at the long time they had taken 
before attending and preferred the private services for perceived greater 
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confidentiality. However, why delay occurs among such group could not be 
explained from this study. One can expand the research by doing further 
exploratory work on those who delayed by comparing between those who 
attended government health facilities and those who sought non-government 
practitioners. 
9.4 Comparison to other studies 
Comparison of explanatory factors identified from other studies is difficult for 
several reasons: 
a. differences in health and health care seeking behaviour of the study 
population 
b. differences in health care system and setting 
c. differences in definition of time period and the use of either median or 
mean. Comparison in this chapter is made with studies with similar 
definitions and where the median was used. 
d, the use of different cut-off point for delay 
e. the rigor of analysis 
In identifying the explanatory factors for delay in the chapter on literature 
review, all studies regardless of whether median or mean was used were 
reviewed. Differences in health and health care seeking behaviour meant that 
a variety of health care providers may have been consulted for diagnosis and 
treatment and delay could arise from these practices including the capacity 
and ability of the providers to make an accurate diagnosis and start treatment 
promptly. For example, in the Gambia, some patients may prefer to consult 
non-governmental clinics but need to be referred to the National TB Control 
Programme as anti-TB drugs are not available in any pharmacies in that 
country and thus limits the ability of private doctors to start treatment. [69] 
Therefore, the explanatory factors for delay in the Gambian study would 
differ with the Sabah study as in Sabah, almost all clinics in the government 
and private sectors can provide treatment. 
The definitions of time period are also influence by the availability of 
different providers and also the health care setting in the study area. For 
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example, when a patient can only access modern medicine through a 
particular clinic, to be referred to another for diagnostic procedures and 
again referred to another for treatment, then a study on delay should take 
into consideration the different time period and delay at all stages. In the 
Lagos study, doctor delay refers to the time period from the first consultation 
with any health provider (including non medical provider) to being seen at the 
Chest Clinic at the General Hospital. Treatment delay is defined as the time 
from being seen at the Chest Clinic and commencement of treatment. [68] 
Therefore, in terms of comparison there are several issues to be addressed. 
Firstly, not all health facilities in Lagos could diagnose TB whereas in Sabah, 
almost all health facilities besides those run by midwives could diagnose TB. 
Secondly, doctor time period in the Lagos study refer to the period between 
referral to the Chest Clinic where as in this Sabah study, it included what was 
termed as 'treatment delay' in the Lagos study. The situation in Lagos is 
similar to that in Zambia and UK where diagnosis and treatment are provided 
at a referral Chest Clinic[26,60] or at government hospitals in Malawi[129]. In 
the South Africa study, the end-point used was 'hospitalisation' which was 
routinely done upon diagnosis. In these studies, a prolonged time period is not 
surprising for those who sought treatment at GP or health clinics compared to 
those whose first contacts were with the hospitals. [63] 
In addition, calculation of time period can be as straightforward as extracting 
the date of symptom onset and first medical consultation from the case notes 
or through interviews as was done by most studies. Even this can differ in the 
symptoms chosen; some studies chose cough as the presenting symptom while 
others used all the other symptoms suggestive of TB. Calculation can also be 
done by averaging the time periods collected from different sources as done 
by Paynter et at. [60] In this Sabah study, the maximum duration of four 
symptoms (cough, hemoptysis, fever and toss of weight) was used in the 
calculation of patient time period. These differences in estimation may result 
in limitations in comparing studies. 
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Differentiation between patient and doctor or health care system time period 
may also be an issue. For example, when patient has to wait to obtain an 
appointment with a health care provider, it should be considered as 
contributing to the health provider time period and not patient time period. 
However, by using `consultation with medical provider' as the beginning point 
for doctor time period, this waiting period for appointment is included in the 
patient time period. In addition, the use of a different cut-off point for delay 
may also revealed different explanatory factors as demonstrated in this study 
by the usage of 14 and 60 days for doctor delay. 
The rigor of analysis also affects the findings especially when comparing 
explanatory variables for delay. Some studies are descriptive in content. [67, 
73,129] In some, only univariate analysis was done[26,30,60,66,68] and 
only in a few that multivariate analysis was performed[30,62.65]. Therefore, 
comparison of explanatory factors needs to be discussed against such 
analytical frameworks. In spite of all the differences, relevant comparisons in 
terms of median and delay are made in the following paragraphs. 
9.4.1 Comparison of patient time period with the literature 
In this study, the percentage of patients who sought treatment after 30 days 
was 51.8% (95% CI: 45.9 - 57.8). In the West Malaysia (Penang) study, the 
percentage was lower at 34%[58]. Other studies have also shown lower 
percentages; Teheran (12%)[67], Ethiopia (41%)[66], Spain (43%)[62]. The 
study conducted in the Philippines showed a similar percentage (50%)[84] and 
two studies showed higher percentages of 83% in Lagos, Nigeria[68] and 85% in 
Tanzania[73]. The percentage in Zambia was lower at 35% [18]. This study was 
carried out among adults presenting with cough in only 2 health centres in 
Lusaka. 
The median patient time period of 60 days (8.6 weeks) is similar to the 
Ethiopian study[66], Lusaka, Zambia[26] and Nigeria[68], longer than the 
reported median of 2 weeks in the West Malaysia studies [57,58] and in that 
seen in other studies such as Spain (22 days)[62], New York (25 days)[64], 
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Botswana (3 weeks)[65], Queensland (30 days)[70], South Africa (4 weeks)[63] 
and UK (34.5 days)[60] but shorter than in Tanzanian study (120 days)[73]. 
9.4.2 Explanatory factors associated with patient delay 
In a multivariate analysis after appropriate adjustment of confounders in a 
multivariate analysis, those whose usual first treatment choice was a non- 
government health facility were twice more likely to have patient delay than 
those whose usual first choice was a government facility (Adjusted OR: 2.28, 
CI: 1.03 - 5.06). This is similar to findings from other studies which compared 
non-governmental facilities such as traditional healers and private clinics to 
government facilities for patient delay. Among smear positive PTB patients 
who sought folk therapy in rural Hunan, China[83], patients with cough who 
had prior attendance at private clinics in Lusaka, Zambia[18] and PTB patients 
in Mwanza, Tanzania[73] who sought treatment from traditional heaters, all 
revealed patient delay compared with those who sought governmental 
providers. This is in contrast to TB patients in South India where those who 
initially consulted a government provider were twice more likely to have 
patient delay than those who sought private clinics. [71] 
As mentioned in 1.2, patient time period reflects the health and health care 
seeking behaviour of an individual. In the Mwanza study, it is understandable 
that one who sought traditional medicine would have longer patient delay as 
the definition of patient delay is from onset to first medical consultation at 
the health facility. [73] However, when patient delay involves private clinics 
such as in the Sabah study and as seen in the study in Lusaka[18] or 
government clinics in South India[71], the reasons for the delay are harder to 
explain. In Sabah, as mentioned in 6.4.1, those with higher income preferred 
private practitioners. It may also be that this group did not perceive their 
symptoms as serious enough to seek treatment or that they were too busy 
with their work to be bothered with the symptoms. 
In the Sabah study, those who lived in 'other' type of house (not 'village' and 
not residential) were less likely to have patient delay compared to those who 
lived in `village' houses (AOR: 0.27, CI: 0.11 - 0.71) but not in those living in 
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residential housing. It should be pointed out that 'others' include a 'mixed' 
group in terms of socio-demographic characteristics and not just the type of 
houses. Almost two thirds of this group preferred government facility and 
almost 83% earned more than USD132 per month. In comparison, although 
almost 75% of those living in 'village' houses also preferred government 
facilities but around half earned less than USD132 per month and thus may 
have financial problems in terms of getting treatment such as transportation 
cost. As such, the former group may have no problem in accessing health 
services in particular government health facilities. No other studies have 
reported a similar finding. 
In addition to the cut-off point of 30 days, another cut-off point of 90 days 
was used to analyse the group with `extreme' patient delay which constituted 
a quarter of the respondents. The reason for analysing those with `extreme' 
delay is to identify whether the explanatory factors are different in those who 
may be more infectious and who could be considered for targeting when 
resources are scarce. 
In the multivariate analysis for patient delay of more than 90 days, the usual 
first place for seeking treatment was associated with patient delay. Those 
who usually sought treatment at non-government facilities were 2.3 times 
more likely to have patient delay of more than 90 days compare to those who 
usually prefer government clinics (AOR: 2.28, CI: 1.11 - 4.68). This finding is 
similar to patient delay of 30 days. 
Those who owned livestock and had co-morbidity were also almost twice more 
likely to have patient delay of more than 90 days (AOR: 1.88, CI: 0.98 - 3.63 
and AOR: 1.95, CI: 0.97 - 3.91). It is difficult to explain why someone who 
owned livestock would have a patient delay of more than 90 days. One can 
again speculate only that difficulty in leaving land and animals may be factors 
leading to delay in health care seeking. However, evidence of the association 
is weak and may be due to chance. 
171 
Chapter 9: Discussion 
Even in the univariate analysis, those with co-morbidity had double the odds 
of patient delay of more than 90 days (OR: 1.92,95% CI: 1.07 - 3.44) 
compared to those without. This may be due to the perception that symptoms 
of TB as due to their medical conditions rather than a new disease. In addition, 
since they were already on regular follow-up, they might have waited until 
their review appointment to seek treatment for the symptoms. 
All the following studies used median as a cut-off point to describe patient 
delay. Findings in the Lagos[68] and the Ethiopian[66] studies reported low or 
inadequate knowledge on TB were reasons for prolonged patient time period. 
Some patients thought that the symptoms were harmless and would improve 
or treated by themselves: 70% of the patients in the Ethiopian study[66], 20% 
in the California study[30] and more than half in the Philippines study[84]. 
Among adults with cough presenting to the health centres in Lusaka, Zambia, 
perception of the health services as being poor was a more important cause to 
delay compared with knowledge on Tß. [18] Similar finding of perceived poor 
reputation of government the reason for seeking treatment at private clinics 
(although expensive) but resulted in patient delay was revealed in the 
Philippines study. [84] In addition, other reasons were the lack of information 
on the availability of free treatment[68], tong distance to the nearest health 
facility[66] and lack of money[84]. 
In the Teheran study, the mean was used as cut-off point to describe delay. 
The mean patient delay was 12.5 days (± 7.5days) and the reasons given for 
their delays were underestimation of the seriousness of their symptoms, being 
too busy, poor access to health care (2%) and dependency on their husbands 
(for the women). [671 Despite such dependency on their husband, women were 
less likely to delay. The authors suggested that the women took their health 
more seriously and are prepared to consult early compared to men. [67] 
There was little association of these factors with gender and ethnicity and 
patient delay in the Sabah study. In the Lusaka, Zambia study, women more 
often seek treatment late. The authors suggested that the heavy workload of 
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women in addition to their lack of education, mobility, independence and lack 
of financial resources may have contributed to women presenting later than 
men. [26] In the New York study, being in the 55-64 age group and spoke a 
primary language other than English were associated with longer patient delay; 
AOR: 10.6, CI: 1.3 - 86.9 and, AOR: 2.5, CI: 1.0 - 5.8 respectively. The delay 
among non-English speaking groups reflected the difficulty in negotiating the 
health care system. The authors suggested that the delay in the 55-64 age 
group may be due to low index of suspicions on the occurrence of TB among 
this group as the focus of 'Think TB' campaigns on TB-HIV gave more emphasis 
on the 25 - 44 age group. [64] 
In the Sabah study, hemoptysis was not examined as a main determinant of 
presentation with TB because it was one of the four main symptoms for which 
the duration was used to determine the time taken to present to health 
services. However, given it was the main symptoms of only 12 patients, its 
importance was explored in the final model and found there was no 
association with time to presentation, unlike in the Ethiopian study which 
found that those with hemoptysis were more likely to have patient delay 
compared to those without. (OR: 1.90, CI: 1.16 - 3.12). [66] The authors 
suggested that patients stayed home for a long time until they noticed an 
alarming symptom such as hemoptysis before seeking treatment. 
Factors associated with long patient delay were also assessed to determine 
which different groups who could end up as long term sources of TB in the 
community. Almost a quarter of the respondents in this study sought 
treatment more than 90 days after onset of illness. This is comparable to the 
findings in Ethiopia[66] and the Philippines[84] where 21% and 20% 
respectively of the smear positive patients sought medical treatment after 90 
days from onset of illness. In Spain, 13% sought treatment after 3 months[62] 
while in Botswana, this figure was lower at 10%[65]. A much larger percentage 
of around 74% of the patients in Tanzania were treated after 3 months from 
the onset of symptoms. [73] 
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The preference for treatment of first choice being private care was also found 
to be associated with patient delay of more than 90 days as with those who 
delayed more than 60 days. In contrast, other settings had other factors 
associated with prolonged patient delay. In Spain, patient delay of more than 
57 days (75th percentile) was associated with age (greatest delay in the 35 -64 
age group), presentation of constitutional symptoms, alcoholism and being 
female. [62] In addition, more women delay more than 57 days before seeking 
treatment. suggested that this may be due to several reasons which needed 
further studies; one of which is that more women in the study seemed to be 
more prone to have extra-pulmonary TB compared to men. [62] 
9.4.3 Doctor time period and median for doctor delay 
The median doctor time period for a total of 260 respondents was 20 days 
(IQR: 7- 59 days, range 0- 551 days). This is very different from the two 
studies in West Malaysia where the median doctor delay longer; 7 weeks [57] 
and 5 weeks [58]. A cut-off point of 14 days was chosen to define `doctor 
delay' after taking into consideration a reasonable time period for sputum 
examination and chest x-ray before commencement of treatment. An 
acceptable period for both diagnostic and treatment time period is one week 
for each. One week is adequate to determine whether a patient has TB in a 
straight forward case. According to the national guidelines, at least 3 sputum 
samples are needed: spot, morning and spot specimens are collected over a 
period of 2 days. In the absence of chest x-ray, a patient with 2 positive 
smears can be started on treatment. Patients are started on treatment by 
medical officers almost immediately after diagnosis. Possible delay in starting 
treatment may occur if there is no medical officer in the health facility (often 
manned by medical assistants) which is common in Sabah. This `delay' has 
been taken into account in the choosing the cut-off point of 14 days for 
doctor delay. 
The median for doctor time period of 20 days (2.9 weeks) is much shorter 
than that found in the West Malaysian studies but comparable to the Nepal 
study (21 days)[75], Taiwan study (23 days)[76] and Hunan study, China (24 
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days)[83]. This value is probably in the middle range of doctor time period 
among studies which have used the same definition for doctor time period; 
from 6 days in Ethiopia[66], 11 days in Queensland[70], 5 weeks in 
Botswana[65] and 8 weeks in Ghana[72]. 
In Sabah, almost 43% of the respondents were put on treatment within 14 days 
of being seen by a medical doctor. In Ethiopia, the median time from first 
medical consultation to time of diagnosis was 6 days. About 53% were put on 
treatment within 6 days of being diagnosed and 90% within 15 days. [66] The 
short doctor time period of about 12 days on average was attributed to the 
high degree of alertness of the health staff on the possibility of TB as the 
prevalence of TB in Ethiopia is high and also the ease of making the diagnosis 
due to the advancement of the disease at consultation. For health centres 
where diagnosis was made late, it was due to shortage of laboratory 
technicians. [66] 
The median period from consultation at a medical facility to commencement 
of treatment in Tanzania was 15 days with a large difference between urban 
and rural areas; 13.5 days versus 41.5 days attributable to the difference in 
accessibility of health services and also the educational level and knowledge 
of the patients. [73] This median of 15 days was also similar to that found in 
the New York study and also varied between those who were evaluated as 
out-patient and in-patients; 21 days versus 10 days. [64] 
In contrast, in three quarters of the respondents in the Teheran study, 
diagnosis was made more than 1 month after medical consultation and which 
the authors implied lack of awareness and skills in making diagnosis of TB 
were to blame. [67] Even in a developed country such as UK, the median 
health service delay was 29.5 days with a shorter delay among those born in a 
high-prevalence country and those seen at the A6tE (Accident and Emergency). 
This maybe due to the fact that those who came in through the AftE tend to 
be more ill and thus investigated more thoroughly. [60] 
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9.4.4 Explanatory factors associated with doctor delay 
According to the authors of the two studies in West Malaysia, most of their 
respondents consulted private practitioners for their symptoms but most 
patients were diagnosed when they eventually sought treatment at 
government clinics. The authors suggested that due to the lack of awareness 
of TB among private practitioners, such long doctor time periods occurred. 
Similar reason for delay among private practitioners has been suggested in 
other studies such as in South Africa[63] and Philippines [84]. In South Africa 
study, patients who presented with TB symptoms were not diagnosed and 
referred to the hospital. Two thirds of them presented to hospitals after self- 
referral or at the insistence of family members, friends or employers. This 
reflected the quality of services provided by such groups which could have 
contributed to longer doctor delay. [84] 
Doctor time period reflects both on the management of patients after 
consultation with a medical doctor and the behaviour of the patients in 
relations to the services. provided. This thesis demonstrates that most patients 
in Sabah did not have problems complying with the requirements by the 
health providers such as sputum examinations and chest x-ray. In this study, 
more than 95% of respondents provided alt 3 sputum specimens within 4 days 
of request and almost all respondents had their chest x-ray done within 2 days. 
Therefore, the doctor time period reflected more on how they were managed 
by the doctors in attendance. 
Those who have never used government facilities mainly preferred private 
doctors as their first provider. It is possible that there exist certain `profiling' 
on patients who sought treatment from private clinics. TB may not be 
suspected among patients of better socio-economic standings or in the 
absence of physical findings and with common symptoms such as cough and 
fever. In the South Africa study by Pronyk et at, the speed of diagnosis was 
higher among those who fitted the conventional risk profile of a TB suspect; 
those with history of migrant tabour and alcohol consumption. In addition, 
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women tended to be diagnosed much later which the authors suggested 
maybe due to their (lower) socio-economic and cultural position in society. [63] 
Other studies found that those who sought traditional healers were more 
likely to have 'doctor or diagnostic or health service' delay [26,33,65,73,83] 
most probably because these healers were not trained to diagnose diseases 
such as TB. In other studies, those who presented to the general practitioners 
were more likely to have 'doctor or diagnostic or health service' delay [26,60, 
71,75] presumably due to a lower index of suspicion among general 
practitioners of the possibility of TB. 
In the multivariate analysis, those who had never used government facility, 
had chest pain and loss of weight were twice more likely to be associated 
with doctor delay. A repeat visit to -the first provider resulted in 
approximately 4 times doctor delay than those who did not (AOR: 3.88, Cl: 
1.79 - 8.39). 
Those who had chest pain were almost thrice more likely while those with loss 
of weight were twice more likely to have doctor delay. This may be due to 
them being suspected of having other diseases; chest pain can often be 
suspected as related to a heart condition and loss of weight when not 
profound could often be treated symptomatically. Loss of weight could be due 
to loss of appetite as a result of other illnesses. A repeat visit to the first 
provider will prolong the doctor time period and may result in doctor delay. 
Again the reason for repeat visits might be that the attending doctors could 
have diagnosed the patient as suffering from other diseases. 
The explanatory factors for doctor delay of more than 60 days differ from 
those for doctor delay of 14 days except. for repeat visit to first provider. 
Those with fever tend to have doctor delay of more than 60 days probably 
because it is a non specific symptom which may be construed as not a very 
serious symptom by the attending doctors. 
177 
Chapter 9: Discussion 
The median time period for doctor delay in this Sabah study is surprisingly 
lower than measured in West Malaysia. The incidence of TB in Sabah is the 
highest in Malaysia and perhaps the level of awareness on TB among private 
practitioners is adequate but need to be heightened. Sputum or chest x-ray 
examinations are often not available in all private clinics which may be a 
reason why patients were often treated symptomatically. For example, when 
a patient sees a private practitioner, in the absence of laboratory facilities, 
there may be a tendency to treat the patient's symptoms rather than subject 
the patient to laboratory examination elsewhere. 
For doctor delay of more than 14 days, the main risk factors were repeat visit 
to the first provider and chest pain. A patient who had to revisit his/her first 
provider is four times more likely to have doctor delay while those with chest 
pain would be twice more likely to have doctor delay. For doctor delay of 
more than 60 days, a repeat visit to the first health provider would also result 
in delay and so was having fever as a symptom. In this Sabah study, 24% (95% 
CI: 19 - 29.5) of respondents had doctor delay of more than 60 days. The 
figure was higher in Botswana where 41% of the patients were put on 
treatment more than 8 weeks after medical consultation. [65] 
In the Lusaka study, repeat health encounters contributed to diagnostic delay. 
This is because in Lusaka, diagnosis and treatment are provided at a central 
Chest Clinic. [26] In the Ethiopian study, similar to the Sabah findings, socio- 
demographic variables were not associated with health service delay. 
However, those living more than 30 minutes walking distance were more 
likely to have health service delay of more than 15 days. [66] 
In New York, the explanatory factors for health care system delay were 
absence of cough, being smear negative, had chest x-ray more than 1 day 
after presentation to a medical provider and being homeless which seemed 
reasonable to cause delay. [64] 
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9.5 Contribution to current body of knowledge 
It is also encouraging to know from the study that almost 90% of the 
respondents sought medical doctors in both government (-73%) and private 
sectors. This could allow for greater focus on these groups of professionals 
who can be monitored by the Ministry of Health especially in terms of 
standards of practice. Few patients (4%) self-medicate or seek traditional 
medicine. This is in contrast to 14% in the Lagos study[68] and Malawi[129] 
and 15.4% in South Africa[63] and 16% in Zambia[26] who sought non modern 
medicine such as traditional healers and prayer houses. In Tanzania, almost 
39% of the patients first visited a traditional heater. [73] 
In addition, the study also revealed the availability and accessibility of health 
services in Sabah. Slightly more than half of the respondents lived within 15 
minutes of travelling time to the nearest health facility and almost 86% within 
30 minutes of travelling time. 
9.6 Improvement for future studies 
Minimising recall bias would improve the internal validity and credibility of 
future studies in the same area. Although recall of events is affected by the 
personal characteristics, perhaps some methodological approaches can be 
modified towards minimising recall bias. Often interviewers do not explain in 
great detail the objectives of the study for various reasons. However, in 
studies such as this, active participation of the respondents is crucial. 
Patients are sometimes presented with 'prompts' to facilitate recall but it 
might be that patients need a different way of recalling events. These 
'prompts' could be identified by doing a focus group discussion among TB 
patients and allowing time and efforts by the patients to recall events. 
In addition to the above, other proxy sources such as clinical records should 
be used. Again, it may be beneficial to discuss the record with the patients to 
get as accurate data as possible. In this way, patients can used these clinical 
records as health diaries to improve recall. However, this involves a conscious 
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effort on the part of health staff to document systematically the onset of 
symptoms. 
A further refinement of this type of study is to follow up a sample of patients 
who first presented with cough and those who eventually developed TB. One 
is then able to assess the time period between onset of symptoms and the 
other `milestones' such as diagnosis and treatment. Needless to mention, this 
involves a lot more resources. 
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10 CHAPTER 10: Recommendations and conclusion 
This chapter describes the potential implications of the study findings on current 
practice and future initiatives. 
10.1 Implication towards current practice 
This study has demonstrated that socio-demographic characteristics of the patients 
were not important explanations for delay in presenting with TB in Sabah, Malaysia. 
However, it highlighted the need to took beyond these characteristics and address 
some of the issues pertaining to health services discussed further here. 
a. Greater awareness and adherence to existing guidelines 
Almost 90% of the patients in this study sought either government or private 
doctors for cure. This health care utilisation pattern allow for concentration of 
efforts towards 2 main groups; the government clinics and private practitioners. 
Intensification of efforts towards raising awareness and index of suspicions for 
patients with cough is possible with these two groups. This will ensure that in 
addition to performing sputum examinations among patients with cough of more 
than 2 weeks, patients will not be subjected to repeated visits. This can be done by 
ensuring the use of the Practice Guidelines for the Control and Management of 
Tuberculosis issued by the MOH Malaysia by all practising doctors both in the 
government and private sectors. 
b. Health education messages 
The findings of this study could also support the incorporation of new messages in 
the health education materials especially at correcting misconceptions regarding 
cause, transmission and infectivity. Infectivity of TB could be explained in greater 
detail to lessen stigma towards TB patients. For example, it would help if people 
knew that TB could not be transmitted through sharing of utensils and is easily 
treated and became non infectious after a few days of treatment. From this study, 
it is quite clear that patients and the community knew where to get treatment and 
are able to request for sputum examination. These practices should be further 
encouraged. In addition, it is imperative that the public are able to recognise the 
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symptoms of TB and also appreciate the grave consequences of TB, not only to its 
patients, but also to the community at large. 
The appropriate channel for health education messages also need to be identified. 
In a study done in North and Middle Vietnam, the knowledge of TB patients was 
high in terms of causes, infectivity and treatment (average score out of 10,7.07 + 
2.02). There was significant difference between those who were given the health 
education in a face-to-face approach compared to other approach such as the 
distribution of leaflets (p-value <0.001). [13] In the West Malaysia study, the mean 
score for knowledge on TB was much higher among the patients who were given 
health education by their attending doctors compared to those who received them 
from other sources such as friends and media. [94] Currently, there is little 
evidence to suggest that knowledge on TB affects health seeking behaviour and 
time period significantly though this may be difficult to assess. It is perhaps more 
appropriate to conduct such research in the community rather than among TB 
patients who have already sought treatment. 
c. Counselling for TB patients 
The effects of TB on its sufferers were documented in this study. Efforts towards 
providing counselling for TB patients should be intensified. The current good 
relationship between the patient and health care provider could facilitate this 
process. Counselling should also be available after the completion of treatment 
because of the residual `ill--health' felt even after cure as shown by Chamla among 
Chinese patients [98] and among Indian patients by Rajeswari[120]. 
d. Dissemination of research findings 
The findings from the qualitative study have been disseminated to senior health 
staff and those involved in the TB Control Programme in Sabah. These findings and 
those -from the quantitative study should be disseminated to a wider audience 
which should include the patients, community and other health staff. This could be 
done by publishing the results and also incorporating the relevant findings in health 
education materials. 
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Research findings may not always change policy but with the dissemination of 
research findings, through new understanding, greater awareness and insight on 
certain issues may result in attitudinal change among health staff to support 
improvement in service delivery. 
10.2 Future initiatives 
10.2.1 Delay and transmission 
The longer a smear positive PTB patient delay seeking treatment, the higher the 
risk of transmission to close contacts. Earlier works by Riley have shown that delay 
of more than 2 months after onset of symptoms has been shown to spread TB to 
domestic contacts. [30] The median patient time period in this study is 60 days. This 
mean than half of the 272 respondents had potentially spread the disease to 
domestic and work contacts. The numbers of domestic contacts are substantial as 
some household have as many as 21 occupants with an average 6 people per 
household. In addition, for 75% of the respondents, the ratio of occupants to rooms 
in their household was two or more. Although the assessment of transmission within 
domestic contacts using these data is inaccurate, it does present a worrying picture 
and strengthens the need for symptomatic patients to seek treatment early and be 
put on treatment urgently. Contact tracing in Sabah has often been difficult to 
accomplish to a satisfactory level in terms of completeness and yield. In areas 
where resource such as manpower is limited, it may be worthwhile concentrating 
contact tracing effort to those patients with patient delay of more than 60 days. 
10.2.2 Delay and Quality Assurance Programme 
Reducing doctor delay can be used as an indicator for a Quality Assurance 
Programmes (QAP) for TB Control Programme. From this study, only 42.7% of the 
respondents have no doctor delay of 14 days. To increase the number of patients 
with no doctor delay would limit the period of infectiousness of the patient and 
thus the transmission to contacts. For example, the target could be set at a higher 
level of 90% and failure to achieve this would result in investigation as to why the 
patient failed to be put on treatment within 14 days of consulting a doctor. Based 
on the national guideline, a model of good care as required for a QAP can be 
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constructed. One of the reasons for doctor delay may well be the failure to subject 
the patients to sputum examination at the first consultation even when patients 
presented with cough of more than 14 days. Such finding and the rigor of 
investigation may contribute to raised awareness and change in attitude and 
practice. More thoughts should go into this idea and when constructed property 
may not be difficult to implement as the concept of QAP is not new in Malaysia. 
The positive aspects of QAP in other programmes, such as raised awareness on 
detrimental practices and identification of shortfall in quality when applied to TB 
control programme can only be beneficial, 
10.3 Future research 
This study has exposed information about health and health care seeking 
behaviours among certain ethnic groups. This needs to be extended to other ethnic 
groups and also among immigrant populations. Notification rates among immigrant 
population is also high; ranges from 100 to 150 cases per 100 000 populations. [5] 
Studies among immigrants and refugees revealed that politico-economic and social 
factors such as fear of immigration authorities[30], poverty and poorly ventilated 
holding places and subsequent living environment among Chinese immigrant in New 
York[130] resulted in patient delay. Similar social problems such as fear of 
immigration authorities are faced among illegal immigrants in Sabah which would 
affect their health care seeking behaviour. 
This study has uncovered risk factors for patient and doctor delay which were not 
realised before. Future research can be replicated with better control for the 
limitations already mentioned in 9.3 above. In addition, the research could also 
assess the effects of delay among patients and their families and the consequence 
of delay in relation to prolong transmission in the community. 
Research can also be build based on the current findings such as exploring the 
reasons for patient and doctor delay such as why delay occurs when patients chose 
private practitioners as their first choice for treatment and best done using 
qualitative methods. 
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10.4 Conclusion 
This study which utilised both qualitative and quantitative approaches provided a 
comprehensive picture of health and health care seeking behaviour among certain 
population in Sabah and how these factors affected the various time periods in the 
management of TB patients. 
The findings from both studies can be used to improve current practices such as the 
adherence to national guideline on the management of TB, provision of appropriate 
health messages, counselling for TB and creating greater awareness among health 
professionals on the patients and community perspectives of TB. New initiatives 
could also be drawn based on the findings of the study in terms of concentration of 
limited resource in areas where it will produce better results for the TB control 
programme such as in contact tracing and the development of a QAP programme. 
This study also opens up new areas for future research such as reasons for delay 
when consulting private doctors. 
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Study, Author, 
Count 
Ethnic'group Findings 
1 TB beliefs among 51 Vietnamese " TB is an infectious lung 
recent Vietnamese refugees (non TB disease 
refugees in New participants) Risk factor for-TB: 
York State. Carey - Hard manual labour, smoking, 
JW, USA[87] alcohol consumption and poor 
nutrition. 
  Believed that asymptomatic 
latent infection is not possible 
and all infection inevitable 
leads to disease 
  Anticipated that having TB 
would adversely impact their 
work, family, and community 
activities and relationships. 
2 Different TB in Vietnamese,   Has good knowledge of TB as 
men and women: 16 focus group being a dangerous and 
beliefs from focus discussions contagious disease cause by 
groups in Vietnam. (FGD)(TB and non germs. 
Long NH. [88] TB participants) Prevailing traditional beliefs 
mainly among older people in 
the rural areas. Four main types 
of TB: 
(1)'Lao truyen' (hereditary TB), 
handed down from older 
generations through 'family 
blood', regardless of sex 
(2) 'Lao luc' (physical TB), 
caused by hard work in which 
more men are affected 
(3) 'Lao tam' (mental TB), 
caused by too much worrying 
and more women are affected 
(4) 'Lao phoi' (lung TB), 
dangerous, caused by TB germs, 
transmitted through the 
respiratory system and more 
men are affected. 
These traditional beliefs may 
contribute to long delays and 
increased social stigma and 
isolation of TB patients and 
their families. 
3 Sociocultural 217 Ethiopians   Do'not regard tubercle bacilli 
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Study, Author, Ethnic group Findings 
Country, 
aspects of TB (non TB 
control in participants) 
Ethiopia. 
Vecchiato NL. [89] 
to be the cause of TB. Prefer to 
seek ethno-botanical remedies. 
4 Perceptions and Mexicans, 11 Perceived causes of TB: 
practices related group interviews contagion via food utensils, 
with TB and with 67 TB excess work, malnutrition and 
treatment patients cold as welt as other causes 
compliance in unrelated to person-to-person 
Chiapas, Mexico. contagion. 
Alvarez-Gordillo 
GC. [90] 
5 Patients' beliefs: Rural South Strong belief that TB is the 
do they affect TB Africans: result of breaking cultural rules 
control? A study in Individual such as not abstaining from sex 
a rural district of interviews with after the death of a family 
South Africa. TB patients and member and after a 
Edginton ME. [91] FGD with patients spontaneous abortion. As such, 
and community. the remedy can only be 
obtained from traditional 
healers. 
6 Cultural meanings Achehnese TB is represented by a semantic 
of TB in Aceh network of illnesses, partly 
Province, Sumatra transmissible, partly related to 
Caprara A., specific phenomena affecting 
Indonesia[92] the individual, such as 'terbuk' 
(poisoning) or 'trouk' (fatigue 
produced by hard work) and are 
not considered contagious. The 
forms of transmission are 
interpreted mostly through 
empirical and analogical 
categories. TB is attributed to 
four different aspects: (a) 
biomedical such as germ theory; 
(b) socio-economic conditions; 
(c) transgression of social rules 
and (d) poisoning and the 
influences of supernatural 
powers. 
Health-seeking behaviour is 
related to the perceived causes 
of the disease, economic factors 
and the accessibility of health 
services. 
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perceived causes positive Filipinos.   Drying sweat on the back, 
of TB among 
patients in Manila, 
Philippines. Auer 
C. [84] 
smoking, microbe, drinking 
alcohol, dirty environment, 
sleeping on cold floor, fatigue, 
working too hard, frequent 
pneumonia, lack of food, 
poverty, to be near a TB case, 
inherited, many sex partners. 
8 From their own Kenyan tribes, 5 Perception of TB: 
perspective. A FGD (TB and non Dangerous disease that is highly 
Kenyan TB participants) contagious and difficult to cure. 
community's A difficult disease that disrupts 
perception of TB. patients' social life leading to 
Liefooghe social isolation and 
R., Kenya[93] stigmatization of the patients 
and their families. 
9 Attitudes and Malaysians (West Attributed symptoms to: 
knowledge of Malaysia) (135   common cold (22%) 
newly diagnosed patients)   `weak' body (9.1%) 
TB patients   overwork (6.8%) 
regarding the   asthma(3.8%), lung cancer 
disease, and (3%), diabetes mellitus (2.3%), 
factors affecting pneumonia (1.5%), TB (1.5%), 
treatment dengue fever, heart failure 
compliance. Liam   cigarette smoking (3%) 
CK., Malaysia[94]   effect of an abortion 
 a spell put on them by 
someone (1.5%) 
10 Social and cultural Mexicans, Orange Symtoms associated with 
factors in the County, CA " benign conditions gripe 
successful control (grippe) or bronquitis 
of TB. Rubel AJ [3] (bronchitis) 
"a folk illness, susto 
" fatigue and weight loss due to 
hard work and lack of sleep 
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PATIENT,,,,,,,. 
Recognition of " How long have you been sick? 
symptoms " Do you remember the time when you first felt ill 
for this disease? 
" What makes you realise that you were not well? 
" What were the signs and symptoms at that time? 
" What did you think was the cause of your 
symptoms? 
" What disease did you think you have at that time? 
Health seeking " What did you do when you first realised that you 
behaviour were sick? 
/pattern " Who did you talk to about your concerns? 
" Did you follow the advice given? 
" What motivates you to seek such care? 
" What prevented you from seeking such care? 
(barriers) 
" Who decides what you should or should not do? 
Perception of " What did you think cause the illness? 
illness " What do you call this illness in your language? 
" What cause you to get this illness? 
" How does it affect you? 
" What were your reactions when you were told that 
you have TB? 
" What were your concerns then? 
Perception of care " What were your expectations from such care? 
received " Did you receive the expected care? 
" What were the positive things about the care that 
you received? 
" What were the negative things? 
Gender difference " Did you have any problem seeking for care for your 
(for women) illness? 
RELATIVE 
Recognition of " How long have your relative been ill with TB? 
symptoms: " Do you remember the time when he/she first fell ill 
for this disease? 
" What makes him/her realise that he/she was not 
welt? 
" What were the signs and symptoms at that time? 
" What makes you realise that he/she was not well? 
Health seeking " What did you do? Did you follow the advice given? 
behaviour 
/pattern 
Perception' of " What did you think cause the illness? 
illness " What do you call this illness in your language? 
What causes you to get this illness? 
Perception of care " What were your expectations from such care? 
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received " Do you think he/she receive the expected care? 
" What were the positive things about the care that 
he/she received? 
" What were the negative things? 
Effect on patient, " How does this disease affect the patient? 
family/relatives " How does this disease affect you/ the family? 
" What changes have you seen in the patient? 
" What changes have taken place in the family and 
household as a result of the illness? 
HEALTH STAFF, 
Perception of " What do you think cause the illness? 
illness " What do the people here call this illness? 
" What causes people to get this illness? 
Health seeking " What do you think a patient will do when he/she 
behaviour develop this illness? 
/pattern 
Perception of care " Do you think he/she receive the expected care? 
received 
Perception of " Why do you think a patient delay in seeking 
delay treatment? 
TRADITIONAL HEALER 
Frequency and " What is the disease known to the 
perspectives on patient/community? 
the cause of " How frequent do you see such illness? 
illness " What did you think cause the illness? 
" What do you call this illness in your language? 
" What causes one to get this illness? /How can one 
get this illness? 
Treatment " How does one get cure from the disease? 
" How can one protect oneself from getting the 
disease? 
" Can you relate to me how you treat a client of 
yours who had TB? 
-VILLAGE HEADMAN, 
Health and " What health problems commonly affect the 
diseases community? 
" Do you have any TB patients in the community? 
Perception of " What is the disease known to the 
illness patient/community? 
" What did you think cause the illness? 
" What do you call this illness in your language? 
" What causes one to get this illness? / How can one 
get this illness? 
Community " What is often the reaction within the community 
reaction towards someone who is infected with TB? 
" Why is there such a reaction? 
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Appendix 4: PATIENT INFORMATION SHEET (FOR TB PATIENTS) 
[PHASE 1] 
The following section must be read by the research assistants to the 
participants in a language they understand well. 
Principal Investigator: Christina Rundi (Hand Phone number: 019-5839528) 
Co-Investigator: 
Dr. Mohd. Yusof Ibrahim, Deputy Director, Sabah Health Department 
Dr. Punam Mangtani, Senior Lecturer 
Dr. Katherine Fielding, Senior Lecturer 
London School of Hygiene and Tropical Medicine 
TITLE OF RESEARCH: 
Factors prolonging the time from onset of symptoms to start of treatment 
among smear positive TB patients in Sabah, East Malaysia. 
THE NATURE AND PURPOSE OF THE STUDY: 
We are doing a research study on tuberculosis (TB) and would like to invite 
you to take part. This study is supervised by the Sabah Health Department and 
the London School of Hygiene and Tropical Medicine and approved by the 
Ministry of Health. 
STUDY DESCRIPTION 
Tuberculosis is a major health problem in Sabah. The purpose of this study is 
to find out what problems are faced by TB patients concerning their illness 
from the time it started until they are put onto treatment. The results of this 
study will inform the Sabah Health Department and the Ministry of Health on 
how to make the current TB Control programme more effective. 
If you decide to participate in this study, you will be one of 16 participants. It 
will involve an interview that will take place at a private room. Interview will 
be conducted by the principal investigator. The maximum length of time of 
your participation in this study will be about I-1.5 hours in the form of an 
interview and will be tape recorded. The interview will involve asking you to 
explain your experiences from the time you fell ill to the present, also include 
the choices of treatment, why such choices were made, what you thought of 
them and the involvement of other people in the decision making process. 
The interview is semi-structured and there may be questions that we might 
ask you in relation to your answers during the interview. 
If necessary, however, the study may be stopped or you may withdraw from 
the study at any time. If you do not wish to have the interview tape recorded 
please do let us know. We also seek your permission to collect some details 
from your clinical records. 
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RISK OF STUDY PARTICIPATION 
There is no obvious risk to you in participating in this study. However, we 
hope that you will let us know if you feel stressed or emotionally or 
psychologically affected by the interview so that we can stop the interview or, 
if needed, refer you for appropriate help or support. 
VOLUNTARY PARTICIPATION 
Your participation in this study is voluntary and that if you decide not to 
participate, you wilt experience no loss of benefits in terms of medical care. 
If you decide to participate, you may change your mind about being in the 
study and may stop at any time. However, you should inform the interviewer 
of this decision immediately. Such a decision on your part will not influence 
the availability of future medical care. 
CONFIDENTIALITY 
AU information provided by you will only be known to the interviewer and 
principal investigator. Any reference to you in person will be removed and 
your name wilt not appear on the transcripts or final report. 
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FORM C-1 
PATIENT CONSENT FORM 
This form will be read out to the patient, who will then be asked to sign two 
copies. One copy is to be kept by the patient, the other to be filed. 
"t have read, or have been read to me, in language understandable to me, 
the above information. The content and meaning of this information has 
been fully explained to me. 
"I "have had time and opportunity to ask questions that I have about the 
study and this form, and all my questions have been answered. I have read, 
or have been read to me, all the contents of this consent form. I 
voluntarily consent and offer to take part in this study. By signing this 
consent form, I certify that all information I have given, is true and correct 
to the best of my knowledge. 
"I understand that I may withdraw from the study at any time without 
giving any reason. 
"1 also agree that my clinical records may be used to provide clinical and 
laboratory information. 
Printed name of subject: 
IC No.: 
Signature of subject 
Date: 
Thumb print of subject (if applicable): 
Printed name of witness: 
IC No.: 
Signature of witness: 
Date: 
Printed name of person explaining consent: 
IC No.: 
Signature of person explaining consent: 
Date: 
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PATIENT INFORMATION SHEET (FOR TB PATIENTS) 
[PHASE 2] 
The following section must be read by the research assistants to the 
participants in a language they understand well. 
Principal Investigator: Christina Rundi 
Co- Investigator: 
Dr. Mohd. Yusof Ibrahim, Deputy Director, Sabah Health Department 
Dr. Punam Mangtani, Senior Lecturer 
Dr. Katherine Fielding, Senior Lecturer 
London School of Hygiene and Tropical Medicine 
TITLE OF RESEARCH: 
Factors prolonging the time from onset of symptoms to start of treatment 
among smear positive TB patients in Sabah, East Malaysia. 
THE NATURE AND PURPOSE OF THE STUDY: 
We are doing a research study on tuberculosis (TB) and would like to invite 
you to take part. This study is supervised by the Sabah Health Department and 
the London School of Hygiene and Tropical Medicine and approved by the 
Ministry of Health. 
STUDY DESCRIPTION 
Tuberculosis is a major health problem in Sabah. The purpose of this study is 
to find out what problems are faced by TB patients concerning their illness 
from the time it started until they are put into treatment. The results of this 
study will inform the Sabah Health Department and the Ministry of Health of 
how to make the current TB Control programme more effective. 
If you decide to participate in this study, you will be one of 250 participants. 
It will involve a private interview that will take place at a private room. The 
maximum length of time of your participation in this study will be about 1- 
1.5 hours in the form of an interview. The interview will use a questionnaire 
which will involve asking you about the symptoms you had at the beginning of 
your disease, where and how you got treatment, what you thought of them 
and the involvement of other people in the decision making process. If 
necessary, however, the study may be stopped or you may withdraw from the 
study at any time. We also seek your permission to collect some details from 
your clinical records. 
RISK OF STUDY PARTICIPATION 
There is no obvious risk to you in participating in this study. However, we 
hope that you will communicate to us should you feel stressed or emotionally 
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or psychologically affected by the interview so that we will be able to refer 
you for support. 
VOLUNTARY PARTICIPATION 
Your participation in this study is voluntary and that if you decide not to 
participate, you will experience no loss of benefits in terms of medical care. 
If you decide to participate, you may change your mind about being in the 
study and may stop at any time. However, you should inform the interviewer 
of this decision immediately. Such a decision on your part will not influence 
the availability of future medical care. 
CONFIDENTIALITY 
All information provided by you will only be known to the interviewer and 
principal investigator. Any reference to you in person will be removed and 
your name will not appear on the forms but a study number and clinic number 
wilt be assigned to your form. We will store the entire questionnaire in a 
locked filing cabinet. We will also store information in one computer which 
will be protected by a password which is only known by the principal 
investigator. 
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FORM C-2 
PATIENT CONSENT FORM 
This form will be read out to the patient, who will then be asked to sign 2 
copies. One copy is to be kept by the patient, the other to be filed. 
"I have read, or have been read to me, in language understandable to me, 
the above information. The content and meaning of this information has 
been fully explained to me. 
"I have had time and opportunity to ask questions that I have about the 
study and this form, and alt my questions have been answered. I have read, 
or have been read to me, all the contents of this consent form. I 
voluntarily consent and offer to take part in this study. By signing this 
consent form, I certify that all information I have given, is true and correct 
to the best of my knowledge. 
"I understand that I may withdraw from the study at any time without 
giving any reason. 
"I also agree that my clinical records may be used to provide clinical and 
laboratory information. 
Printed name of subject: 
IC No.: 
Signature of subject 
Date: 
Thumb print of subject (if applicable): 
Printed name of witness: 
IC No.: 
Signature of witness: 
Date: 
Printed name of person explaining consent: 
IC No.: 
Signature of person explaining consent: 
Date: 
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PATIENTS 
Sex Age 
(yrs) 
Ethnic Marital 
status 
Occupation 
Patient 1 Female 33 Brunei Married Clerk 
Patient 2 Male 36 Indian Married Own business 
Patient 3 Female 45 Bajau Married Housewife 
Patient 4 Male 56 Chinese Single Unemployed 
Patient 5 Male 57 Kadazan Single Pensioner 
Patient 6 Female 58 Kadazan Married Housewife 
Patient 7 Female 23 Rungus Single Unemployed 
Patient 8 Male 56 Rungus Married Farmer 
Patient 9 Female 57 Bajau Married Housewife 
Patient 10 Male 60 Rungus Married Farmer 
Patient 11 Male 25 Rungus Single Estate worker 
Patient 12 Female 27 Dusun Married Self-employed 
Patient 13 Male 34 Dusun Married Self-employed 
Patient 14 Male 18 Murut Single Unemployed 
Patient 15 Female 66 Dusun Married Housewife 
Patient 16 Male 33 Dusun Single Unemployed 
Patient 17 Mate 44 Dusun Married Farmer 
RELATIVES, SPOUSES, NEIGHBOURS Et OTHER KEY INFORMANTS 
Sex Age 
(yrs) " 
Ethnic Marital 
status 
Occupation 
Non patient 1 Female 45 Rungus Married Housewife 
Non patient 2 Female 46 Rungus Married Housewife 
Non patient 3 Female 55 Rungus Married Traditional healer 
Non patient 4 Mate 65 Bajau Married Farmer 
Non patient 5 Male 56 Bajau Married Self-employed 
Non patient 6 Female 55 Bajau Married Housewife 
Non patient 7 Mate 27 Bajau Married Fisherman 
Non patient 8 Female 45 Rungus Married Housewife 
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Non patient 9 Female 47 Rungus Married Housewife 
Non patient Female 50 Rungus Married Housewife 
10 
Non patient Male 47 Rungus Married Farmer 
11 
Non patient Female 52 Rungus Married Housewife 
12 
Non patient Female 55 Rungus Married Traditional Healer 
13 
Non patient Male 54 Sungai Married Farmer/Village 
14 head 
Non patient Female 46 Murut Married Cleaner 
15 
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Date Place/District *Number Date District/place "Number 
3.12.05 Kota Kinabalu 
(KK) 
Putatan 
1 
1 
23.2.06 Tuaran 4 
5.12.05 Penam ang 2 27.2.06 Kudat 3 
6-7.12.05 Luang, KK 6 2.3.06 Penam ang 4 
8.12.05 Inanarn, KK 5 3.3.06 Inanam, KK 1 
9.12.05 Menggatat, KK 3 Likas, KK 1 
12.12.05 Putatan 1 7.3.06 Menggatal, KK 7 
13.12.05 Papar 5 8-10.3.06 Ranau 9 
14.12.05 Tuaran 6 14.3.06 Luyang, KK 1 
15 -16.12.05 Kota Marudu 6 16.3.06 Inanam, KK 4 
19 - 20.12.05 Keningau 11 20.3.06 Kudat 9 
21.12.05 Penampang 2 21.3.06 Kudat 4 
11.1.06 Penampang 6 Kota Marudu 3 
12 - 13.1.06 Luyang, KK 2 22.3.06 Pitas 5 
16.1.06 Luyang, KK 1 Kota Marudu 4 
Menggatal, KK 1 23-24.3.06 Kota Marudu 8 
17.1.06 Paar 8 29.3.06 Lu an , KK 1 
18.1.06 Beaufort 9 31.3.06 Kota Kinabalu 1 
19-20.1.06 Ranau 5 3-4.4.06 Keningau 13 
23.1.06 Tuaran 7 5.4.06 Sook, Keningau 1 
Kudat 10 6.4.06 Papar 8 
24.1.06 Pitas 2 Beaufort 3 
Kota Marudu 1 7.4.06 Beaufort 2 
25.1.06 Kota Marudu 10.4.06 Men gatal, KK 2 
26 - 27.1.06 Keningau 2 12.4.06 Teli ok, KK 
3 
3.2.06 Luyang, KK 10 Likas, KK 1 
Inanam, KK 2 13.4.06 Tuaran 1 
Penampang 2 17.4.06 Kudat 3 
6.2.06 Teli ok, KK 3 18.4.06 Pitas 2 
Menggatal, KK 3 Kota Marudu 3 
Luyang, KK 5 19.4.06 Luyang, KK 2 
7.2.06 Luyang, KK 5 20.4.06 Luyang, KK 2 
8.2.06 Luyang, KK Ranau 1 
Bukit Padang, KK 1 21.4.06 Keningau 1 
9.2.06 Luyang, KK 3 Luyang, KK I 
13.2.06 Luyang, KK 7 Sook 2 
15.2.06 Papar 2 24.4.06 Inanam, KK 3 
Luyang, KK 1 Tamparuti, 
Tuaran 
1 
16.2.06 Luyang, KK 5 25.4.06 Luyang, KK 1 
20.2.06 Kinarut, Papar 3 Putatan 1 
21.2.06 Luyang, KK 1 26.4.06 Tuaran 4 
22.2.06 Beaufort 4 27.4.06 Luyang, KK 2 
* Number interviewed 
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SABAH HEALTH DEPARTMENT 
STUDY ON TIME PERIOD (2005) 
I. Place of interview 
I TB Chest Clinic 
2 Health Centre 
3 Hospital Ward 
4 Patient's home 
5 Others (specify) 
2. Respondent ID 
3. Interviewer ID 
4. Date of interview 
5. Informed consent for interview signed 
2 Health Centre 
3 Hospital Ward 
4 Patient's home 
5 Others (sr)ecifv) 
2. Respondent ID 
3. Interviewer ID 
4. Date of interview 
F-TI-71 
Day Month Year 
Unknown 
1 es 
No 
efused 
DATA ENTRY INFORMATION 
6. First entry 
6.1 ID of person entering data 
7. Second entry 
7.1 ID of person entering data 
Da v Month Year 
Day Month Year 
II 
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INTRODUCTION 
CONFIDENTIAL - Tear off this page and send to PI 
SOCIO-DEMOGRAPHIC INFORMATION 
1. What is your full name? 
2. Identification number 
3. What is your home address? (give landmark if house has no number) 
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4. How old are you? (in years) 
5. Sex 
1B Male 
2 Female 
6. Ethnic grou 
I2C 
3A 
4E 
7. Type of residence: 
7.1 House 
I Kadazan 
2 Dusun 
3 Murut 
4 Bajau 
1 Village house 
2 Residential area 
3 Squatter area 
4 Estate house (plantation) 
7.2 Insti tution 
9 Psychiatric Institution [Go to Q. 81 
10 Prison [Go to Q. 8] 
11 Rehabilitation centre [Go to Q. 8] 
12 Senior citizen home [Go to Q. 8] 
13 Hostel [Go to Q. 8] 
14 
H 
Others (soecifv) 
7.3 How many bedrooms are there in the house? 
7.4 How many people are staying in the same house? 
8. Location of residence: 
9. Education level: 
I None 
2 Primary 
3 Secondary 
10. Marital status: 
1 Single 
2 Married 
3 Separated 
1 Urban 
2 Rural 
5 Malay 
6 Chinese 
7 Others (specify) 
5 Long house 
6 Shared quarters 
7 Quarters 
8 Others (specify) 
77 
F-I 
4 Form 6/Diploma/Certificate 
5 Degree 
6 Others (specify) 
4 Divorced 
5 Widowed 
9 Refused 
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11.1 Main occupation [respondent] 
1 None 
2 Student 
3 Housewife 
4 Unskilled labour 
5 Skilled labour 
6 Trade/business 
7 Farmer 
8 Fisherman 
9 Retired 
10 Government servant 
11 Professional 
12 Others (specify) 
11.1 Main occupation [Head of household] 
1 None 
2 Student 
3 Housewife 
4 Unskilled labour 
5 Skilled labour 
6 Trade/business 
7 Farmer 
8 Fisherman 
9 Retired 
10 Government servant 
11 Professional 
12 Others (sDecifv) 
12. Income per month [respondent]: 
1 No fixed income 
2< RM 500 
3 RM 500 - RM 999 
13. Income per month [household: 
1 No fixed income 
2< RM 500 
3 RM 500 - RM 999 
14. Do you own any of the following? 
14.1 House 1 Yes 
14.2 Car/boatlother transport 1 Yes 
14.3 Land for farming 1 Yes 
14.4 Animals 1 Yes 
14.5 Television 1 Yes 
14.6 Radio 1 Yes 
4 RM 1000-RM 3000 
5> RM 3000 
9 Refused 
4 RM 1000-RM 3000 
5> RM 3000 
9 Refused 
2 No 9 Refused 
2 No 9 Refused 
2 No 9 Refused 
2 No 9 Refused 
2 No 9 Refused 
2 No 9 Refused 
MEDICAL HISTORY 
15. Before this illness, did you suffer from any conditions that limited your ability to get around? 
[Example: visit friends, get to the clinic, and perform basic activities such as getting water/wood] 
1P Yes 
2 No 
16. Do you have any medical condition as told by a doctor? 
1 Yes [Go to Q. 17] 
2 No [Go to Q. 18] 
3 Don't know [Go to Q. 18] 
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17. If yes, what kind of condition? 
17.1 Diabetes 1 Yes 2 No 3 Don't know 
17.2 Renal failure 1 Yes 2 No 3 Don't know 
17.3 Cancer 1 Yes 2 No 3 Don't know 
17.4 Asthma I Yes 2 No 3 Don't know 
17.5 Chronic Obstructive 1 
pulmonary disease 
Yes 2 No 3 Don't know 
17.6 HIV/AIDS I Yes 2 No 3 Don't know 
17.7 Taking immunosuppressive I 
drugs 
Yes 2 No 3 Don't know 
17.8 Others (specify) 1 Yes 2 No 3 Don't know 
F7 i 
18. History of TB in the family? 
I Yes [Go to Q. 191 
2 No [Go to Q. 20] 
3 Don't know [Go to Q. 20] 
19. When was the most recent episode of TB in your family? 
P Months ago 98 Not sure 
20. What is the nearest private or public health facility from your home? 
21. How do you get to this facility? 
1 Walk 
2 Own car 
3 Own boat 
4 Public carlbus 
5 Public boat 
6 Others (specify) 
22. In general, how long does it take you to reach this facili ? 
0 Unknown 41-2 hrs 
I <15min 5 >2hrs 
2 15 - 29 min 9 Refused 
3 30 - 59 min 
23. What is the nearest hospital from your home? 
24. How do you et to this hospital? 
I Walk 
2 Own car 
3 Own boat 
4 Public car/bus 
5 Public boat 
6 Others (specify) 
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25. In general, how long does it take you to reach this hos itai? 
01 Unknown 4 1- 2 hrs 
1 <15min 5 >2hrs 
2 15 - 29 min 9 Refused 
3 130 - 59 min 
26. Have you ever use the services in the clinic or hospital? 
1P Yes [Go to Q. 27] 
2 No [Go to Q. 28] 
27. How often did you use their services in the past year? F-I 
28. What was the reason you did not use their services during the past year? [You may tick more 
than 1 response] 
1 Not sick 
2 Prefer other form of treatment (private clinic, traditional healer 
3 Not so good experience in the past [Go to Q. 28.1] 
4 Obstacles in getting treatment [Go to Q. 28.2] 
5 Others (sDecifv) 
28.1 Please share your experience. 
28.2 What was the most significant obstacle you face in ettin treatment? 
1 Distance to clinic 4 Too busy 
2 Financial 5 Do not want to leave work/children 
3 Transportation 6 Others (specify) 
29. If you fall ill, where is the first place you seek treatment? 
1 Government clinic 4 Depends on the illness ex lain 
2 Private clinic 
3 Traditional healer 5 Others (specify) 
SYMPTOMS 
30. Tuberculosis can affect people in different ways and over time the symptoms can change. 
People are often treated for other conditions like malaria or typhoid before the correct diagnosis 
of tuberculosis is made. Can you think back to when you first got sick and tell me about the first 
symptoms you noticed (for example: cough, fever, weight loss) -Maximum 3 responses. 
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30.1 Respiratory 
Cough 1 Yes 2 No 
Breathlessness I Yes 2 No 
Chest Pain I Yes 2 No 
Coughing blood I Yes 2 No 
Hoarseness I Yes 2 No 
30.2 Constitutional 
Fever 1 Yes 2 No 
Loss of appetite 1 Yes 2 No 
Loss of weight 1 Yes 2 No 
Insomnia 1 Yes 2 No 
Fatigue/lethargy 1 Yes 2 No 
31. How long ago did you first notice these symptoms? 
Day Month Year 
OR 
Year 
OR 
OR 
Month 
i 
0 Cannot recall 
32. Did you seek help because of these symptoms? 
1R Yes 
2 No [Go to Q. 34] 
32.1 How long after you have decided to seek treatment before you actually went? days 
33. What particular symptoms first led you to seek care outside your home? [Maximum 3 
responses) 
33.1 Respiratory 
1 Cough 4P Coughing blood 
2 Breathlessness 5 Hoarseness 
3 Chest pain 
33.2 Constitutional 
1 Fever 4P Insomnia 
2 Loss of appetite 5 Fatigue/lethargy 
3 Loss of weight 
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34. After you noticed the symptom(s) above, how long did you wait before seeking help? 
Days 
Months 
98 Not sure 
HEALTH CARE UTILISATION 
35. Where did you first go for treatment? 
1 Unknown 4 Private Doctor 
2 Pharmacy 5 Traditional healer 
3 Public/Govt. Doctor 9 Refused 
36. Do you recall the specific or approximate date of this visit? 
Dam Month Year 
OR 
ýý 
Year 
77-1 
OR 
OR 
Month 
Cannot recall 
37. What is the main reason(s) you chose this place? [Maximum 3 responses] 
0 Unknown 5 Suggested by friends, relatives 
9 Refused 6 Always go there 
1 Near to home 7 Referred by health provider 
2 Good reputation 8 Belief in the treatment 
3 Pleasant staff 10 No other choice 
4 Strong medicine 11 Others (specify) 
38. How do ou get to this place? 
I Walk 
2 Own car 
3 Own boat 
4 Public car/bus 
5 Public boat 
6 Others (specify) 
39. How Ion does it take you to reach this place? 
0 Unknown 4 1- 2 hrs 
1 <15min 5 >2hrs 
2 15 - 29 min 9 Refused 
3 30 - 59 min 
40. What health problem did they say you have? 
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41. By what name did they, call it? [specific, summary or short description in patient's words] 
42. Overall did this provider and the staff have a good attitude and treated you with respect? 
1B Yes 9 [I Refused 
2 No 
43. Was there more than I encounter? 
1 C] Yes 2 [i No 
44. Besides the above, where as did you seek treatment? 
0 None 3 Private Doctor 
9 Refused 4 Traditional Healer 
1 Pharmacy 5 Local Herbalist 
2 Public/Govt Doctor 6 Others (specify) 
[NOTE: Q. 45 & 46, to be asked to those who seek treatment other than govt facility] 
45. Why did you it the government health clinic? 
0 Unknown 
9 Refused 
I Referred by other provider 
2 Symptoms worsened 
3 Suggested by friends, relatives 
4 Others (specify) 
46. Do you recall the specific or approximate date of this visit? 
I Month Year 
OR 
I- L_I 
Year 
OR 
OR 
Month 
Cannot recall 
47. How many encounters were at government health facilities before diagnosis of TB was made? 
47.1 Please list the clinic. 
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47.2 Were you referred to the hospital for further investi ation? 
I fl Yes 2 No 
47.3 Where was the diagnosis of TB made? 
47.4 Were you admitted to the ward after diagnosis? 
1 C] Yes 20 No 
EXAMINATION 
48. Were you asked to give sputum sample? 
I Yes [Go to Q. 49.3] 
2 No [Go to Q. 49.1] 
49.1 At which visit was sputum sample requested? 
Visit [Go to 0.49.3] 
None at all [Go to Q. 49.2] 
Can't remember [Go to Q. 49.3] 
49.2 At which clinic was sputum sample requested? 
49.3 How many specimens were you asked to give, in total? 
50. Did you have any problem providing all requested sputum specimen? 
I Yes [Go to Q. 51] 
2 No [Go to Q. 52] 
Can't remember [Go to Q. 52] 
9 Refused [Go to Q. 52] 
51. Please give the reason. 
I Felt better 
2 Felt embarrassed 
3 Forgetfulness 
4 No transport 
5 Long waiting time at the clinics 
6 Could not leave work or 
responsibilities 
7 Concerned about loss of wages 
8 Not concern/indifferent 
10 Financial constraint 
11 Others (soecifv) 
52. How many days did it take you to complete sending all the specimens? Q 
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53. What 
0 
was th e reason for the delay? 
Unknown 
97 Not applicable 
9 Refused 
1 Earliest appointment date 
2 Could not take time off at home 
and/or work 
3 
H 
Family concerns 
4 Physically unable 
5 No transport 
6 Fear of diagnosis 
7 Not concern/indifferent 
8 Financial constraint 
10 11 Others 
54, Did the rovider request that you have a chest x-ray done? 
I Yes [Go to Q. 551 
2 No [Go to Q. 60] 
Can't remember [Go to 0.60] 
9 Refused [Go to Q. 60] 
55. Did you have a chest x-ray done? 
I Yes [Go to Q. 57] 
2 No [Go to Q. 56] 
Can't remember [Go to Q. 60] 
9 Refused [Go to Q. 60] 
56. If No, wh di dn't you have the X-ray? 
0 Unknown 
97 Not applicable 
9 Refused 
I Earliest appointment date 
2 Could not take time off at home 
and/or work 
3 
H 
Family concerns 
4 Physically unable 
5 No transport 
6 Fear of diagnosis 
7 Not concemrndifferent 
8 Financial constraint 
10 Others (specify) 
57. How many days did it take you to get a chest x-ray done from the time it was requested? 
58. What was the reason for the delay? 
0 Unknown 
97 Not applicable 
9 Refused 
1 Earliest appointment date 
H 
2 Could not take time off at home and/or 
work 
3 Family concerns 
4 Physically unable 
5 No transport 
6 Fear of diagnosis 
7 Not concernrndifferent 
8 Financial constraint 
10 11 Others 
59. How many x-rays were done before diagnosis was made? I 
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PATIENT'S KNOWLEDGE AND PERCEPTION OF TB 
60. Have you heard of TB before your illness? 
1 Yes [Go to Q. 60.1] 
2 No [Go to Q. 61] 
9 Refused [Go to Q. 611 
60.1 Please state what you have heard about TB. 
61. What do You think is the cause of TB? 
0 Don't know 
9 Refused 
1 germ 
2 hereditary 
3 poverty 
4 superstitious beliefs 
5 dietary 
6 worry/depression 
7 alcohol 
62. In your o inion, is TB infectious? 
1 Yes 
2 No 
8 Dirty environment 
10 Dust 
11 Contaminated food 
12 Gastric pain 
13 smoking 
14 hard work 
15 fate 
16 cold/wet condition 
17 Others (specify) 
Don't know 
9 Refused 
62.1 How does it spread? 
Don't know 
9 Refused 
I From an infected person 
2 hereditary 
3E Eating together 
4 Talking face to face 
5 Others (specify) 
63. Do you think that with treatment, someone with TB can be completely cured? 
I Yes [please elaborate] 
2 No [please elaborate] 
Don't know 
9 Refused 
64. TB can affect its patient's lives in many ways. How has TB affected your life? 
PHYSICAL 
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FINANCIAL 
EMOTIONAL. 
LIFE PRACTICE 
64.1 In your o inion, is it a disgrace to get TB? 
I Yes [please elaborate] 
2 No [please elaborate] 
Don't know 
9 Refused 
64.2 In your opinion, should a TB patient be isolated from other people? 
1 Yes [please elaborate] 
2 No [please elaborate] 
Don't know 
9 Refused 
64.3. In your o inion, should a TB patient be invited to any social gathering? 
1 Yes [please elaborate) 
2 No [please elaborate] 
Don't know 
9 Refused 
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64.4. In your opinion, can a single person with TB mar 
1 Yes [please elaborate] 
2 No [please elaborate] 
Don't know 
9 Refused 
65.1. If somennR has TR_ helshP avoids taIkinn nhni it it with nthar. narcnns 
1 2 3 4 5 6 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disagree Disagree agree 
65.2. If a young person catches TB, he/she will experience the consequences for the rest of 
his/her life. 
1 2 3 4 5 6 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disagree Disagree agree 
65.3. It is difficult to eam your living after recovering from TB. 
1 2 3 4 5 6 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disagree Disagree agree 
F, 5 d PannIa whn ara traatarM fnr 7R chn ld talk to nthars ahnet it 
1 2 3 4 5 6 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disagree Disagree agree 
65.5. After recovering from TB, everyone treats you in the same way as before. 
123456 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disagree Disagree agree 
66.6. It is a disgrace for the family to have a family member with TB. 
1 2 3 4 5 6 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disc ree Disagree agree 
66.7. Even your best friends sometimes desert you when you have an infectious disease. like TB. 
1 2 3 4 5 6 
Very strongly Strongly Disagree Agree Strongly agree Very strongly 
disagree Disagree agree 
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PERCEPTION OF HEALTH SERVICES 
66. Overall, how convenient or inconvenient was it for you to reach the facility? 
1 Convenient [Go to Q. 68] 
2 Inconvenient [Go to Q. 67) 
91 Refused [Go to Q. 681 
67. What made this process difficult or inconvenient? (Maximum 3 responses) 
0 Don't know 5 Lack of privacy 
9 Refused 6 Staff knowledge 
1 Travel time to health facility 7 Numerous visits 
2 Waiting time 8 Finding out results 
3H Clinic hours 10 Return visit to HCP for follow up 
4 Staff attitude 11 Others (specify) 
68. What was your perception of the health facility before you went there for treatment? 
0 Unknown 3 Moderate 
9 Refused 4 Poor 
1 Excellent 5 Very poor 
2 Good 6 Neutral 
69. What is your perception of. the health facility after you have been diagnosed and started on 
treatment? 
0 Unknown 3 Moderate 
9 Refused 4 Poor 
1 Excellent 5 Very poor 
2 Good 6 Neutral 
70. How would you rate the following? (Scale of 1-5,5 being the highest] 
Staff knowledge on diagnosis 
Staff attitude 
Waiting time for consultation 
Waiting time for sputum examination 
Waiting time for results 
OTHERS 
71. Have you consume alcohol in the past? 
I Yes [Go to Q. 72] 
2 No [Go to Q. 75] 
9 Refused [Go to Q. 75] 
72. Do you still consume alcohol? 
1 Yes [Go to Q. 73] 
2 No [Go to Q. 75] 
9 Refused [Go to Q. 75] 
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73. How often do you consume alcohol? 
9 Refused 
1 Everyday 
2>2 times a week 
3 once a week 
4> once a month 
5 once in several months 
6 once a year 
74. How much do you consume each time? 
9 Refused 
1 About a glass 
2 2- 3 glasses each time 
3? 4 glasses each time 
75, Have you smoke in the past? 
I Yes [Go to Q. 76] 
2 No [Go to Q. 78] 
9 Refused [Go to Q. 781 
76. Do you still smoke? 
I Yes [Go to Q. 77] 
2 No [Go to Q. 78) 
9 Refused [Go to Q. 78] 
77. On average, how many cigarettes do you smoke a day? 
78. Have you ever been involved with drugs? 
T Yes 
2 No 
9 Refused 
Thank you very much for your cooperation. 
DATA ABSTRACTION SHEET 
Respondent ID: 
1. Date of diagnosis 
Day Month Year 
2. Smear results 
Day Month Year 
2.1 First specimen 
ýDay 
Month Year 
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I Positive 
2 Negative 
3 Inconclusive 
4 Not done 
5 Not sent by patient 
6 Result lost 
2.2 Second specimen 
Day Month Year 
I Positive 
2 Negative 
3 Inconclusive 
4 Not done 
5 Not sent by patient 
6 Result lost 
2.3 Third specimen 
Dam Month Year 
II 
Positive 
2 Negative 
3 Inconclusive 
4 Not done 
5 Not sent by patient 
6 Result lost 
2.4 More than 3 specimens taken 
1 Yes 
2 No 
2.5 How many sputum samples were taken and examined? 
3. Other investigations 
3.1 Chest x-ray 
F Month Year 
1P Yes 
2 No 
3.1.1 How many times was chest x-ray performed? 
TJ 
3.2 Sputum culture 
IP Yes [Go to 3.2.1] 
2 No [Go to 4] 
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3.2.1 Date sent: 
Year Day Month 
3.2.2 Date of result: 
Dam Month Year 
3.2.3 Result: 
4. Treatment initiation date 
Day Month Year 
ýý 
5. Height: (cm) 
6. Weight: (kg) L 
Abstracted by: 
Date: 
Year D Month 
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Appendix 8: Results of univariate analysis for patient delay of more than 
90 days. 
a. Univariate analysis of socio-demographic and social history factors 
(distal determinants) and patient delay of more than 90 days (n=272) 
No : i; ' , 
Confidence '° x_ 
. , ýi,. ý'vf`. 
1ýF': ýý. ý"iý^. -- Ä, '; ' cot dela. 
1-V 
delaV, '- : interval° value , e /r Jý 
C 
(Cl) (" 
4`i, r 
Urban 59 (21.7) 50 9 (15.2) 1 
Rural 213 (78.3) 158 55 (25.8) 1.93 0.89-4.21 0.09 
Sex 
Male 172 (63.9) 133 39 (22.7) 1 
Female 100 (36.1) 75 25 (25) 1.13 0.64-2.02 0.66 
Age group (years) 
18 - 29 82 (30.1) 67 15 (18.3) 1 
30 - 39 51 (18.8) 36 15 (29.4) 1.86 0.82-4.24 
40 - 49 55 (20.2) 45 10 (18.2) 0.99 0.41 - 2.40 
50 - 59 38 (14) 24 14 (36.8) 2.60 1.10-6.19 
60 - 88 46 (16.9) 36 10 (21.7) 1.24 0.51 - 3.04 0.16 
Race 
KDM 128 (47.1) 96 32 (25) 1 
Bajau 48 (17.6) 40 8 (16.7) 0.6 0.25-1.41 
Other indigenous 73 (26.8) 56 17 (23.3) 0.91 0.46-1.79 
Chinese 14 (5.2) 10 4 (28.6) 1.2 0.35-4.09 
Others 9 (3.3) 6 3 (33.3) 1.5 0.35 - 6.35 0.71 
Marital status 
Single 62 (22.8) 46 16 (25.8) 1 
Married 186 (68.4) 146 40 (21.5) 0.79 0.40-1.53 
Others 24 (8.8) 16 8 (33.3) 1.44 0.52-3.99 0.41 
Education 
(amiss-l ) 
None 56 (20.7) 41 15 (26.8) 1 
Primary 96 (35.4) 75 21 (21.9) 0.76 0.36-1.64 
Secondary 99 (36.5) 75 24 (24.2) 0.87 0.41 - 1.85 
Tertiary Et above 20 (7.4) 16 4 (20) 0.68 0,20-2.37 0.89 
Household 
income (amiss=8) 
No fixed income 17 (6.4) 12 5 (29.4) 1 
< USD 132 73 (27.7) 55 18 (24.7) 0.78 0.24-2.53 
USD 132 - 263 82 (31.1) 66 16 (19.5) 
0.58 0.18-1.89 
> USD 263 92 (34.8) 70 22 (23.9) 0.75 0.24-2.38 0.77 
Own house 
No 98 (36) 79 19 (19.4) 1 
Yes 174 (64) 129 45 (25.9) 1.45 0.79-2.66 0.22 
Own transport 
No 179 (65.8) 138 41 (22.9) 1 
Yes 93 (34.2) 70 23 (24.7) 1.11 0.62- 1.99 0.74 
Own 
Ldnd(nmiss=l 
No 131 (48.3) 98 33 (25.2) 1 
Yes 140 (51.7) 110 30 (21.4) 0.81 0.46-1.42 0.46 
Livestock 
No 175 (64.3) 139 36 (20.6) 1 
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No"' EP entý',: t ORtonfidence 
:( col, delay deläji `. ý. ", ` °; ,? tervatY value* 
k 9'' ý'n 'i ; z5.. ß^, ?M^, 
" 
"»s f 'w, ý+: at" `-. S'" .. r, r" Y'. '. P,. 
`.. Yt'i: ":. 
(r07ý'%) 
. `fi'r ý, ý'`' _ 
l(CI 
F:. t : 
'. 
4ýý r; r ý. 4' 
Yes 97 (35.7) 69 28 (28.9) 1.57 0.88-2.78 0.12 
TV/radio(nmiss=4) 
No 41 (15.3) 31 10 (24.4) 1 
Yes 227 (84.7) 173 54 (23.8) 0.97 0.44-2.10 0.93 
Type of house 
`Village' 215 (79) 158 57 (26.5) 1 
Residential 29 (10.7) 27 2 (6.9) 0.20 0.05-0.89 
Others 28 (10.3) 23 5 (17.9) 0.60 0.22 - 1.66 0.03 
Alcohol intake 
(nmiss=1) 
Never 98 (36.2) 80 18 (18.4) 1 
Past intake 140 (51.7) 102 38 (27.1) 1.65 0.88-3.12 
Current 33 (12.2) 25 8 (24.2) 1.42 0.55-3.66 0.28 
History of 
smoking (nm, ss=1) Never 114 (42.1) 91 23 (20.2) 1 
Ex-smoker 121 (44.6) 90 31 (25.6) 1.36 0.74-2.51 
Current 36 (13.3) 26 10 (27.8) 1.52 0.64-3.60 0.50 
n- L-e- _.. _t 
drug abuse 
(nmiss-l) 
No 254 (93.7) 195 59 (23.2) 1 
Yes 17 (6.3) 12 5 (29.4) 1.38 0.46-4.08 0.56 
* p"value from likelihood ratio test 
b. Univariate analysis of medical and family history factors (intermediate 
determinants) and patient delay of more than 90 days 
lity problem 
No 184 (67.7) 148 36 (19.6) 1 
Yes 88 (32.3) 60 28 (31.8) 1.92 1.07-3.44 0.03 
Family history of TB 
(Amiss-l ) 
No 132 (48.7) 100 32 (24.2) 1 
Yes 139 (51.3) 107 32 (23.0) 0.93 0.53-1.64 0.81 
* p-value from likelihood ratio test 
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No 239 (87.9) 182 57 (23.9) 1 
Yes 33 (12.1) 26 7 (21.2) 0.86 0.35-2.09 0.74 
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c. Univariate analysis of health care utilisation factors and patient delay of 
more than 90 days 
Covariate' col %) No &`, Patient i. -~ OR Confidence. ` 'ry w 
 del V interval value - , i_^, _ ýih: ý,,: ate; .ý., "týr ., 'a'S-F ,ý ear 7,; 3. s ýaý. 
y 
'ssý',... +;, r. ýas 
Ever use 
government health 
facility 
No 42 (15.4) 31 11 (26.2) 1.18 0.56-2.52 
Yes 230 (84.6) 177 53 (23.0) 1 0.66 
Number of times 
used over past year 
(nmiss=3) 
Never use 42 (15.6) 31 11 (26.2) 1 
None 49(18.2) 38 11 (22.5) 0.82 0.31 - 2.13 
1-2 times 65 (24.2) 54 11 (16.9) 0.57 0.22-1.48 
3 or more 113 (42) 82 31 (27.4) 1.06 0.48 - 2.38 0.42 
Travelling time to 
the nearest clinic 
(nmiss=2) 
< 15 min 144 (53.3) 114 30 (20.8) 1 
15 - 29 min 89 (33) 
66 23 (25.8) 1.32 0.71 - 2.47 
> 30 min 37 (13.7) 
27 10 (27) 1.41 0.61 -3.23 0.58 
Transport to the 
nearest clinic 
Public transport 123 (45.2) 87 36 (29.3) 1 
Own transport 101 (37.1) 82 19 (18.8) 0.56 0.30 - 1.05 
Walk 48 (17.7) 39 9 (18.8) 0.56 0.24 - 1.27 0.05 
Travelling time to 
the nearest hospital 
(nmiss=l) 
< 15 min 49 (18.1) 39 
10 (20.4) 1 
15 - 29 min 
98 (36.2) 72 26 (26.5) 1.41 0.62-3.22 
> 30 min 124 (45.7) 
96 28 (22.6) 1.14 0.50-2.56 0.67 
Transport to the 
nearest hospital 
Public transport 164 (60.3) 122 42 (25.6) 
Own transport 102 (37.5) 80 22(21.6) 
Walk 6 (2.2) 6 0 
Usual first place for 
treatment (nmiss=l ) 
Gov facility 198 (73.1) 156 42 (21.2) 1 
Others 73 (26.9) 51 22 (30.1) 1.60 0.87-2.94 0.12 
Treatment choice 
(for current illness) 
Gov clinic 200 (73.5) 153 47 (23.5) 1 
Others 72 (26.5) 55 17(23.6) 0.98 1.0 0.53-1.90 
Travelling time to 
treatment choice 
< 15 min 96 (35.3) 78 18 (18.8) 1 
15 - 29 min 95 (34.9) 71 24 (25.3) 1.46 
0.73-2.92 
> 30 min 81 (29.8) 59 22 (27.2) 1.62 0.79-3.28 
0.36 
Transport to 
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Patient.: '; OR Confidence, : . ý, to 
value , 
delays:,, r;.;.., ; in rva 
treatment choice 
Public transport 134 (49.3) 94 40 (29.8) 1 
Own transport 112 (41.2) 92 20 (17.9) 0.51 0.28-0.94 
Walk 26 (9.5) 
- 
22 4(15.4) 0.43 0.14-1.32 0.05 
* p-value from likelihood ratio test 
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Appendix 9: Results of univariate analysis for doctor delay of more than 60 
days 
a. Univariate analysis of socio-demographic and social history factors 
(distal determinants) and doctor delay of more than 60 days (n=260) 
°` , 
Covariate < "H °: °: ýý. n (col %). z: ` "ýý No ýý"' ` ; Doctor-ý= _ 
OR ýý ý ý, Confidence . ry° ,F p-ý 
Y. 
`_,, 
., ý°; ý; ý 
'ý;. h'delay"ý°ý' Fdelayý zý. ý ý : interval(CI);, *'value `! ý .. YF. :. jýti "'wiýý`: ýiý+ - -'^'j'", i, F r'nT . `. I%4. -, SLt"' ,,, -}`ýiA. 'ý'> -ýr: 
r', 
`` 
. Y. yyd .:. ýt. ' 
4,1'""Y.. 
ß 
; t: 
Y, 7! - w, f W3ý iti. 
ý. j, ýý 
ý`I ý,. . 
ii" . 
ý, ', i X`e. xýý,.. 
f_` .,., , ,... ý:,, ý<...... 
ý., t:.,.. _ ..,,.. _ý. °. ý, ýý . ý, ,' (row. %)__ .., . _. ý,,, .. 4.... 
`s.. ý 
Location 
Urban 60 () 44 16 (26.7) 1 
Rural 200() 153 47 (23.5) 0.84 0.44-1.64 0.62 
Sex 
Mate 166 (63.9) 125 41 (24.7) 1 
Female 94 (36.1) 72 22 (23.4) 0.93 0.51 - 1.69 0.82 
Age group (years) 
18 - 29 77 (29.6) 57 20(26) 1 
30 - 39 50 (19.2) 37 13 (26) 1.00 0.44-2.25 
40 - 49 54 (20.8) 41 13 (24.1) 0.90 0.40-2.02 
50 - 59 37 (14.2) 28 9 (24.3) 0.92 0.37-2.27 
60 - 88 42 (16.2) 34 8 (19.1) 0.67 0.27-1.69 
0.93 
Race 
KDM 122 (46.9) 89 33 (27.1) 1 
Bajau 46 (17.7) 35 11 (23.9) 0.85 0.39 - 1.86 
Other indigenous 69 (26.5) 53 16 (23.2) 0.81 0.41 -1.62 
Chinese 14 (5.4) 13 1 (7.1) 0.21 0.03 - 1.65 
Others 9 (3.5) 7 2 (22.2) 0.77 0.15-3.90 0.49 
Marital status 
Single 60 (23.1) 43 17 (28.3) 1 
Married 181 (69.6) 139 42 (23.2) 0.76 0.39-1.48 
Others 19 (7.3) 15 4 (21.1) 0.67 0.19-2.33 0.69 
Education 
(nmtss=1) 
None 52 (20.1) 43 9(17.3) 1 
Primary 90 (34.8) 65 25 (27.8) 1.84 0.78-4.31 
Secondary 99 (38.2) 74 25 (25.3) 1.61 0.69-3.77 
Tertiary Et above 18 (6.9) 14 4 (22.2) 1.37, 0.36-5.13 0.54 
Household 
income (n, 5=7) No fixed income 15 (5.9) 9 6 (40) 1 
< USD 132 71 (28.1) 56 15 (21.1) 0.40 0.12-1.31 
USD 132 - 263 77 (30.4) 53 24 (31.2) 
0.68 0.22-2.12 
> USD 263 90(35.6) 73 17 (18.9) 0.35 0.11-1-11 0.13 
No 167 (64.1) 126 41 (24.5) 1 
Yes 93 (35.8) 71 22 (23.7) 0.95 0.54-1.72 0.87 
Own transport 
No 91 (35) 66 25 (27.5) 1 
Yes 169 (65) 131 38 (22.5) 1.30 0.73-2.34 0.37 
Own Land(n,, ss=1) 
No 133 (51.3) 102 31 (23.3) 1 
Yes 126 (48.7) 94 32 (25.4) 0.89 0.50-1.57 0.69 
Livestock 
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Cavariate n (col %) , 
; Doctor OR ": ý"° ,, '. Confidence, }, `p. -` ill"4 : 
delay ;. ksr,; Bela ws 
interval CI value, 
No 90 (34.6) 66 24 (26.7) 1 
Yes 170 (65.4) 131 39 (22.9) 1.22 0.68-2.20 0.50 
TV/radio(nm; ss=4) No 219 (85.5) 164 55 (25.1) 1 
Yes 37 (14.4) 30 7 (18.9) 1.44 0.60-3.46 0.40 
Type of house 
`Village' 204 (78.4) 87 117 (57.3) 1 
Residential 28 (10.8) 10 18 (64.3) 1.3 0.54-3.14 
Others 28 (10.8) 14 14 (50) 1.08 0.43-2.70 0.84 
Alcohol intake 
(nmiss=l) 
Never 93 (35.8) 45 48 (51.6) 1 
Past intake 133 (51.1) 51 82 (61.6) 1.34 0.71 - 2.53 
Current 34 (13.1) 15 19 (55.9) 1.62 0.66-3.96 0.50 
History of 
smoking (nm; ss=1) Never 109 (41.9) 46 63 (57.8) 1 
Ex-smoker 116 (44.6) 50 66 (56.9) 1.06 0.58-1.96 
Current 35 (13.5) 15 20 (57.1) 0.94 0.38-2.33 0.96 
Drug misuse 
No 243 (93.5) 186 57 (23.5) 1 
Yes 17 (6.5) 11 6 (35.3) 
- 
1.78 0.63-5.05 0.27 
* p-value from likelihood ratio test 
b. Univariate analysis of medical and family history (intermediate 
determinants) and doctor delay of more than 60 days 
Covariate . .`rn, 
No Doctor,, -, = OR : r. ' ° Confidence. ' p-value* r 
ý. 'deläjrý 
, 'i 'ýt. 
't, rvý5 "t`P'2ý :, týý . Y. , ht`_ýýüýYý'ý'iý, _'r' 
Yýq.. 
'( 1 .: ý°r . "F: ýL ý'ýýý, !, b:. 
Problem with 
mobility 
No 228 (87.7) 172 56 (24.6) 1 
Yes 32 (12.3) 25 7 (21.9) 0.86 0.35-2.10 0.74 
Co-morbidity 
No 175 (67.3) 135 40 (22.9) 1 
Yes 85( 32.7) 62 23 (27.1) 1.25 0.69-2.27 0.46 
Family history of 
TB (tlmiss=l) 
No 126 (48.7) 95 31 (24.6) 1 
Yes 133 (51.3) 101 32 (24.1) 0.97 0.55-1.72 0.92 
o-value from likelihood ratio test 
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c. Univariate analysis of symptoms (proximal determinants) and doctor 
delay of more than 60 days 
Covariate =- ntE., <,.:..,.. No Doctor 0R;, Confidence` 
'`ý w. 'v 
ýý'r^ý * 
... 
ý'y ý:: , ', Mý. ý. 
ýýs: 
i. ýM1ý "X :" r"..: '+k... r 
ý, aý t- ; "kam` ;, 7ý- r"r:,. 'ýý' 
' 
'` 
(col %) de(ay, delay interval; value* .f 
.., 
: mss ii. =. ý"ýý'"':: ds " ý'i,, 'F . t': 
"F 4:: 
ßi , gtý.. s;, c'. , 
ý': <:: 
C:; 
^. ý, c. ^. 
ý, 
ý ",. d'`.,; r,., .. r' 
ß...... i. 
No 21 (8.1) 16 5(23.8) 1 
Yes 239 (91.9) 181 58 (24.3) 1.03 0.36-2.93 0.96 
Chest pain 
No 123 (47.3) 100 23 (18.7) 1 
Yes 137 (52.7) 97 40 (29.2) 1.79 0.99-3.23 0.05 
Shortness of 
breath 
No 96 (36.9) 82 14 (14.6) 1 
Yes 164 (63.1) 115 49 (29.9) 2.49 1.28-4.87 0.006 
Hemoptysis 
No 132 (50.8) 102 30 (22.7) 1 
Yes 128 (49.2) 95 33 (25.8) 1.18 0.67-2.09 0.57 
Loss of appetite 
No 76 (29.2) 57 19 (25) 1 
Yes 184 (70.8) 140 44 (23.9) 0.94 0.51 - 1.75 0.85 
Loss of weight 
No 36 (13.8) 31 5 (13.9) 1 
Yes 224 (86.2) 166 58 (25.9) 2.17 0.80-5.87 0.12 
Insomnia 
No 88 (33.8) 65 23 (26.1) 1 
Yes 172 (66.2) 132 40 (23.3) 0.86 0.47 - 1.55 0.61 
Fever 
No 59 (22.7) 52 7(11.9) 1 
Yes 201 (77.3) 145 56 (27.9) 2.87 1.21 - 6.78 0.01 
Lethargy 
No 50 (19.2) 43 7(14) 1 
Yes 210 (80.8) 154 56 (26.7) 2.23 0.94-5.29 0.06 
from likelihood ratio test 
d. Univariate analysis of health care utilisation (intermediate determinants) 
and doctor delay of more than 60 days 
}:. t Covariate 
,, '. ; : 'd x cot %= Belav' y "' Delä 
Vý ,;;,,. ,.. e ;r': interval ,'b 
value* ýiC" ý, ýýý1Tn f: C, "ýý'ý 
)t 
vV. Jýýý1.. ýnv:. i /.:.. 
_"yn. '-. -Sýýfl-°k'ý"ýý. ý ''fir, 
i 
4`ý 'ý' _fgv.  -- týtS. -(i 
{ývý'ýý: r 
' 'li ^~! 
^ft ýý 
`. 
ýýhvr ^.. iMýe <. 
'ý. 
3t` 
... -.. 
°iY^ýH.. 
"Mýi 
. 
=1! -"y'"}. 
ý 
ýýH-0''Yý+^'kt. ýr jrvw. J) aý: '; c.. l. r iý(Cý, 'Y NM\. ýý 
Ever use 
government 
health facility 
Yes 
No 
220 (84.6) 
40 (15.4) 
172 
25 
48 (21.8) 
15 (37.5) 
1 
2.15 1.05-4.40 0.04 
Number of times 
used over past 
year (nm; ss=3) Never use 40 (15.6) 25 15 (37.5) 1 
None 50 (19.5) 40 10(20) 0.42 0.16-1.07 
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(col 'cleläV Deläv' interva1 ' A/ " J JP e. "' . ý1 
4 
`" 
` r ;. value*. ... r x } A` d. f 
,t *y'r 
, ýr'. 
`r` ý"' 
'r ýfýSi Y. 
ý'y. 
v 
"t#. 
.I 
"S" 
l. {: 
Ali, :vA (row. %) 
..: Rh , 'u 'rte. }_ -t 
S 
_ 
"'x 
(Cl) 
1-2 times 61 (23.7) 53 8 (13.1) 0.25 0.09-0.67 
3 or more 106 (41.2) 77 29 (27.4) 0.63 0.29 - 1.35 0.03 
Travel time to 
the nearest 
clinic (nmiss=2) 
15 min 140 (54.3) 102 38 (27.1) 1 
15 - 29 min 83 (32.2) 65 18 (21.7) 0.74 0.39-1.41 
> 30 min 35 (13.6) 29 6(17.1) 0.55 0.21 -1.44 0.37 
Transport to the 
nearest clinic 
Public transport 116 (44.6) 91 25 (21.5) 1 
Own transport 96 (36.9) 69 27 (28.1) 1.42 0.76-2.67 
Walk 48 (18.5) 37 11 (22.9) 1.08 0.48-2.42 0.53 
Travel time to 
the nearest 
hospital (nmiss=l) 
15 min 46 (17.8) 38 8 (17.4) 1 
15 - 29 min 94 (36.3) 71 23 (24.5) 1.54 0.63-3.77 
> 30 min 119 (45.9) 87 32 (26.9) 1.75 0.74-4.14 0.42 
Transport to the 
nearest hospital 
Public transport 157 (60.4) 119 38 (24.2) 
Own transport 97 (37.3) 72 25 (25.8) 
Walk 6 (2.3) 6 0 
Usual first 
choice of 
treatment 
(nmiss=1) 
Gov clinic 189 (73) 146 43 (22.7) 1 
Others 70 (27) 50 20 (28.6) 1.36 0.73-2.52 0.33 
Treatment 
choice for 
current illness 
(TB) 
Gov clinic 189 (72.7) 149 40 (21.2) 1 
Others 71 (27.3) 48 23 (32.4) 1.78 0.97-3.28 0.06 
Travel time to 
treatment 
choice 
< 15 min 94 (36.2) 71 23 (24.5) 1 
15 - 29 min 88 (33.8) 
65 23 (26.1) 1.09 0.56-2.13 
> 30 min 78(30) 61 17 (21.8) 0.86 0.42-1.76 0.80 
Transport to the 
treatment 
choice 
Public transport 128 (49.2) 97 31 (24.2) 1 
Own transport 107 (41.1) 82 25 (23.4) 0.95 0.52-1.74 
Walk 25 (9.6) 18 7(28) 1.22 0.46 - 3.18 0.89 
* p-value from likelihood ratio test 
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f. Univariate analysis of health provider factors (proximal determinants) 
and doctor delay of more than 60 days 
Covariate; n `. F No, Doctor' : JOR Confidence , p=ý>", C, tr a.. "a,, _f ýr. iy.. " 'it< ýd ': l':. =i; '`J>ý - . 
i: 
Lyv 
`. 
ýyý. , y. i"; 
+, 
ý`ý*",... ' *ý. 
cot ,:: 
de la 'äe1ä ;. _ 
'; 
r . interval 
value 
row 
IV1 
Sputum exam at 
1s, visit 
Yes 181 (69.6) 146 35 (19.3) 1 
No 79 (30.4) 51 28 (35.4) 2.75 0.24-0.79 0.005 
No 
Yes 
169 (65) 
91 (35) 
144 
53 
25 (14.8) 
38 (41.8) 
1 
4.13 2.21 - 7.71 <0.001 
Referral made 
No 233 (89.6) 176 57 (24.5) 1 
Yes 27 (10.4) 21 6 (22.2) 0.88 0.34-2.30 0.80 
Hospitalised 
No 200 (76.9) 153 47 (23.5) 1 
Yes 60 (23.1) 44 16 (26.7) 1.18 0.61 - 2.29 0.62 
rom likelihood ratio test 
ýý*ý ýý 
ti o ,' 
